,SYMBOL,COMPANY NAME,SUBJECT,DETAILS,BROADCAST DATE/TIME,RECEIPT,DISSEMINATION,DIFFERENCE,ATTACHMENT,Date,Open,High,Low,Close,Adj Close,Volume,Dividends,Stock Splits,Next_Date,Sentiment
0,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'intimation under regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015   regulatory order'.",12-Feb-2024 19:46:38,2024-02-12 19:46:38,12-Feb-2024 19:46:43,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_12022024194638_SEIntimationforgst.pdf,12-02-2024,1539.8499755859375,1555.0999755859375,1521.0999755859375,1534.449951171875,1534.449951171875,4059288,0.0,0.0,19-02-2024,0
1,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 12, 2024, titled ""press release - inclusion of sun pharma in the s&p global sustainability yearbook 2024"".",12-Feb-2024 10:16:44,2024-02-12 10:16:44,12-Feb-2024 10:16:50,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_12022024101644_IntimationSE20240212_SunPharma_SandP_Sustainability_Yearbook_Signed.pdf,12-02-2024,1539.8499755859375,1555.0999755859375,1521.0999755859375,1534.449951171875,1534.449951171875,4059288,0.0,0.0,19-02-2024,0
2,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'intimation under regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015   incorporation of a subsidiary company'.",06-Feb-2024 19:40:52,2024-02-06 19:40:52,06-Feb-2024 19:40:59,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06022024194052_SEIntimationforsetupanewcompany.pdf,06-02-2024,1450.0,1478.0,1446.550048828125,1475.0999755859375,1466.7388916015625,1893995,0.0,0.0,13-02-2024,0
3,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'intimation under regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015   incorporation of a subsidiary company'.",05-Feb-2024 21:40:20,2024-02-05 21:40:20,05-Feb-2024 21:40:25,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_05022024214020_SEIntimationTaroPharmaCorporation.pdf,05-02-2024,1426.800048828125,1466.0,1423.5999755859375,1463.800048828125,1455.5030517578125,3481964,0.0,0.0,12-02-2024,0
4,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 31, 2024, titled ""sun pharma reports q3fy24 results"".",31-Jan-2024 14:22:08,2024-01-31 14:22:08,31-Jan-2024 14:22:14,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31012024142208_IntimationSE20240131_Q3FY24_Financial_Press_Release_Signed.pdf,31-01-2024,1371.699951171875,1438.9000244140625,1366.9000244140625,1418.449951171875,1410.409912109375,5796356,0.0,0.0,07-02-2024,1
5,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that board of directors at its meeting held on january 31, 2024, declared interim dividend of rs. 8.5 per equity share.",31-Jan-2024 14:20:49,2024-01-31 14:20:49,31-Jan-2024 14:20:55,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31012024142049_BMOutcomeQ3.pdf,31-01-2024,1371.699951171875,1438.9000244140625,1366.9000244140625,1418.449951171875,1410.409912109375,5796356,0.0,0.0,07-02-2024,1
6,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended december 31, 2023.",31-Jan-2024 14:13:24,2024-01-31 14:13:24,31-Jan-2024 14:13:31,00:00:07,https://nsearchives.nseindia.com/corporate/BMOutcomeQ3_31012024141324.pdf,31-01-2024,1371.699951171875,1438.9000244140625,1366.9000244140625,1418.449951171875,1410.409912109375,5796356,0.0,0.0,07-02-2024,1
7,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 17, 2024, titled ""bayer and sun pharma sign marketing and distribution agreement for second brand of finerenone in india "".",17-Jan-2024 13:21:02,2024-01-17 13:21:02,17-Jan-2024 13:21:09,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_17012024132102_SEIntimationforpressrelease.pdf,17-01-2024,1312.0,1320.449951171875,1294.3499755859375,1299.0,1291.6370849609375,2544642,0.0,0.0,25-01-2024,1
8,SUNPHARMA,Sun Pharmaceutical Industries Limited,board meeting intimation, about board meeting to be held on 31-jan-2024 to consider and approve the quarterly unaudited financial results of the company for the period ended december 2023 and dividend.,15-Jan-2024 15:34:23,2024-01-15 15:34:23,15-Jan-2024 15:34:30,00:00:07,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_15012024153423_PRIOR_INTIMATION_16353_1021033_15012024033423_WEB.xml,15-01-2024,1329.199951171875,1340.0,1321.5999755859375,1329.3499755859375,1321.8150634765625,1475983,0.0,0.0,23-01-2024,0
9,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'intimation under regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015'.",11-Jan-2024 12:24:30,2024-01-11 12:24:30,11-Jan-2024 12:24:34,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_11012024122430_SEIntimationforgst.pdf,11-01-2024,1328.0,1331.9000244140625,1310.199951171875,1316.25,1308.789306640625,1320281,0.0,0.0,18-01-2024,0
10,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'intimation under regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015'.",03-Jan-2024 19:58:06,2024-01-03 19:58:06,03-Jan-2024 19:58:13,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_03012024195806_SEIntimationforgst.pdf,03-01-2024,1296.199951171875,1304.6500244140625,1291.1500244140625,1298.5999755859375,1291.2392578125,1699057,0.0,0.0,10-01-2024,0
11,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",27-Dec-2023 15:11:55,2023-12-27 15:11:55,27-Dec-2023 15:12:04,00:00:09,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27122023151155_SEintimationforCTW.pdf,27-12-2023,1250.0,1255.4000244140625,1241.25,1252.449951171875,1245.350830078125,2005268,0.0,0.0,03-01-2024,0
12,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'inclusion of specialty product ilumetri, (tildrakizumab injection) in category b of china s national reimbursement drug list'.",13-Dec-2023 13:00:22,2023-12-13 13:00:22,13-Dec-2023 13:00:27,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_13122023130022_SEIntimation.pdf,13-12-2023,1218.300048828125,1239.5999755859375,1212.6500244140625,1233.0999755859375,1226.110595703125,2448178,0.0,0.0,20-12-2023,0
13,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'update on non-binding indication of interest to acquire shares of taro pharmaceutical industries ltd.'.,12-Dec-2023 03:19:15,2023-12-12 03:19:15,12-Dec-2023 03:19:19,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_12122023031915_SEIntimationforupdateonacquisition.pdf,12-12-2023,1249.0,1250.0,1212.6500244140625,1218.0,1211.09619140625,2832873,0.0,0.0,19-12-2023,0
14,SUNPHARMA,Sun Pharmaceutical Industries Limited,change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent, about change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent,07-Dec-2023 21:12:50,2023-12-07 21:12:50,07-Dec-2023 21:12:57,00:00:07,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_07122023211250_CIM_15033_994747_07122023091249_WEB.xml,07-12-2023,1231.0,1241.9000244140625,1228.9000244140625,1239.300048828125,1232.2755126953125,1478355,0.0,0.0,14-12-2023,0
15,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 01, 2023, titled ""sun pharma reports q2fy24 results"".",01-Nov-2023 13:33:55,2023-11-01 13:33:55,01-Nov-2023 13:34:03,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01112023133355_IntimationSE20231101_Q2FY24_Financial_Results_Signed.pdf,01-11-2023,1092.0,1132.550048828125,1082.5999755859375,1116.199951171875,1109.8731689453125,3973264,0.0,0.0,08-11-2023,1
16,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended september 30, 2023.",01-Nov-2023 13:22:45,2023-11-01 13:22:45,01-Nov-2023 13:22:52,00:00:07,https://nsearchives.nseindia.com/corporate/OutcomeFinalSigned_01112023132245.pdf,01-11-2023,1092.0,1132.550048828125,1082.5999755859375,1116.199951171875,1109.8731689453125,3973264,0.0,0.0,08-11-2023,1
17,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 30, 2023, titled ""sun pharma and zydus sign licensing agreement for co-marketing of desidustat, a critical treatment for chronic kidney disease patients in india"".",30-Oct-2023 11:01:16,2023-10-30 11:01:16,30-Oct-2023 11:02:07,00:00:51,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30102023110116_IntimationSigned.pdf,30-10-2023,1115.699951171875,1119.949951171875,1103.8499755859375,1115.199951171875,1108.8787841796875,1078813,0.0,0.0,06-11-2023,0
18,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 16, 2023, titled ""nidlegy  phase iii pivotal trial meets the study s primary objective demonstrating statistically significant and clinically meaningful improvement in recurrence-free survival for patients with locally advanced fully resectable melanoma"".",16-Oct-2023 11:06:15,2023-10-16 11:06:15,16-Oct-2023 11:06:21,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_16102023110615_Press_release_PIVOTAL.pdf,16-10-2023,1141.5,1147.25,1133.050048828125,1135.300048828125,1128.864990234375,1144308,0.0,0.0,23-10-2023,0
19,SUNPHARMA,Sun Pharmaceutical Industries Limited,board meeting intimation, about board meeting to be held on 01-nov-2023 to inter-alia consider and approve the unaudited financial results of the company for the quarterly ended september 2023 .,13-Oct-2023 18:51:02,2023-10-13 18:51:02,13-Oct-2023 18:51:07,00:00:05,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_13102023185102_PRIOR_INTIMATION_11625_951781_13102023065101_WEB.xml,13-10-2023,1126.0999755859375,1147.199951171875,1122.0,1145.300048828125,1138.808349609375,1934884,0.0,0.0,20-10-2023,0
20,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 12, 2023, titled ""cequa showed sustained improvement in dry eye disease patients switched from restasis"".",12-Oct-2023 16:42:42,2023-10-12 16:42:42,12-Oct-2023 16:42:47,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_12102023164242_IntimationSE20231012_Cequa_for_patients_Restasis_Signed.pdf,12-10-2023,1129.0,1132.550048828125,1121.199951171875,1130.4000244140625,1123.99267578125,1221965,0.0,0.0,19-10-2023,0
21,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 06, 2023, titled ""sun pharma announces us fda filing acceptance of new drug application (nda) for deuruxolitinib"".",06-Oct-2023 09:05:28,2023-10-06 09:05:28,06-Oct-2023 09:05:34,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06102023090528_DeuruxolitinibUSFDAFilingAcceptanceReleaseOct23.pdf,06-10-2023,1128.0,1132.1500244140625,1123.0999755859375,1127.300048828125,1120.9102783203125,1056281,0.0,0.0,13-10-2023,0
22,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 27, 2023, titled ""sun pharma canada launches prwinleviￂﾮ (clascoterone cream 1% w/w), a novel topical treatment for acne"".",27-Sep-2023 12:13:52,2023-09-27 12:13:52,27-Sep-2023 12:13:57,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27092023121352_IntimationSE20230927_Winlevi_launch_in_Canada_Signed.pdf,27-09-2023,1126.1500244140625,1145.9000244140625,1123.199951171875,1139.949951171875,1133.488525390625,2332018,0.0,0.0,05-10-2023,0
23,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",25-Sep-2023 16:11:55,2023-09-25 16:11:55,25-Sep-2023 16:12:01,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25092023161155_SEsigned.pdf,25-09-2023,1126.199951171875,1136.800048828125,1121.6500244140625,1124.050048828125,1117.6787109375,1009279,0.0,0.0,03-10-2023,0
24,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 14, 2023, titled ""sun pharma and pharmazz inc. enter into licensing agreement for introducing tyvalzi  (sovateltide) in india"".",14-Sep-2023 10:14:59,2023-09-14 10:14:59,14-Sep-2023 10:15:05,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_14092023101459_IntimationSE20230914_licensing_agreement_Sovateltide_Signed.pdf,14-09-2023,1148.75,1150.9000244140625,1138.75,1143.800048828125,1137.3167724609375,2065163,0.0,0.0,22-09-2023,0
25,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting,"sun pharmaceutical industries limited has submitted the exchange a copy srutinizers report of  annual general meeting held on august 28, 2023. further, the company has informed the exchange regarding voting results.",29-Aug-2023 18:51:30,2023-08-29 18:51:30,29-Aug-2023 18:51:34,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29082023185130_IntimationSigned.pdf,29-08-2023,1125.050048828125,1125.050048828125,1106.449951171875,1111.5999755859375,1105.2991943359375,1749707,0.0,0.0,05-09-2023,0
26,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of annual general meeting held on august 28, 2023",28-Aug-2023 18:53:37,2023-08-28 18:53:37,28-Aug-2023 18:53:41,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28082023185337_IntimationSigned.pdf,28-08-2023,1110.050048828125,1124.1500244140625,1105.1500244140625,1117.0,1110.668701171875,1959645,0.0,0.0,04-09-2023,0
27,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure under regulation 30a of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",14-Aug-2023 19:44:51,2023-08-14 19:44:51,14-Aug-2023 19:45:50,00:00:59,https://nsearchives.nseindia.com/corporate/SUNPHARMA_14082023194451_SEIntimation30A.pdf,14-08-2023,1131.0,1142.0,1120.5,1134.25,1127.8209228515625,1824622,0.0,0.0,22-08-2023,0
28,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure (details of litigation) under regulation 30 of the sebi (listing obligation and disclosure requirements) regulations, 2015 '.",14-Aug-2023 19:41:27,2023-08-14 19:41:27,14-Aug-2023 19:43:26,00:01:59,https://nsearchives.nseindia.com/corporate/SUNPHARMA_14082023194127_SEIntimationLitigation.pdf,14-08-2023,1131.0,1142.0,1120.5,1134.25,1127.8209228515625,1824622,0.0,0.0,22-08-2023,0
29,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended june 30, 2023.",03-Aug-2023 14:05:07,2023-08-03 14:05:07,03-Aug-2023 14:05:17,00:00:10,https://nsearchives.nseindia.com/corporate/OutcomeSigned_03082023140507.pdf,03-08-2023,1130.25,1169.699951171875,1122.3499755859375,1141.0,1134.5325927734375,8460399,0.0,0.0,10-08-2023,0
30,SUNPHARMA,Sun Pharmaceutical Industries Limited,notice of shareholders meetings-xbrl, about notice of shareholders meeting for annual general meeting to be held on 28-aug-2023,27-Jul-2023 22:22:52,2023-07-27 22:22:52,27-Jul-2023 22:22:59,00:00:07,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_27072023222252_NOTICE_OF_SHAREHOLDERS_MEETINGS_902095_27072023102252_WEB.xml,27-07-2023,1128.0,1155.3499755859375,1116.300048828125,1134.949951171875,1124.53955078125,6366612,0.0,0.0,03-08-2023,0
31,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of annual general meeting to be held on august 28, 2023",27-Jul-2023 18:09:03,2023-07-27 18:09:03,27-Jul-2023 18:09:18,00:00:15,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27072023180903_AnnualReportFY23.pdf,27-07-2023,1128.0,1155.3499755859375,1116.300048828125,1134.949951171875,1124.53955078125,6366612,0.0,0.0,03-08-2023,0
32,SUNPHARMA,Sun Pharmaceutical Industries Limited,board meeting intimation, about board meeting to be held on 03-aug-2023 to inter-alia consider and approve the unaudited financial results of the company for the quarterly ended june 2023 .,11-Jul-2023 15:02:41,2023-07-11 15:02:41,11-Jul-2023 15:02:48,00:00:07,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_11072023150241_PRIOR_INTIMATION_6857_879421_11072023030240_WEB.xml,11-07-2023,1052.0,1074.75,1049.050048828125,1072.25,1062.414794921875,4369937,0.0,0.0,18-07-2023,0
33,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"dilip shanghviￂﾠhas submitted to the exchange a copy of disclosure under regulation 31(4) of the securities and exchange board of indiaￂﾠ(substantial acquisition of shares and takeovers) regulations, 2011.ￂﾠ",07-Jul-2023 15:52:46,2023-07-07 15:52:46,07-Jul-2023 15:53:52,00:01:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_07072023155246_SUNPHARMA.pdf,07-07-2023,1033.5,1051.199951171875,1028.75,1035.699951171875,1026.199951171875,1721224,0.0,0.0,14-07-2023,0
34,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",28-Jun-2023 10:03:06,2023-06-28 10:03:06,28-Jun-2023 10:03:11,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28062023100306_SEIntimationforwindowclosure.pdf,28-06-2023,995.0,1025.550048828125,995.0,1021.7999877929688,1012.4274291992188,5296330,0.0,0.0,06-07-2023,0
35,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 19, 2023, titled ""sun pharma announces health canada approval of prwinleviￂﾮ (clascoterone cream 1%) for topical treatment of acne"".",19-Jun-2023 18:02:13,2023-06-19 18:02:13,19-Jun-2023 18:02:17,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_19062023180213_IntimationSigned.pdf,19-06-2023,995.1500244140624,1006.7000122070312,993.75,1001.7999877929688,992.6109619140624,1327862,0.0,0.0,26-06-2023,0
36,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'update   effective date of appointment of mr. rolf hoffmann as an independent director'.,15-Jun-2023 21:03:54,2023-06-15 21:03:54,15-Jun-2023 21:03:59,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_15062023210354_4RolfSigned.pdf,15-06-2023,988.5,994.7999877929688,985.7000122070312,988.4000244140624,979.3338623046876,2731724,0.0,0.0,22-06-2023,0
37,SUNPHARMA,Sun Pharmaceutical Industries Limited,change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent, about change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent,30-May-2023 17:23:07,2023-05-30 17:23:07,30-May-2023 17:23:28,00:00:21,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_30052023172307_CIM_5933_858257_30052023052306_WEB.xml,30-05-2023,965.0,967.4500122070312,956.2999877929688,959.5999755859376,950.7980346679688,2624815,0.0,0.0,06-06-2023,1
38,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 30, 2023, titled ""sun pharma announces china nmpa approval for ilumetri (tildrakizumab injection) for treatment of adults with moderate-to-severe plaque psoriasis"".",30-May-2023 17:17:16,2023-05-30 17:17:16,30-May-2023 17:17:25,00:00:09,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30052023171717_IntimationSigned.pdf,30-05-2023,965.0,967.4500122070312,956.2999877929688,959.5999755859376,950.7980346679688,2624815,0.0,0.0,06-06-2023,1
39,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 30, 2023, titled ""sun pharma and philogen enter into an exclusive distribution, license, and supply agreement for commercializing specialty product, nidlegy  in europe, australia and new zealand"".",30-May-2023 10:33:55,2023-05-30 10:33:55,30-May-2023 10:34:03,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30052023103355_IntimationFinalSigned.pdf,30-05-2023,965.0,967.4500122070312,956.2999877929688,959.5999755859376,950.7980346679688,2624815,0.0,0.0,06-06-2023,1
40,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 26, 2023, titled ""press release sun pharma q4 fy23 financial result"".",26-May-2023 15:00:41,2023-05-26 15:00:41,26-May-2023 15:00:53,00:00:12,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26052023150041_PressReleaseSigned.pdf,26-05-2023,943.9500122070312,976.7000122070312,937.0,969.9000244140624,961.0035400390624,4137189,0.0,0.0,02-06-2023,0
41,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended march 31, 2023.",26-May-2023 14:47:35,2023-05-26 14:47:35,26-May-2023 14:47:43,00:00:08,https://nsearchives.nseindia.com/corporate/OutcomeSigned_26052023144735.pdf,26-05-2023,943.9500122070312,976.7000122070312,937.0,969.9000244140624,961.0035400390624,4137189,0.0,0.0,02-06-2023,0
42,SUNPHARMA,Sun Pharmaceutical Industries Limited,board meeting intimation, about board meeting to be held on 26-may-2023 to consider and approve the yearly audited financial results of the company for the period ended march 2023 and dividend.,11-May-2023 15:10:10,2023-05-11 15:10:10,11-May-2023 15:10:15,00:00:05,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_11052023151010_PRIOR_INTIMATION_4079_840621_11052023031010_WEB.xml,11-05-2023,953.7999877929688,963.9000244140624,952.0,961.0499877929688,952.2346801757812,1296607,0.0,0.0,18-05-2023,0
43,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated april 25, 2023, titled ""sun pharma launches cequaￂﾮ, a novel therapy for dry eye disease in india"".",25-Apr-2023 12:45:46,2023-04-25 12:45:46,25-Apr-2023 12:45:53,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25042023124546_IntimationSigned.pdf,25-04-2023,980.0,982.9000244140624,967.0,972.5,963.5797119140624,2377746,0.0,0.0,03-05-2023,0
44,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",27-Mar-2023 18:25:15,2023-03-27 18:25:15,27-Mar-2023 18:25:24,00:00:09,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27032023182515_Intimationsigned.pdf,27-03-2023,980.0,990.9500122070312,963.0,983.4500122070312,974.4292602539062,2473222,0.0,0.0,05-04-2023,0
45,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated march 22, 2023, titled ""osteoarthritis candidate mm-ii showed durable pain relief in global phase 2b study"".",22-Mar-2023 18:05:37,2023-03-22 18:05:37,22-Mar-2023 18:05:43,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_22032023180537_IntimationSigned.pdf,22-03-2023,957.0,974.4000244140624,956.5999755859376,972.0499877929688,963.1337890625,1626129,0.0,0.0,29-03-2023,0
46,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 10, 2023, titled ""sun pharma announces us fda approval for generic lenalidomide capsules"".",10-Feb-2023 10:59:11,2023-02-10 10:59:11,10-Feb-2023 10:59:19,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_10022023105911_IntimationSE20230210_USFDA_Approval_Lenalidomide_Capsules_Signed.pdf,10-02-2023,1006.7999877929688,1014.3499755859376,996.7000122070312,1006.5999755859376,997.3668823242188,1530150,0.0,0.0,17-02-2023,0
47,SUNPHARMA,Sun Pharmaceutical Industries Limited,change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent, about change in directors/ key managerial personnel/ auditor/ compliance officer/ share transfer agent,01-Feb-2023 11:51:41,2023-02-01 11:51:41,01-Feb-2023 11:51:50,00:00:09,https://nsearchives.nseindia.com/corporate/xbrl/SUNPHARMA_01022023115141_CIM_452_782478_01022023115141_WEB.xml,01-02-2023,1036.449951171875,1043.949951171875,1005.0999755859376,1014.9000244140624,998.0968017578124,4717887,0.0,0.0,08-02-2023,0
48,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 31, 2023, titled ""sun pharma reports q3fy23 results"".",31-Jan-2023 14:26:26,2023-01-31 14:26:26,31-Jan-2023 14:26:32,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31012023142626_IntimationSE20230131_Q3FY23_Financial_Press_Release_signed.pdf,31-01-2023,1055.0,1060.300048828125,1026.050048828125,1034.5,1017.3722534179688,5265462,0.0,0.0,07-02-2023,0
49,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended december 31, 2022.",31-Jan-2023 13:28:17,2023-01-31 13:28:17,31-Jan-2023 13:28:25,00:00:08,https://nsearchives.nseindia.com/corporate/IntimationSigned_31012023132817.pdf,31-01-2023,1055.0,1060.300048828125,1026.050048828125,1034.5,1017.3722534179688,5265462,0.0,0.0,07-02-2023,0
50,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 30, 2023, titled ""sun pharma acquires disperzymeￂﾮ and phlogamￂﾮ brands to strengthen its anti-inflammatory portfolio"".",30-Jan-2023 11:42:13,2023-01-30 11:42:13,30-Jan-2023 11:42:22,00:00:09,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30012023114213_IntimationSE20230130_Disperzyme_and_Phlogam_brand_acquisition_signed.pdf,30-01-2023,1041.949951171875,1072.1500244140625,1040.199951171875,1051.699951171875,1034.2874755859375,3320916,0.0,0.0,06-02-2023,0
51,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting,"sun pharmaceutical industries limited has submitted the exchange a copy srutinizers report of  postal ballot. further, the company has informed the exchange regarding voting results.",27-Jan-2023 20:51:22,2023-01-27 20:51:22,27-Jan-2023 20:51:27,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27012023205122_IntimationSigned.pdf,27-01-2023,1044.949951171875,1051.0,1034.0,1043.4000244140625,1026.1248779296875,3448013,0.0,0.0,03-02-2023,0
52,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'corrigendum to our intimation dated december 23, 2022 for filing of sustainability report 2021-22'.",27-Jan-2023 18:06:03,2023-01-27 18:06:03,27-Jan-2023 18:06:10,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27012023180603_20230127IntimationSE_Corrigendum_Sustainability_Report_2021_22_Signed.pdf,27-01-2023,1044.949951171875,1051.0,1034.0,1043.4000244140625,1026.1248779296875,3448013,0.0,0.0,03-02-2023,0
53,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 25, 2023, titled ""sun pharma launches sezaby  (phenobarbital sodium) in the u.s. for treatment of neonatal seizures"".",25-Jan-2023 14:06:09,2023-01-25 14:06:09,25-Jan-2023 14:06:21,00:00:12,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25012023140609_IntimationSE20230125_launch_SEZABY_in_US_Signed.pdf,25-01-2023,1030.300048828125,1045.6500244140625,1030.300048828125,1040.050048828125,1022.83056640625,1753333,0.0,0.0,02-02-2023,0
54,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 17, 2023, titled ""sun pharma to announce third quarter results on january 31, 2023"".",17-Jan-2023 15:49:57,2023-01-17 15:49:57,17-Jan-2023 15:49:59,00:00:02,https://nsearchives.nseindia.com/corporate/SUNPHARMA_17012023154957_IntimationSE20130117_Q3FY23_Result_Announcement_31Jan2023_Signed.pdf,17-01-2023,1035.449951171875,1036.0,1026.800048828125,1032.699951171875,1015.60205078125,1245848,0.0,0.0,24-01-2023,0
55,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned usfda pulls up sun pharma for lapses in halol plant.  the response from the company is attached.,17-Jan-2023 15:17:00,2023-01-17 15:17:00,17-Jan-2023 15:17:38,00:00:38,https://nsearchives.nseindia.com/corporate/SUNPHARMA_17012023151735_IntimationSigned.pdf,17-01-2023,1035.449951171875,1036.0,1026.800048828125,1032.699951171875,1015.60205078125,1245848,0.0,0.0,24-01-2023,0
56,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 11, 2023, titled ""sun pharma launches palbociclib, a novel targeted therapy for advanced breast cancer with a unique patient assistance program"".",11-Jan-2023 10:16:23,2023-01-11 10:16:23,11-Jan-2023 10:16:30,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_11012023101623_IntimationSE230111_Launch_of_Palbociclib_in_India_Signed.pdf,11-01-2023,1012.0,1033.050048828125,1008.3499755859376,1028.0,1010.9799194335938,3258157,0.0,0.0,18-01-2023,0
57,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",26-Dec-2022 12:50:28,2022-12-26 12:50:28,26-Dec-2022 12:50:30,00:00:02,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26122022125028_Intimation.pdf,26-12-2022,1010.0,1011.7999877929688,988.7000122070312,1000.0499877929688,983.4926147460938,2307374,0.0,0.0,02-01-2023,0
58,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release, about press release dated 18-nov-2022 titled sezaby￢ﾄﾢ phenobarbital sodium powder for injection) approved by us fda for the treatment of neonatal seizures,18-Nov-2022 09:38:09,2022-11-18 09:38:09,18-Nov-2022 09:38:16,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_18112022093809_IntimationSE20221118_Phenobarbital_approval.pdf,18-11-2022,1015.25,1017.8499755859376,1006.0,1009.5999755859376,992.884521484375,1130682,0.0,0.0,25-11-2022,0
59,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release, about press release dated 09-nov-2022 titled sun pharma and sparc enter into a license agreement for commercialization of phenobarbital for injection in the us,09-Nov-2022 11:54:36,2022-11-09 11:54:36,09-Nov-2022 11:54:41,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_09112022115436_IntimationSigned.pdf,09-11-2022,1020.0499877929688,1036.6500244140625,1010.0,1013.5499877929688,996.7691040039062,2268760,0.0,0.0,16-11-2022,0
60,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release, about press release dated 01-nov-2022 titled press release sun pharma q2fy23 financial result,01-Nov-2022 14:18:03,2022-11-01 14:18:03,01-Nov-2022 14:18:17,00:00:14,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01112022141803_IntimationSE20221101_Q2FY23_Result_Announcement_Signed.pdf,01-11-2022,1021.9500122070312,1049.0,1019.1500244140624,1036.5999755859375,1019.4375,5264069,0.0,0.0,09-11-2022,0
61,SUNPHARMA,Sun Pharmaceutical Industries Limited,appointment,sun pharmaceutical industries limited  has informed the exchange about appointment of sanjay asher as independent director of the company w.e.f. 01-nov-2022,01-Nov-2022 13:39:48,2022-11-01 13:39:48,01-Nov-2022 13:39:53,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01112022133948_IntimationSigned.pdf,01-11-2022,1021.9500122070312,1049.0,1019.1500244140624,1036.5999755859375,1019.4375,5264069,0.0,0.0,09-11-2022,0
62,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,sun pharmaceutical industries limited  has informed the exchange about board meeting held on 01-nov-2022 to consider financial statements for the period ended september 2022,01-Nov-2022 13:36:12,2022-11-01 13:36:12,01-Nov-2022 13:36:17,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01112022133612_IntimationSigned.pdf,01-11-2022,1021.9500122070312,1049.0,1019.1500244140624,1036.5999755859375,1019.4375,5264069,0.0,0.0,09-11-2022,0
63,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," about press release dated 11-oct-2022 titled sun pharma to announce second quarter results on november 01, 2022",11-Oct-2022 16:17:57,2022-10-11 16:17:57,11-Oct-2022 16:17:59,00:00:02,https://nsearchives.nseindia.com/corporate/SUNPHARMA_11102022161757_IntimationSE20221011_Q2FY23_Result_Announcement_Signed.pdf,11-10-2022,950.7999877929688,951.9000244140624,940.0,944.75,929.1082763671876,2426935,0.0,0.0,18-10-2022,0
64,SUNPHARMA,Sun Pharmaceutical Industries Limited,general updates," about submission of certificate under regulation 74(5) of securities and exchange board of india (depositories and participants) regulations, 2018 for the quarter ended september 30, 2022",10-Oct-2022 18:17:15,2022-10-10 18:17:15,10-Oct-2022 18:17:20,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_10102022181715_intimationsigned.pdf,10-10-2022,945.9500122070312,954.25,935.25,946.0499877929688,930.38671875,1683827,0.0,0.0,17-10-2022,0
65,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting, about voting results and  scrutinizer report of annual general meeting held on 29-aug-2022,30-Aug-2022 17:19:12,2022-08-30 17:19:12,30-Aug-2022 17:19:17,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30082022171912_IntimationSignedFinal.pdf,30-08-2022,883.0,895.5,882.0,893.0499877929688,878.2642211914062,3672052,0.0,0.0,07-09-2022,0
66,SUNPHARMA,Sun Pharmaceutical Industries Limited,general updates, about submission of esg overview for financial year 2021 - 2022 of sun pharmaceutical industries limited,11-Aug-2022 16:39:09,2022-08-11 16:39:09,11-Aug-2022 16:39:16,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_11082022163909_IntimationSigned.pdf,11-08-2022,923.0,926.9000244140624,917.4500122070312,921.0499877929688,902.8364868164062,1526395,0.0,0.0,19-08-2022,0
67,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting, about notice of annual general meeting to be held on 29-aug-2022,05-Aug-2022 17:14:54,2022-08-05 17:14:54,05-Aug-2022 17:14:58,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_05082022171454_AnnualReportIntimationSigned.pdf,05-08-2022,919.5,929.0,911.9000244140624,915.9500122070312,897.83740234375,3317738,0.0,0.0,16-08-2022,0
68,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," about press release dated 03-aug-2022 titled sun pharma chairman, israel makov to retire on completion of term",03-Aug-2022 08:30:51,2022-08-03 08:30:51,03-Aug-2022 08:30:54,00:00:03,https://nsearchives.nseindia.com/corporate/SUNPHARMA_03082022083051_IntimationSigned.pdf,03-08-2022,915.0,917.7999877929688,893.5499877929688,897.0,879.2620849609375,2863168,0.0,0.0,11-08-2022,0
69,SUNPHARMA,Sun Pharmaceutical Industries Limited,general updates," about 30th annual general meeting to be held on august 29, 2022",02-Aug-2022 17:20:24,2022-08-02 17:20:24,02-Aug-2022 17:20:26,00:00:02,https://nsearchives.nseindia.com/corporate/SUNPHARMA_02082022172024_IntimationSigned.pdf,02-08-2022,918.7000122070312,926.5999755859376,912.0499877929688,917.25,899.111572265625,2043767,0.0,0.0,10-08-2022,0
70,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release, about press release dated 29-jul-2022 titled sun pharma reports q1fy23 results,29-Jul-2022 13:50:00,2022-07-29 13:50:00,29-Jul-2022 13:50:16,00:00:16,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29072022135000_IntimationSE20220729_SPIL_Q1FY23_Financial_Press_ReleaseSIgned.pdf,29-07-2022,897.0,951.9500122070312,879.0,943.2000122070312,924.5484619140624,11315800,0.0,0.0,05-08-2022,0
71,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,sun pharmaceutical industries limited  has informed the exchange about board meeting held on 29-jul-2022 to consider financial statements for the period ended june 2022,29-Jul-2022 13:39:15,2022-07-29 13:39:15,29-Jul-2022 13:39:20,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29072022133913_OutcomeofBM29072022.pdf,29-07-2022,897.0,951.9500122070312,879.0,943.2000122070312,924.5484619140624,11315800,0.0,0.0,05-08-2022,0
72,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," about press release dated 26-jul-2022 titled sun pharma and cosmo announce territory expansion of license and supply agreements for winleviￂﾮ to include japan, australia, new zealand, brazil, mexico and russia",26-Jul-2022 11:03:48,2022-07-26 11:03:48,26-Jul-2022 11:03:53,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26072022110348_IntimationSE20220726_licensing_agreement_with_Cosmo_for_Winlevi_Signed.pdf,26-07-2022,869.2000122070312,877.4000244140625,862.0,867.6500244140625,850.492431640625,1560211,0.0,0.0,02-08-2022,1
73,SUNPHARMA,Sun Pharmaceutical Industries Limited,general updates," about certificate in terms of regulation 74(5) of sebi (depositories and participants) regulations, 2018",08-Jul-2022 13:42:03,2022-07-08 13:42:03,08-Jul-2022 13:42:13,00:00:10,https://nsearchives.nseindia.com/corporate/SUNPHARMA_08072022134203_IntimationSigned.pdf,08-07-2022,853.5,859.5,849.75,857.7000122070312,840.7391357421875,2927832,0.0,0.0,15-07-2022,0
74,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"disclosure under regulation 31 under sebi (sast) regulations, 2011 has been submitted.",20-Jun-2022 17:02:45,2022-06-20 17:02:45,20-Jun-2022 17:02:59,00:00:14,https://nsearchives.nseindia.com/corporate/SUNPHARMA_20062022170245_Discl_Reg31_SUNPHARMA_20062022.pdf,20-06-2022,801.0,813.5,794.5,805.2999877929688,789.3754272460938,2745302,0.0,0.0,27-06-2022,0
75,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended march 31, 2022.",31-May-2022 12:24:20,2022-05-31 12:24:20,31-May-2022 12:24:30,00:00:10,https://nsearchives.nseindia.com/corporate/Outcome_31052022122420.pdf,31-05-2022,867.25,882.7999877929688,851.2000122070312,860.5999755859375,843.5818481445312,24360628,0.0,0.0,07-06-2022,0
76,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"press release relating to financial results for the fourth quarter and full year ending march 31st, 2022.",30-May-2022 15:46:26,2022-05-30 15:46:26,30-May-2022 15:46:37,00:00:11,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30052022154626_IntimationSE20220530_Press_Release_Q4FY22_Financial_Results.pdf,30-05-2022,905.0,915.5,886.5,888.2999877929688,870.7340698242188,3541617,0.0,0.0,06-06-2022,0
77,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that board of directors at its meeting held on 30-may-2022, declared dividend of rs. 3 per equity share.",30-May-2022 15:39:36,2022-05-30 15:39:36,30-May-2022 15:39:52,00:00:16,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30052022153936_Outcome30may2022.pdf,30-05-2022,905.0,915.5,886.5,888.2999877929688,870.7340698242188,3541617,0.0,0.0,06-06-2022,0
78,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,sun pharmaceutical industries limited  has informed the exchange about board meeting held on 30-may-2022 to consider financial statements for the period ended march 2022 and dividend,30-May-2022 15:39:35,2022-05-30 15:39:35,30-May-2022 15:39:43,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30052022153934_Outcome30may2022.pdf,30-05-2022,905.0,915.5,886.5,888.2999877929688,870.7340698242188,3541617,0.0,0.0,06-06-2022,0
79,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release, about press release dated 27-may-2022 titled acquisition of uractivtm portfolio from fiterman pharma in romania,27-May-2022 09:30:28,2022-05-27 09:30:28,27-May-2022 09:30:44,00:00:16,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27052022093024_IntimationSigned.pdf,27-05-2022,901.9500122070312,912.7999877929688,896.0,903.9000244140624,886.025634765625,2374509,0.0,0.0,03-06-2022,0
80,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," about press release dated 18-may-2022 titled launching of brillo, a first-in-class oral lipid-lowering drug in india.",18-May-2022 14:56:33,2022-05-18 14:56:33,18-May-2022 14:56:40,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_18052022145629_BrilloPressReleaseSigned.pdf,18-05-2022,891.0,909.0,888.0,899.1500244140625,881.36962890625,2878378,0.0,0.0,25-05-2022,0
81,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharma to announce fourth quarter results on may 30, 2022.",16-May-2022 12:42:31,2022-05-16 12:42:31,16-May-2022 12:42:38,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_16052022124231_IntimationSE20220516_Q4FY22_Result_Announcement_signed.pdf,16-05-2022,881.9500122070312,894.75,875.0499877929688,885.5999755859375,868.0874633789062,2739020,0.0,0.0,23-05-2022,0
82,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,sun pharma announces us fda approval for generic mesalamine extended release capsules.,12-May-2022 16:00:48,2022-05-12 16:00:48,12-May-2022 16:00:53,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_12052022160047_IntimationSE20220512_USFDA_Approval_For_Melasamine_ER_Capsules.pdf,12-05-2022,852.9000244140625,855.8499755859375,835.2000122070312,850.0,833.1914672851562,2700591,0.0,0.0,19-05-2022,0
83,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,promoter/promoter group of sun pharmaceutical industries limited has submitted a disclosure under regulation 31(4) of sebi takeover regulations for the year ended 31-mar-2022,07-Apr-2022 19:44:34,2022-04-07 19:44:34,07-Apr-2022 19:49:45,00:05:11,https://nsearchives.nseindia.com/corporate/AN_O07042022194434.xlsx,07-04-2022,928.0999755859376,948.0,926.8499755859376,930.9500122070312,912.5407104492188,2728625,0.0,0.0,18-04-2022,0
84,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,promoter/promoter group of sun pharmaceutical industries limited has submitted a disclosure under regulation 31(4) of sebi takeover regulations for the year ended 31-mar-2022,07-Apr-2022 19:21:18,2022-04-07 19:21:18,07-Apr-2022 19:21:23,00:00:05,https://nsearchives.nseindia.com/corporate/AN_O07042022192118.xlsx,07-04-2022,928.0999755859376,948.0,926.8499755859376,930.9500122070312,912.5407104492188,2728625,0.0,0.0,18-04-2022,0
85,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,promoter/promoter group of sun pharmaceutical industries limited has submitted a disclosure under regulation 31(4) of sebi takeover regulations for the year ended 31-mar-2022,07-Apr-2022 19:19:02,2022-04-07 19:19:02,07-Apr-2022 19:19:22,00:00:20,https://nsearchives.nseindia.com/corporate/AN_O07042022191902.xlsx,07-04-2022,928.0999755859376,948.0,926.8499755859376,930.9500122070312,912.5407104492188,2728625,0.0,0.0,18-04-2022,0
86,SUNPHARMA,Sun Pharmaceutical Industries Limited,general updates," about compliance certificate - regulation 7 (3) of sebi (listing obligations and disclosure requirements) regulations, 2015",06-Apr-2022 19:34:46,2022-04-06 19:34:46,06-Apr-2022 19:34:50,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06042022193442_1_Reg73_March2022_Signed.pdf,06-04-2022,927.7999877929688,938.7999877929688,925.0,928.0999755859376,909.7470703125,1881754,0.0,0.0,13-04-2022,0
87,SUNPHARMA,Sun Pharmaceutical Industries Limited,general updates," about certificate under regulation 74(5) of securities and exchange board of india (depositories and participants) regulations, 2018 for the quarter ended march 31, 2022",06-Apr-2022 19:28:03,2022-04-06 19:28:03,06-Apr-2022 19:28:11,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06042022192757_Reg745_Signed.pdf,06-04-2022,927.7999877929688,938.7999877929688,925.0,928.0999755859376,909.7470703125,1881754,0.0,0.0,13-04-2022,0
88,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release, about press release dated 30-mar-2022 titled sun pharma to introduce its version of vortioxetine in india under an exclusive patent license from lundbeck ,30-Mar-2022 11:29:16,2022-03-30 11:29:16,30-Mar-2022 11:29:21,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30032022112910_IntimationSE20220330_introduce_Vortioxetine_in_IndiaSigned.pdf,30-03-2022,922.0,922.0,908.4000244140624,920.5999755859376,902.3953857421876,2084073,0.0,0.0,06-04-2022,0
89,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," about disclosure of event and information pursuant to regulation 30 of securities and exchange board of lndia (listing obligations and disclosure requirements) regulations, 2015, as amended (""sebi listing regulations"") - update on acquisition",29-Mar-2022 19:42:04,2022-03-29 19:42:04,29-Mar-2022 19:42:19,00:00:15,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29032022194152_DisclosureunderReg30Zenotech.pdf,29-03-2022,908.0499877929688,922.0,901.0999755859376,919.3499755859376,901.1701049804688,3177777,0.0,0.0,05-04-2022,0
90,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release, about press release dated 25-mar-2022 titled sun pharma presents phase 3 data for winleviￂﾮ (clascoterone) cream 1% for the topical treatment of acne vulgaris at the aad annual meeting ,25-Mar-2022 16:26:58,2022-03-25 16:26:58,25-Mar-2022 16:27:03,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25032022162657_IntimationSE20220325_Phase_3_data_for_WinleviSigned.pdf,25-03-2022,911.8499755859376,914.9500122070312,896.2999877929688,902.3499755859376,884.5062255859375,1571676,0.0,0.0,01-04-2022,0
91,SUNPHARMA,Sun Pharmaceutical Industries Limited,communication to shareholders as per reg 30," about communication to shareholders as per regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015,  we are enclosing the investor presentation.",24-Mar-2022 16:04:22,2022-03-24 16:04:22,24-Mar-2022 16:04:28,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_24032022160422_IntimationSE20220324_Investor_Presentation_March_2022Signed.pdf,24-03-2022,886.0,914.7000122070312,885.5,908.8499755859376,890.8777465820312,3141478,0.0,0.0,31-03-2022,0
92,SUNPHARMA,Sun Pharmaceutical Industries Limited,litigations/disputes/regulatory actions, about signing of binding memorandum of understanding as to material terms of settlement (￢ﾀﾜbinding term sheet￢ﾀﾝ)  with the direct purchaser and end-payor plaintiffs in the in re ranbaxy generic drug application antitrust litigation in the u.s. district court for the district of massachusetts (usa).,23-Mar-2022 21:17:45,2022-03-23 21:17:45,23-Mar-2022 21:17:56,00:00:11,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23032022211742_Reg30IntimationMoUUSLitigation23032022Signed.pdf,23-03-2022,918.0,926.0,895.7999877929688,900.7999877929688,882.9868774414062,2578669,0.0,0.0,30-03-2022,0
93,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," about agreement to acquire 68,86,500 (11.28%) equity shares of zenotech laboratories limited, a subsidiary of the company.",21-Mar-2022 21:07:46,2022-03-21 21:07:46,21-Mar-2022 21:07:50,00:00:04,"https://nsearchives.nseindia.com/corporate/SUNPHARMA_21032022210743_SPILIntimationunderReg30March21,2022.pdf",21-03-2022,912.5,931.0,911.2999877929688,913.7999877929688,895.7298583984375,3878744,0.0,0.0,28-03-2022,0
94,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 31, 2022, titled ""sun pharma reports q3fy22 results"".",31-Jan-2022 14:15:08,2022-01-31 14:15:08,31-Jan-2022 14:15:16,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31012022141508_IntimationSE20220131_Q3FY22_Financial_Press_Release.pdf,31-01-2022,830.0999755859375,849.75,820.0499877929688,834.5,811.59375,8041517,0.0,0.0,07-02-2022,1
95,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended december 31, 2021.",31-Jan-2022 13:41:21,2022-01-31 13:41:21,31-Jan-2022 13:43:02,00:01:41,https://nsearchives.nseindia.com/corporate/Outcome31012022_31012022134121.pdf,31-01-2022,830.0999755859375,849.75,820.0499877929688,834.5,811.59375,8041517,0.0,0.0,07-02-2022,1
96,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 27, 2022, titled ""sun pharma launches prcequa  (cyclosporineophthalmic solution 0.09% w/v), the first dry eye treatment with nanomicellar (ncell ) technology*, in canada"".",27-Jan-2022 09:15:31,2022-01-27 09:15:31,27-Jan-2022 09:15:39,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27012022091531_IntimationSE02220127_Launch_Cequa_in_Canada.pdf,27-01-2022,802.0,817.4000244140625,791.2999877929688,812.0999755859375,789.80859375,3593525,0.0,0.0,03-02-2022,1
97,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend updates," that the board of directors of the company, at its meeting scheduled to be held on monday, january 31, 2022, will inter-alia consider declaration of interim dividend on the equity shares of the company, for the financial year 2021-22.",25-Jan-2022 14:07:31,2022-01-25 14:07:31,25-Jan-2022 14:07:45,00:00:14,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25012022140731_StockExchangeIntimationInterimDividendJan252022.pdf,25-01-2022,791.0,811.7000122070312,784.7999877929688,808.0499877929688,785.8697509765625,3779497,0.0,0.0,02-02-2022,1
98,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 18, 2022, titled ""sun pharma to announce third quarter results on january 31, 2022"".",18-Jan-2022 17:01:07,2022-01-18 17:01:07,18-Jan-2022 17:01:14,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_18012022170107_IntimationSE20220118_Q3FY22_Result_Announcement_Signed.pdf,18-01-2022,855.0,867.2000122070312,845.0,846.7000122070312,823.4588623046875,3354708,0.0,0.0,25-01-2022,0
99,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated december 28, 2021, titled ""sun pharma receives dcgi approval for molxvirￂﾮ (molnupiravir) in india "".",28-Dec-2021 14:16:55,2021-12-28 14:16:55,28-Dec-2021 14:17:01,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28122021141655_IntimationSE20211228_Launch_Molnupiravir_in_India.pdf,28-12-2021,796.0,819.9000244140625,794.2000122070312,815.0999755859375,792.7262573242188,5477769,0.0,0.0,04-01-2022,0
100,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",20-Dec-2021 12:22:23,2021-12-20 12:22:23,20-Dec-2021 12:22:28,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_20122021122223_IntimationofWindowclosure.pdf,20-12-2021,768.0,774.7000122070312,753.0499877929688,763.9500122070312,742.9802856445312,7474026,0.0,0.0,27-12-2021,0
101,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated december 15, 2021, titled ""sun pharma announces us fda approval for generic amphotericin b liposome injection"".",15-Dec-2021 16:28:37,2021-12-15 16:28:37,15-Dec-2021 16:28:42,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_15122021162837_IntimationSE20211215_Amphotericin_USFDA_approval.pdf,15-12-2021,752.5,778.8499755859375,745.2999877929688,775.0999755859375,753.82421875,6231786,0.0,0.0,22-12-2021,0
102,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'intimation about settlement of dusa pharmaceuticals, inc., with biofrontera inc. and its associatecompanies'.",30-Nov-2021 14:34:41,2021-11-30 14:34:41,30-Nov-2021 14:34:45,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30112021143441_StockExchangeIntimationBiofronteraInc301121.pdf,30-11-2021,751.0,761.6500244140625,746.0499877929688,753.5999755859375,732.914306640625,5505266,0.0,0.0,07-12-2021,0
103,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 11, 2021, titled ""sun pharma geared to introduce molnupiravir, licensed from msd and ridgeback, under the brand name molxvirￂﾮ in india"".",11-Nov-2021 17:41:37,2021-11-11 17:41:37,11-Nov-2021 17:41:45,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_11112021174137_IntimationSE20211111_Introduce_molnupiravir_in_India.pdf,11-11-2021,808.9500122070312,810.4500122070312,792.0999755859375,794.8499755859375,773.0321044921875,2107377,0.0,0.0,18-11-2021,0
104,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned sun pharma, lupin recall products in us market..  the response from the company is attached.",09-Nov-2021 18:08:00,2021-11-09 18:08:00,09-Nov-2021 18:08:17,00:00:17,https://nsearchives.nseindia.com/corporate/SUNPHARMA_09112021180811_SPILStockexchangeclarificationletterNov92021.pdf,09-11-2021,800.0,812.0,797.0,801.3499755859375,779.3536376953125,3232291,0.0,0.0,16-11-2021,0
105,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 02, 2021, titled ""sun pharma reports q2fy22 results"".",02-Nov-2021 14:32:24,2021-11-02 14:32:24,02-Nov-2021 14:32:29,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_02112021143224_IntimationSE20211102_PR_Q2FY22_Financial_Result.pdf,02-11-2021,814.6500244140625,836.0,782.75,815.4000244140625,793.01806640625,17608860,0.0,0.0,10-11-2021,0
106,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial results updates,"approval of unaudited standalone and consolidated financial results for the quarter and half year ended september 30, 2021 with limited review report",02-Nov-2021 13:29:13,2021-11-02 13:29:13,02-Nov-2021 13:29:17,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_02112021132913_FInalcials2021LR.pdf,02-11-2021,814.6500244140625,836.0,782.75,815.4000244140625,793.01806640625,17608860,0.0,0.0,10-11-2021,0
107,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended september 30, 2021.",02-Nov-2021 13:17:26,2021-11-02 13:17:26,02-Nov-2021 13:19:01,00:01:35,https://nsearchives.nseindia.com/corporate/Financialresultssep2021_02112021131726.pdf,02-11-2021,814.6500244140625,836.0,782.75,815.4000244140625,793.01806640625,17608860,0.0,0.0,10-11-2021,0
108,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 01, 2021, titled ""sun pharma announces availability of winleviￂﾮ (clascoterone) cream 1% in the u.s. for topical treatment of acne vulgaris"".",01-Nov-2021 09:20:03,2021-11-01 09:20:03,01-Nov-2021 09:20:15,00:00:12,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01112021092003_IntimationSE20211101_WINLEVI_availability_in_US.pdf,01-11-2021,798.9500122070312,813.8499755859375,787.0,811.7999877929688,789.5169067382812,1935341,0.0,0.0,09-11-2021,0
109,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 28, 2021, titled ""sun pharma s prilumya  (tildrakizumab injection)now available to help canadians living with moderate-to-severe plaque psoriasis"".",28-Oct-2021 12:57:21,2021-10-28 12:57:21,28-Oct-2021 12:57:25,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28102021125721_IntimationSE20211028_ILUMYA_availability_in_Canada.pdf,28-10-2021,823.9500122070312,829.1500244140625,803.0499877929688,807.5999755859375,785.43212890625,1647229,0.0,0.0,04-11-2021,0
110,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 19, 2021, titled ""sun pharma to announce second quarter results on november 02, 2021"".",19-Oct-2021 16:43:22,2021-10-19 16:43:22,19-Oct-2021 16:43:27,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_19102021164322_IntimationSE20211019_Q2FY22_Result_Announcement.pdf,19-10-2021,837.0,842.2000122070312,825.6500244140625,827.3499755859375,804.6399536132812,2029762,0.0,0.0,26-10-2021,0
111,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'please find enclosed certificate as per para 4 of annexure ii to the sebi circular no. sebi/ho/ddhs/ddhs/cir/p/2019/115 dated october 22, 2019.'.",14-Oct-2021 12:19:34,2021-10-14 12:19:34,14-Oct-2021 12:19:39,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_14102021121934_CFOCertificate30092021.pdf,14-10-2021,843.9000244140625,850.0,838.25,841.2999877929688,818.2071533203125,2300231,0.0,0.0,22-10-2021,0
112,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 28, 2021, titled ""sun pharma launches chericofￂﾮ 12 in india, a novel formulation that provides relief from cough for up to 12 hours "".",28-Sep-2021 10:36:19,2021-09-28 10:36:19,28-Sep-2021 10:36:24,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28092021103618_IntimationSE20210928_launches_Chericof12.pdf,28-09-2021,766.7000122070312,791.0,754.9500122070312,775.0999755859375,753.82421875,4938824,0.0,0.0,05-10-2021,1
113,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",23-Sep-2021 19:00:06,2021-09-23 19:00:06,23-Sep-2021 19:00:11,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23092021190006_ClosureofTradingwindow.pdf,23-09-2021,771.0999755859375,777.2000122070312,766.0999755859375,769.8499755859375,748.71826171875,2109768,0.0,0.0,30-09-2021,1
114,SUNPHARMA,Sun Pharmaceutical Industries Limited,scheme of arrangement, about scheme of arrangement sanctioned by hon'ble national company law tribunal,16-Sep-2021 18:40:17,2021-09-16 18:40:17,16-Sep-2021 18:40:27,00:00:10,https://nsearchives.nseindia.com/corporate/SUNPHARMA_16092021184017_IntimationunderReg30.pdf,16-09-2021,780.0,784.5499877929688,778.2999877929688,781.0499877929688,759.6109008789062,1353677,0.0,0.0,23-09-2021,0
115,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 08, 2021, titled ""sun pharma forays into nutrition bar segment with the launch of revital nxt"".",08-Sep-2021 12:23:48,2021-09-08 12:23:48,08-Sep-2021 12:23:52,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_08092021122348_IntimationSE20210908_Signed.pdf,08-09-2021,767.2999877929688,778.9500122070312,763.5499877929688,777.4500122070312,756.1098022460938,2548562,0.0,0.0,16-09-2021,0
116,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting,"sun pharmaceutical industries limited has submitted the exchange a copy srutinizers report of  annual general meeting held on august 31, 2021. further, the company has informed the exchange regarding voting results.",01-Sep-2021 21:27:11,2021-09-01 21:27:11,01-Sep-2021 21:27:16,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01092021212710_29thAGMVotingResults.pdf,01-09-2021,795.0499877929688,803.9000244140625,787.0,788.5,766.8563842773438,2811619,0.0,0.0,08-09-2021,0
117,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'chairman speech at the 29th annual general meeting held on 31 august 2021'.,31-Aug-2021 19:55:40,2021-08-31 19:55:40,31-Aug-2021 19:55:44,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31082021195540_IntimationSE20210831AGMSPEECHsigned.pdf,31-08-2021,787.4500122070312,801.0,783.7000122070312,794.0499877929688,772.2540893554688,7435465,0.0,0.0,07-09-2021,0
118,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of annual general meeting held on august 31, 2021",31-Aug-2021 19:21:11,2021-08-31 19:21:11,31-Aug-2021 19:21:17,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31082021192111_CombinedOutcomeof29thAGMupload.pdf,31-08-2021,787.4500122070312,801.0,783.7000122070312,794.0499877929688,772.2540893554688,7435465,0.0,0.0,07-09-2021,0
119,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 31, 2021, titled ""sun pharma and cassiopea announce the expiry of the hsr act process and the successful consummation of their winleviￂﾮ (clascoterone cream 1%) agreement"".",31-Aug-2021 10:54:19,2021-08-31 10:54:19,31-Aug-2021 10:54:23,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31082021105419_IntimationSE20210831signed.pdf,31-08-2021,787.4500122070312,801.0,783.7000122070312,794.0499877929688,772.2540893554688,7435465,0.0,0.0,07-09-2021,0
120,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of annual general meeting to be held on august 31, 2021",06-Aug-2021 15:14:30,2021-08-06 15:14:30,06-Aug-2021 15:14:36,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06082021151430_SPILCoverLetterwithAnnualReport202021.pdf,06-08-2021,786.5,796.4500122070312,781.5499877929688,785.2000122070312,761.6405029296875,4064324,0.0,0.0,13-08-2021,0
121,SUNPHARMA,Sun Pharmaceutical Industries Limited,book closure," that register of members & share transfer books of the company will remain closed from 25-aug-2021 to 31-aug-2021 for the purpose of di & mt. the 29th annual general meeting of the shareholders of the company  would be held on tuesday, august 31, 2021 at 03:00 p.m. ist through vc/ oavm.",04-Aug-2021 16:45:24,2021-08-04 16:45:24,04-Aug-2021 16:45:28,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_04082021164524_SPILAGMBookClosureIntimation04082021.pdf,04-08-2021,791.0,797.9000244140625,779.7000122070312,785.75,762.1739501953125,5796169,0.0,0.0,11-08-2021,0
122,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 30, 2021, titled ""sun pharma reports q1fy22 financial results"".",30-Jul-2021 14:13:13,2021-07-30 14:13:13,30-Jul-2021 14:13:19,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30072021141313_IntimationSE20210730.pdf,30-07-2021,702.9500122070312,783.75,696.1500244140625,773.9500122070312,750.7279663085938,35893710,0.0,0.0,06-08-2021,0
123,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended june 30, 2021.",30-Jul-2021 13:55:15,2021-07-30 13:55:15,30-Jul-2021 13:57:02,00:01:47,https://nsearchives.nseindia.com/corporate/OutcomeBMJuly302021_30072021135515.pdf,30-07-2021,702.9500122070312,783.75,696.1500244140625,773.9500122070312,750.7279663085938,35893710,0.0,0.0,06-08-2021,0
124,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 26, 2021, titled ""sun pharma and cassiopea spa announce signing of license and supply agreements for winleviￂﾮ (clascoterone cream 1%) in us and canada"".",26-Jul-2021 09:57:26,2021-07-26 09:57:26,26-Jul-2021 09:57:31,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26072021095726_IntimationSE20210726.pdf,26-07-2021,695.2000122070312,705.0,695.2000122070312,703.4000244140625,682.2948608398438,4715053,0.0,0.0,02-08-2021,1
125,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 16, 2021, titled ""sun pharma to announce first quarter results on july 30, 2021"".",16-Jul-2021 16:57:27,2021-07-16 16:57:27,16-Jul-2021 16:57:31,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_16072021165727_IntimationSE20210716.pdf,16-07-2021,684.9000244140625,695.6500244140625,682.6500244140625,688.5999755859375,667.9389038085938,3479357,0.0,0.0,26-07-2021,0
126,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 01, 2021, titled ""sun pharma launches  sunkalp  on the occasion of national doctors  day"".",01-Jul-2021 10:34:13,2021-07-01 10:34:13,01-Jul-2021 10:34:19,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01072021103413_IntimationSE20210701.pdf,01-07-2021,675.0,685.7999877929688,673.7000122070312,684.1500244140625,663.6224365234375,4102748,0.0,0.0,08-07-2021,0
127,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 29, 2021, titled ""pharma majors collaborate for clinical trial of investigational oral anti-viral drug molnupiravir for covid-19"".",29-Jun-2021 16:12:29,2021-06-29 16:12:29,29-Jun-2021 16:12:41,00:00:12,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29062021161229_IntimationSE20210629.pdf,29-06-2021,673.25,681.5,673.0999755859375,677.5999755859375,657.2688598632812,2937766,0.0,0.0,06-07-2021,0
128,SUNPHARMA,Sun Pharmaceutical Industries Limited,related party transactions," about disclosure under regulation 23(9) of the sebi (listing obligations and disclosure requirements) regulations, 2015 w.r.t. related party transactions for the half year ended  march 31, 2021",25-Jun-2021 20:06:13,2021-06-25 20:06:13,25-Jun-2021 20:06:24,00:00:11,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25062021200613_RPTDisclosuretoSE31032021.pdf,25-06-2021,664.7999877929688,677.4000244140625,664.7999877929688,672.25,652.0794677734375,3010243,0.0,0.0,02-07-2021,0
129,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",23-Jun-2021 11:43:41,2021-06-23 11:43:41,23-Jun-2021 11:43:47,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23062021114341_WindowclosureintimationQ123062021.pdf,23-06-2021,666.7999877929688,672.3499755859375,664.25,665.25,645.2894897460938,2631031,0.0,0.0,30-06-2021,0
130,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 22, 2021, titled ""sun pharma announces settlement of patent litigation forgeneric revlimidￂﾮ (lenalidomide) in us"".",22-Jun-2021 07:33:16,2021-06-22 07:33:16,22-Jun-2021 07:33:21,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_22062021073316_239_IntimationSE20210622.pdf,22-06-2021,678.0,680.25,665.8499755859375,666.7999877929688,646.79296875,4577152,0.0,0.0,29-06-2021,0
131,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 02, 2021, titled ""sun pharma and ferring pharmaceuticals enter into licensing agreement for introducing caritecￂﾮ in india"".",02-Jun-2021 13:45:58,2021-06-02 13:45:58,02-Jun-2021 13:46:13,00:00:15,https://nsearchives.nseindia.com/corporate/SUNPHARMA_02062021134558_213_IntimationSE20210602.pdf,02-06-2021,671.0,678.0999755859375,670.1500244140625,677.4500122070312,657.1234130859375,4978457,0.0,0.0,09-06-2021,0
132,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'acquisition of trademarks and patent license for dapagliflozin and its combinations from astrazeneca ab by sun pharma and its subsequent change in business relationship under the distribution services agreement, 2016 ( distribution agreement  ) with astrazeneca pharma india limited '.",28-May-2021 11:04:43,2021-05-28 11:04:43,28-May-2021 11:04:50,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28052021110443_StockExchangeIntimationSUNAZ28052021.pdf,28-05-2021,694.0,694.5,666.2999877929688,669.75,649.6544799804688,28316552,0.0,0.0,04-06-2021,0
133,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 27, 2021, titled ""sun pharma reports q4fy21 results"".",27-May-2021 16:30:40,2021-05-27 16:30:40,27-May-2021 16:30:47,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27052021163040_201_IntimationSE20210527.pdf,27-05-2021,707.25,709.75,694.5,699.5,678.5118408203125,9875654,0.0,0.0,03-06-2021,0
134,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting," regarding, approval of the audited standalone and consolidated financial statements for the quarter and year ended march 31, 2021 by the board of director at its board meeting held on may 27, 2021.",27-May-2021 16:00:40,2021-05-27 16:00:40,27-May-2021 16:00:53,00:00:13,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27052021160040_Outcome27052021Final.pdf,27-05-2021,707.25,709.75,694.5,699.5,678.5118408203125,9875654,0.0,0.0,03-06-2021,0
135,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that board of directors at its meeting held on may 27, 2021, recommended final dividend of 2 per equity share.",27-May-2021 15:57:21,2021-05-27 15:57:21,27-May-2021 15:57:26,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27052021155721_Outcome27052021Final.pdf,27-05-2021,707.25,709.75,694.5,699.5,678.5118408203125,9875654,0.0,0.0,03-06-2021,0
136,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended march 31, 2021.",27-May-2021 15:53:24,2021-05-27 15:53:24,27-May-2021 15:55:02,00:01:38,https://nsearchives.nseindia.com/corporate/Outcome27052021Final_27052021155324.pdf,27-05-2021,707.25,709.75,694.5,699.5,678.5118408203125,9875654,0.0,0.0,03-06-2021,0
137,SUNPHARMA,Sun Pharmaceutical Industries Limited,appointment," regarding appointment of ms rama bijapurkar as additional independent director of the company w.e.f. may 21, 2021.",20-May-2021 22:56:21,2021-05-20 22:56:21,20-May-2021 22:56:28,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_20052021225617_StockExchangeIntimation20052021.pdf,20-05-2021,700.0,701.6500244140625,685.0,686.8499755859375,666.2413330078125,6226376,0.0,0.0,27-05-2021,0
138,SUNPHARMA,Sun Pharmaceutical Industries Limited,appointment," regarding appointment of mr pawan goenka as additional independent director of the company w.e.f. may 21, 2021.",20-May-2021 22:56:17,2021-05-20 22:56:17,20-May-2021 22:56:24,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_20052021225617_StockExchangeIntimation20052021.pdf,20-05-2021,700.0,701.6500244140625,685.0,686.8499755859375,666.2413330078125,6226376,0.0,0.0,27-05-2021,0
139,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 12, 2021, titled ""sun pharma to announce fourth quarter results on may 27, 2021"".",12-May-2021 15:39:34,2021-05-12 15:39:34,12-May-2021 15:39:41,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_12052021153934_191_IntimationSE20210512.pdf,12-05-2021,714.9500122070312,714.9500122070312,700.0,702.8499755859375,681.7613525390625,7250661,0.0,0.0,20-05-2021,0
140,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 10, 2021, titled ""sun pharma signs voluntary licensing agreement with eli lilly for expanding access to baricitinib to help alleviate the burden of covid-19 in india"".",10-May-2021 11:45:43,2021-05-10 11:45:43,10-May-2021 11:45:50,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_10052021114543_190_IntimationSE20210510.pdf,10-05-2021,688.0,703.5,683.5999755859375,698.2000122070312,677.2507934570312,10924222,0.0,0.0,18-05-2021,0
141,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned merck taps 5 indian drugmakers to expand covid drug production.  the response from the company is attached.,29-Apr-2021 11:22:00,2021-04-29 11:22:00,29-Apr-2021 11:22:46,00:00:46,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29042021112238_ReplytoStockExchangeMSDforMolnupiravir29042021Final.pdf,29-04-2021,648.9500122070312,652.0,641.0999755859375,644.5,625.162109375,5676290,0.0,0.0,06-05-2021,1
142,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"ￂﾠpromoter/member of the promoter group of the company has informed the exchange regarding disclosure under regulation 30 and regulation 31(4) of sebi sast regulations 2011ￂﾠas at march 31, 2021.",20-Apr-2021 11:11:53,2021-04-20 11:11:53,20-Apr-2021 11:11:57,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_20042021111153_Sunpharma.pdf,20-04-2021,643.7999877929688,659.5,639.1500244140625,645.1500244140625,625.7926635742188,13831258,0.0,0.0,28-04-2021,0
143,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," about acquisition by one of its wholly owned indian subsidiary,  which has subscribed to partnership interest in abcd technologies llp (to be renamed as indohealth services llp)",25-Mar-2021 19:11:52,2021-03-25 19:11:52,25-Mar-2021 19:11:59,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25032021191152_IntimationtoStockExchange25032021.pdf,25-03-2021,584.4000244140625,587.9500122070312,571.5,575.75,558.4749145507812,4710869,0.0,0.0,05-04-2021,1
144,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",23-Mar-2021 11:54:18,2021-03-23 11:54:18,23-Mar-2021 11:54:24,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23032021115418_WindowclosureintimationQ423032021.pdf,23-03-2021,591.2000122070312,594.7000122070312,583.0,587.8499755859375,570.2117919921875,5341729,0.0,0.0,31-03-2021,0
145,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting,"sun pharmaceutical industries limited has submitted the exchange a copy srutinizers report of  court convened general meeting held on march 16, 2021. further, the company has informed the exchange regarding voting results.",18-Mar-2021 13:44:42,2021-03-18 13:44:42,18-Mar-2021 13:44:46,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_18032021134442_VotingResultsandScrutinizerReport18032021.pdf,18-03-2021,587.4000244140625,591.5499877929688,572.0,574.5499877929688,557.3108520507812,5537584,0.0,0.0,25-03-2021,0
146,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of court convened general meeting held on march 16, 2021",16-Mar-2021 19:09:36,2021-03-16 19:09:36,16-Mar-2021 19:09:40,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_16032021190936_ProceedingsofNCLTconvenedmeetings16032021.pdf,16-03-2021,606.0,609.9500122070312,599.25,602.2999877929688,584.2282104492188,4189930,0.0,0.0,23-03-2021,0
147,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," that one of its wholly owned subsidiaries has agreed to acquire by way of allotment to it, 428,571 ordinary shares (equivalent to 12.5% fully diluted equity stake) of wrs bioproducts pty ltd, australia",05-Mar-2021 15:14:38,2021-03-05 15:14:38,05-Mar-2021 15:14:45,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_05032021151438_SPILStockExchangeIntimationWRSBioproducts05032021.pdf,05-03-2021,619.4500122070312,619.4500122070312,606.9000244140625,611.2000122070312,592.8611450195312,6127488,0.0,0.0,15-03-2021,0
148,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 25, 2021, titled ""sun pharma launches website for its long-term care  portfolio in the u.s."".",25-Feb-2021 09:36:42,2021-02-25 09:36:42,25-Feb-2021 09:36:46,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25022021093642_IntimationSE20210225.pdf,25-02-2021,606.4000244140625,618.9000244140625,602.7000122070312,609.5499877929688,591.2607421875,6261754,0.0,0.0,04-03-2021,0
149,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 23, 2021, titled ""sun pharma to introduce complete range of brivaracetam at an affordable price for epilepsy treatment in india"".",23-Feb-2021 14:09:35,2021-02-23 14:09:35,23-Feb-2021 14:09:38,00:00:03,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23022021140935_IntimationSE20210223.pdf,23-02-2021,595.0,608.3499755859375,592.0,604.0499877929688,585.9257202148438,7564187,0.0,0.0,02-03-2021,0
150,SUNPHARMA,Sun Pharmaceutical Industries Limited,copy of newspaper publication,submission of copies of newspaper advertisement regarding notice of the national company law tribunal ( nclt ) convened meetings of the sun pharmaceutical industries limited ( the company ),10-Feb-2021 17:04:27,2021-02-10 17:04:27,10-Feb-2021 17:04:30,00:00:03,https://nsearchives.nseindia.com/corporate/SUNPHARMA_10022021170427_IntimationtoSEforNewspaperAdvtofNCLTMeetingsCAA.pdf,10-02-2021,623.0499877929688,631.5499877929688,614.0999755859375,627.0999755859375,608.2841186523438,6902162,0.0,0.0,17-02-2021,0
151,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of court convened general meeting to be held on march 16, 2021, separately for equity shareholders and unsecured creditors of the company",05-Feb-2021 15:40:36,2021-02-05 15:40:36,05-Feb-2021 15:40:42,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_05022021154036_109IntimationwithNoticesofNCLTmtgstoSEReg30.pdf,05-02-2021,633.5,644.25,623.1500244140625,634.75,610.368896484375,10981738,0.0,0.0,12-02-2021,0
152,SUNPHARMA,Sun Pharmaceutical Industries Limited,record date, that record date for the purpose of interim dividend  is 10-feb-2021,29-Jan-2021 14:28:53,2021-01-29 14:28:53,29-Jan-2021 14:28:58,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29012021142853_OutcomeofBoardMeeting290121.pdf,29-01-2021,568.0,600.0,554.0999755859375,586.2000122070312,563.68359375,22539938,0.0,0.0,05-02-2021,1
153,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 29, 2021, titled ""sun pharma reports q3fy21 results"".",29-Jan-2021 14:26:07,2021-01-29 14:26:07,29-Jan-2021 14:26:14,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29012021142607_IntimationSE20210129.pdf,29-01-2021,568.0,600.0,554.0999755859375,586.2000122070312,563.68359375,22539938,0.0,0.0,05-02-2021,1
154,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that board of directors at its meeting held on january 29, 2021, declared interim dividend of 5.50 per equity share.",29-Jan-2021 14:11:43,2021-01-29 14:11:43,29-Jan-2021 14:11:49,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29012021141143_OutcomeofBoardMeeting290121.pdf,29-01-2021,568.0,600.0,554.0999755859375,586.2000122070312,563.68359375,22539938,0.0,0.0,05-02-2021,1
155,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended december 31, 2020.",29-Jan-2021 14:06:41,2021-01-29 14:06:41,29-Jan-2021 14:08:07,00:01:26,https://nsearchives.nseindia.com/corporate/OutcomeofBoardMeeting290121_29012021140641.zip,29-01-2021,568.0,600.0,554.0999755859375,586.2000122070312,563.68359375,22539938,0.0,0.0,05-02-2021,1
156,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend updates," that the board of directors of the company, at its meeting scheduled to be held on friday, january 29, 2021, will inter-alia consider declaration of interim dividend on the equity shares of the company, for the financial year 2020-21.",21-Jan-2021 08:16:58,2021-01-21 08:16:58,21-Jan-2021 08:17:05,00:00:07,https://nsearchives.nseindia.com/corporate/SUNPHARMA_21012021081658_StockExchangeIntimationInterimDividend202021.pdf,21-01-2021,598.0,598.75,580.6500244140625,582.9000244140625,560.510498046875,4546393,0.0,0.0,29-01-2021,0
157,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 04, 2021, titled ""sun pharma announces initiation of phase 2 clinical trial of scd-044 in patients with moderate to severe plaque psoriasis"".",04-Jan-2021 17:39:10,2021-01-04 17:39:10,04-Jan-2021 17:39:15,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_04012021173910_IntimationSE20210104.pdf,04-01-2021,600.0,609.4500122070312,595.2000122070312,604.4000244140625,581.1846313476562,11329298,0.0,0.0,11-01-2021,0
158,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 04, 2021, titled ""sun pharma to announce third quarter results on january 29, 2021"".",04-Jan-2021 12:32:04,2021-01-04 12:32:04,04-Jan-2021 12:32:12,00:00:08,https://nsearchives.nseindia.com/corporate/SUNPHARMA_04012021123204_IntimationSE20210104.pdf,04-01-2021,600.0,609.4500122070312,595.2000122070312,604.4000244140625,581.1846313476562,11329298,0.0,0.0,11-01-2021,0
159,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",23-Dec-2020 11:36:09,2020-12-23 11:36:09,23-Dec-2020 11:38:30,00:02:21,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23122020113609_WindowClosureIntimationQ3202021.pdf,23-12-2020,570.0,576.5499877929688,566.0999755859375,574.5999755859375,552.5291748046875,4958783,0.0,0.0,31-12-2020,0
160,SUNPHARMA,Sun Pharmaceutical Industries Limited,related party transactions," about the disclosure under regulation 23(9) of the sebi (listing obligations and disclosure requirements) regulations, 2015",01-Dec-2020 11:16:54,2020-12-01 11:16:54,01-Dec-2020 11:16:58,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01122020111654_RPTDisclosure30092020.pdf,01-12-2020,518.0,542.75,512.6500244140625,539.3499755859375,518.6331176757812,25388623,0.0,0.0,08-12-2020,1
161,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 03, 2020, titled ""sun pharma reports q2fy21 results,"".",03-Nov-2020 16:39:06,2020-11-03 16:39:06,03-Nov-2020 16:39:11,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_03112020163906_67_IntimationSE20201103.pdf,03-11-2020,472.0499877929688,490.6000061035156,465.75,485.6000061035156,466.94775390625,16853462,0.0,0.0,10-11-2020,0
162,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended september 30, 2020.",03-Nov-2020 14:58:38,2020-11-03 14:58:38,03-Nov-2020 15:00:34,00:01:56,https://nsearchives.nseindia.com/corporate/OutcomeofBoardMeetingQ2Nov032020Final_03112020145838.zip,03-11-2020,472.0499877929688,490.6000061035156,465.75,485.6000061035156,466.94775390625,16853462,0.0,0.0,10-11-2020,0
163,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 22, 2020, titled ""sun pharma to announce second quarter results on november 03, 2020"".",22-Oct-2020 14:33:19,2020-10-22 14:33:19,22-Oct-2020 14:33:24,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_22102020143319_59_IntimationSE201022.pdf,22-10-2020,491.2000122070313,491.3999938964844,481.7000122070313,485.5499877929688,466.899658203125,6428694,0.0,0.0,29-10-2020,-1
164,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'certificate under regulation 74(5) of securities and exchange board of india (depositories and participants) regulations, 2018 for the quarter ended 30th september, 2020'.",09-Oct-2020 21:35:25,2020-10-09 21:35:25,09-Oct-2020 21:35:30,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_09102020213525_Reg74_30092020.pdf,09-10-2020,525.0,529.2999877929688,511.0499877929688,512.9000244140625,493.1991271972656,11468529,0.0,0.0,16-10-2020,-1
165,SUNPHARMA,Sun Pharmaceutical Industries Limited,closure of buy back," regarding closure of buy back with effect from september 25, 2020",25-Sep-2020 22:25:43,2020-09-25 22:25:43,25-Sep-2020 22:25:46,00:00:03,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25092020222543_IntimationofclosureofBuyback25092020.pdf,25-09-2020,496.0,496.0,483.8500061035156,489.6499938964844,470.8421936035156,9665092,0.0,0.0,05-10-2020,1
166,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",23-Sep-2020 19:43:24,2020-09-23 19:43:24,23-Sep-2020 19:43:28,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23092020194324_IntimationWindowClosureQ22021.pdf,23-09-2020,520.5,521.0,498.25,502.8999938964844,483.583251953125,10846053,0.0,0.0,30-09-2020,0
167,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 23, 2020, titled ""sun pharma announces the launch of ilumyaￂﾮ (tildrakizumab) for treatment of plaque psoriasis in japan"".",23-Sep-2020 07:44:03,2020-09-23 07:44:03,23-Sep-2020 07:44:08,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23092020074403_IntimationSE20200923.pdf,23-09-2020,520.5,521.0,498.25,502.8999938964844,483.583251953125,10846053,0.0,0.0,30-09-2020,0
168,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'chairman speech at the 28th annual general meeting of sun pharmaceutical industries ltd., held on august 27, 2020'.",27-Aug-2020 19:25:23,2020-08-27 19:25:23,27-Aug-2020 19:25:29,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27082020192523_28thAGMSpeech27Aug2020.pdf,27-08-2020,528.9500122070312,537.0,524.4000244140625,532.25,511.8058776855469,8564601,0.0,0.0,03-09-2020,0
169,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of annual general meeting held on august 27, 2020",27-Aug-2020 19:08:02,2020-08-27 19:08:02,27-Aug-2020 19:08:08,00:00:06,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27082020190802_28AGMproceedings27082020.pdf,27-08-2020,528.9500122070312,537.0,524.4000244140625,532.25,511.8058776855469,8564601,0.0,0.0,03-09-2020,0
170,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 25, 2020, titled ""press release of our subsidiary company relating to civil settlement agreements with us department of justice"".",25-Aug-2020 08:19:01,2020-08-25 08:19:01,25-Aug-2020 08:19:05,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25082020081901_IntimationtoSEPressReleaseAug252020.pdf,25-08-2020,533.5999755859375,535.1500244140625,523.4500122070312,525.0999755859375,504.9304809570313,4414315,0.0,0.0,01-09-2020,0
171,SUNPHARMA,Sun Pharmaceutical Industries Limited,copy of newspaper publication," about copy of newspaper publication published regarding i) notice of the 28th annual general meeting of the company for the financial year 2019-20, to be held on thursday, august 27, 2020 by video conferencing/ other audio visual means,, ii) e-voting and iii) book closure, after sending of electronic copy of the annual report (inter-alia containing the notice of 28th annual general meeting) through email to the shareholders whose email id were available.",06-Aug-2020 19:49:35,2020-08-06 19:49:35,06-Aug-2020 19:49:38,00:00:03,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06082020194935_CoveringletterfornewspaperadAug62020.pdf,06-08-2020,533.9000244140625,541.4500122070312,526.1500244140625,532.25,510.8328247070313,10919796,0.0,0.0,13-08-2020,0
172,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 04, 2020, titled ""sun pharma launches fluguardￂﾮ (favipiravir) in india at rs. 35 per tablet "".",04-Aug-2020 14:43:44,2020-08-04 14:43:44,04-Aug-2020 14:43:48,00:00:04,https://nsearchives.nseindia.com/corporate/SUNPHARMA_04082020144344_IntimationSE20200804.pdf,04-08-2020,522.0,532.4000244140625,517.25,528.9500122070312,507.6656188964844,11950138,0.0,0.0,11-08-2020,0
173,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of annual general meeting to be held on august 27, 2020",03-Aug-2020 16:34:24,2020-08-03 16:34:24,03-Aug-2020 16:34:29,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_03082020163424_CoveringLetterforAnnualReportSubmissionFinal.pdf,03-08-2020,534.0999755859375,540.2000122070312,516.7999877929688,519.4000244140625,498.5,25348229,0.0,0.0,10-08-2020,0
174,SUNPHARMA,Sun Pharmaceutical Industries Limited,copy of newspaper publication," about copy of newspaper advertisement published regarding i) notice of the 28th annual general meeting of the company for the financial year 2019-20, to be held on thursday, august 27, 2020 by video conferencing/ other audio visual means,, ii) e-voting and iii) book closure, under regulation 30 read with regulation 47 of the sebi (listing obligations and disclosure requirements) regulations, 2015",03-Aug-2020 16:21:15,2020-08-03 16:21:15,03-Aug-2020 16:21:20,00:00:05,https://nsearchives.nseindia.com/corporate/SUNPHARMA_03082020162115_CoveringletterforNewspaperSubmissionFinal.pdf,03-08-2020,534.0999755859375,540.2000122070312,516.7999877929688,519.4000244140625,498.5,25348229,0.0,0.0,10-08-2020,0
175,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 31, 2020, titled ""sun pharma reports q1fy21 results. "".",31-Jul-2020 15:26:00,2020-07-31 15:26:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31072020152631_IntimationSE20200731.pdf,31-07-2020,514.25,541.0,507.5,531.7000122070312,510.3050231933594,41253676,0.0,0.0,07-08-2020,0
176,SUNPHARMA,Sun Pharmaceutical Industries Limited,amalgamation/merger," about approval of scheme of amalgamation and merger of sun pharma global fze, an indirect wholly owned subsidiary of the company, into the company by the board of directors at its meeting held on july 31, 2020",31-Jul-2020 14:55:00,2020-07-31 14:55:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31072020145541_Outcome31072020.pdf,31-07-2020,514.25,541.0,507.5,531.7000122070312,510.3050231933594,41253676,0.0,0.0,07-08-2020,0
177,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended june 30, 2020.",31-Jul-2020 14:46:05,2020-07-31 14:46:05,-,-,https://nsearchives.nseindia.com/corporate/Outcome31072020_31072020144605.zip,31-07-2020,514.25,541.0,507.5,531.7000122070312,510.3050231933594,41253676,0.0,0.0,07-08-2020,0
178,SUNPHARMA,Sun Pharmaceutical Industries Limited,copy of newspaper publication, about copy of newspaper publication regarding notice for transfer of equity shares and unclaimed dividend to the investor education and protection fund (iepf) account.,29-Jul-2020 19:57:00,2020-07-29 19:57:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29072020195724_IntimationofnewspaperpublicationforIEPF.PDF,29-07-2020,485.7000122070313,496.2999877929688,484.1499938964844,493.0,473.1622924804688,8531803,0.0,0.0,05-08-2020,1
179,SUNPHARMA,Sun Pharmaceutical Industries Limited,book closure, that register of members & share transfer books of the company will remain closed from 21-aug-2020 to 27-aug-2020 (both days inclusive) for the purpose of holding of annual general meeting and payment of final dividend.,28-Jul-2020 22:24:00,2020-07-28 22:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28072020222425_SPILAGMBookClosureIntimation1920.pdf,28-07-2020,475.5,483.75,473.25,482.6000061035156,463.1807556152344,5917155,0.0,0.0,04-08-2020,1
180,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 24, 2020, titled ""press release of our subsidiary company relating to global resolution of doj antitrustinvestigations"".",24-Jul-2020 02:41:00,2020-07-24 02:41:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_24072020024114_SEIntimationJuly242020.pdf,24-07-2020,490.0,497.7999877929688,481.25,485.6000061035156,466.0600280761719,19812185,0.0,0.0,31-07-2020,1
181,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 23, 2020, titled ""press release sun pharma q1 fy21 financial result on july 31, 2020"".",23-Jul-2020 21:13:00,2020-07-23 21:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23072020211354_IntimationSE20200723.pdf,23-07-2020,477.9500122070313,481.8500061035156,474.0499877929688,476.0,456.8463134765625,5416291,0.0,0.0,30-07-2020,1
182,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'submission of certificate under regulation 74(5) of securities and exchange board of india (depositories and participants) regulations, 2018 for the quarter ended 30th june, 2020'.",13-Jul-2020 16:01:00,2020-07-13 16:01:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_13072020160154_Reg74final.pdf,13-07-2020,495.0,501.7000122070313,492.2999877929688,499.7000122070313,479.5926208496094,7504299,0.0,0.0,20-07-2020,0
183,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 29, 2020, titled ""sun pharma announces japan mhlw approval of ilumyatm for the treatment of plaque psoriasis "".",29-Jun-2020 12:03:00,2020-06-29 12:03:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29062020120325_IntimationSE20200629.pdf,29-06-2020,475.5,487.3500061035156,475.0,482.0,462.6048583984375,5727377,0.0,0.0,06-07-2020,0
184,SUNPHARMA,Sun Pharmaceutical Industries Limited,related party transactions," about the intimation under regulation 23(9) of the sebi (listing obligations and disclosure requirements) regulations, 2015",24-Jun-2020 19:11:00,2020-06-24 19:11:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_24062020191123_RPTDisclosureIntimationtoSE.pdf,24-06-2020,502.0,503.3999938964844,481.0,484.3999938964844,464.90826416015625,8567595,0.0,0.0,01-07-2020,0
185,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 24, 2020, titled ""sun pharma announces pre-clinical data on gl0034, an experimental nce to treat type 2 diabetes and obesity"".",24-Jun-2020 13:57:00,2020-06-24 13:57:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_24062020135754_IntimationSE20200624.pdf,24-06-2020,502.0,503.3999938964844,481.0,484.3999938964844,464.90826416015625,8567595,0.0,0.0,01-07-2020,0
186,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",22-Jun-2020 11:30:00,2020-06-22 11:30:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_22062020113041_SEIntimationWindowClosure.pdf,22-06-2020,492.2000122070313,501.2000122070313,486.0,493.2000122070313,473.3542175292969,9203804,0.0,0.0,29-06-2020,0
187,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 15, 2020, titled ""sun pharma and hikma enter into exclusive licensing agreement for ilumya  for middle east & north africa regions "".",15-Jun-2020 12:26:00,2020-06-15 12:26:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_15062020122655_IntimationSE20200615.pdf,15-06-2020,481.0,489.3999938964844,472.7000122070313,485.7999877929688,466.2519226074219,10727187,0.0,0.0,22-06-2020,0
188,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 05, 2020, titled ""sun pharma initiates phase ii clinical trial on aqch, a phytopharmaceutical drug, as potential treatment for covid-19 patients"".",05-Jun-2020 11:19:00,2020-06-05 11:19:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_05062020111949_IntimationSE20200605.pdf,05-06-2020,501.0,511.0,492.2000122070313,494.25,474.3619689941406,22798341,0.0,0.0,12-06-2020,0
189,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"promoter of  regarding the disclosure pursuant to the provisions of regulation 30 & 31(4) of the sebi (substantial acquisition of shares and takeovers) regulations, 2011 as at 31st march, 2020",02-Jun-2020 08:48:00,2020-06-02 08:48:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_02062020084844_SUNPHARMA.pdf,02-06-2020,470.0,481.0,468.1499938964844,473.1000061035156,454.06298828125,10978049,0.0,0.0,09-06-2020,1
190,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 29, 2020, titled ""sun pharma receives approval from dcgi to initiate clinical trial with nafamostat in covid-19 patients"".",29-May-2020 15:12:00,2020-05-29 15:12:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29052020151254_IntimationSE20200529.pdf,29-05-2020,460.0,481.6000061035156,458.0,474.25,455.166748046875,12662824,0.0,0.0,05-06-2020,0
191,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 28, 2020, titled ""sun pharma and sparc enter into a worldwide license agreement for scd-044."".",28-May-2020 15:03:00,2020-05-28 15:03:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28052020150334_IntimationSE20200528.pdf,28-05-2020,453.8999938964844,461.6499938964844,444.7000122070313,459.1000061035156,440.62640380859375,12632972,0.0,0.0,04-06-2020,1
192,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 27, 2020, titled ""sun pharma reports q4fy20 results"".",27-May-2020 16:17:00,2020-05-27 16:17:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27052020161725_IntimationSE20200527.pdf,27-05-2020,464.8999938964844,464.8999938964844,443.3999938964844,450.8999938964844,432.75628662109375,13253937,0.0,0.0,03-06-2020,1
193,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that board of directors at its meeting held on may 27, 2020, recommended final dividend of 1 per equity share.",27-May-2020 15:07:00,2020-05-27 15:07:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27052020150703_Financials27052020FINAL.pdf,27-05-2020,464.8999938964844,464.8999938964844,443.3999938964844,450.8999938964844,432.75628662109375,13253937,0.0,0.0,03-06-2020,1
194,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended march 31, 2020.",27-May-2020 15:01:06,2020-05-27 15:01:06,-,-,https://nsearchives.nseindia.com/corporate/Financials27052020FINAL_27052020150106.zip,27-05-2020,464.8999938964844,464.8999938964844,443.3999938964844,450.8999938964844,432.75628662109375,13253937,0.0,0.0,03-06-2020,1
195,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 19, 2020, titled ""sun pharma to announce fourth quarter results on may 27, 2020"".",19-May-2020 19:52:00,2020-05-19 19:52:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_19052020195259_IntimationSE20200519.pdf,19-05-2020,443.7999877929688,456.0,438.6000061035156,441.7000122070313,423.9264831542969,10126393,0.0,0.0,27-05-2020,0
196,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'please find enclosed certificate under regulation 74(5) of sebi (dp) regulations 2018'.,24-Apr-2020 20:38:00,2020-04-24 20:38:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_24042020203801_Certificate74.pdf,24-04-2020,476.9500122070313,497.0,473.5499877929688,485.5499877929688,466.0120239257813,23394027,0.0,0.0,04-05-2020,0
197,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated march 27, 2020, titled ""sun pharma commits donation of medicines and hand sanitizers to support india s covid-19 pandemic response"".",27-Mar-2020 23:35:00,2020-03-27 23:35:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_27032020233512_IntimationSE20200327.pdf,27-03-2020,347.0,352.5,333.0,338.25,324.6391906738281,7745135,0.0,0.0,07-04-2020,1
198,SUNPHARMA,Sun Pharmaceutical Industries Limited,public announcement - buyback of shares, that submission of corrigendum to public announcement issued in relation to the buy-backof equity shares by sun pharmaceutical industries limited,26-Mar-2020 08:24:00,2020-03-26 08:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26032020082450_CorrigendumtoPA.pdf,26-03-2020,365.0,368.0,336.1000061035156,338.29998779296875,324.68719482421875,11670467,0.0,0.0,03-04-2020,1
199,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'publication of corrigendum to public announcement issued in relation to the buy-back of equity shares of the company'.,25-Mar-2020 20:21:00,2020-03-25 20:21:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25032020202109_CorrigendumtoPA.pdf,25-03-2020,332.0,350.79998779296875,329.54998779296875,347.6499938964844,333.6609802246094,6174391,0.0,0.0,01-04-2020,0
200,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",24-Mar-2020 18:13:00,2020-03-24 18:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_24032020181334_stockexchangeintimation.pdf,24-03-2020,330.0,348.0,330.0,335.1499938964844,321.6639404296875,6408582,0.0,0.0,31-03-2020,1
201,SUNPHARMA,Sun Pharmaceutical Industries Limited,public announcement - buyback of shares," that filing of public announcement for buy-back of equity shares by the company pursuant to the provisions of regulation 16 of the sebi (buy-back of securities) regulations, 2018 and regulation 30 of the sebi (listing obligations and disclosure requiremeents) regulations, 2015",19-Mar-2020 19:41:00,2020-03-19 19:41:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_19032020194145_PublicAnnoucement.pdf,19-03-2020,351.70001220703125,374.4500122070313,347.6499938964844,360.3999938964844,345.8978881835937,8728092,0.0,0.0,26-03-2020,-1
202,SUNPHARMA,Sun Pharmaceutical Industries Limited,buyback," that the board of directors of the company, at its meeting held on march 17, 2020, has, inter alia, approved the buy-back by the company of its equity shares of face value of re. 1 /- each ( equity shares) from the open market through stock exchange mechanism as prescribed under the securities and exchange board of india (buy-back of securities) regulations, 2018 (buy-back regulations) at a maximum price of rs. 425 /- (rupees four hundred twenty five only) per equity share (maximum buy-back price) payable in cash, for an aggregate maximum amount of up to rs. 1700,00,00,000/- (rupees one thousand seven hundred crores only) excluding transaction costs viz. brokerage, advisor's fees, intermediaries fees, public announcement publication fees, filing fees, turnover charges, applicable taxes such ds securities transaction tax, goods and services tax, income tax, stamp duty and other incidental and related expenses (""transaction costs"") (maximum buy-back size), which represents 9 .83% and 4.44% of the total paid-up equity share capital and free reserves (including securities premium account) as per the latest audited standalone financial statements and audited consolidated financial statements, respectively of the company for the financial year ended march 3 i, 2019, from the equity shareholders/beneficial owners of equity shares of the company, except promoter(s), members of promoter group and persons acting in concert ( buy-back).",17-Mar-2020 13:57:00,2020-03-17 13:57:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_17032020135751_Outcome.pdf,17-03-2020,376.0,395.6000061035156,364.2000122070313,370.1499938964844,355.2555847167969,12903597,0.0,0.0,24-03-2020,-1
203,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 26, 2020, titled ""sun pharma launches riomet er oral suspension in the us"".",26-Feb-2020 15:10:00,2020-02-26 15:10:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26022020151045_IntimationSE20200226.pdf,26-02-2020,385.1000061035156,386.9500122070313,372.5,374.7000122070313,359.6225280761719,12146582,0.0,0.0,04-03-2020,1
204,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'submission of newspaper advertisement under regulation 30 read with regulation 47 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",10-Feb-2020 18:01:00,2020-02-10 18:01:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_10022020180114_StockExchangeIntimation06022020ID.pdf,10-02-2020,428.5499877929688,432.75,418.2999877929688,420.2999877929688,400.4962463378906,3638523,0.0,0.0,17-02-2020,0
205,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 06, 2020, titled ""sun pharma reports q3fy20 results, q3 gross sales at rs. 8,039 crores, q3 net profit at rs. 914 crores"".",06-Feb-2020 15:37:00,2020-02-06 15:37:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06022020153703_IntimationSE20100206.pdf,06-02-2020,428.2000122070313,438.0,424.0,430.6499938964844,410.358642578125,7745520,0.0,0.0,13-02-2020,0
206,SUNPHARMA,Sun Pharmaceutical Industries Limited,record date," that the company has fixed record date as february 18, 2020 for the purpose of interim dividend.",06-Feb-2020 15:27:00,2020-02-06 15:27:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06022020152700_SUNPHARMA.pdf,06-02-2020,428.2000122070313,438.0,424.0,430.6499938964844,410.358642578125,7745520,0.0,0.0,13-02-2020,0
207,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that board of directors at its meeting held on february 06, 2020, declared interim dividend of rs. 3 per equity share.",06-Feb-2020 15:08:00,2020-02-06 15:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_06022020150841_Outcome06022020.pdf,06-02-2020,428.2000122070313,438.0,424.0,430.6499938964844,410.358642578125,7745520,0.0,0.0,13-02-2020,0
208,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended december 31, 2019.",06-Feb-2020 15:05:06,2020-02-06 15:05:06,-,-,https://nsearchives.nseindia.com/corporate/Outcome06022020_06022020150506.zip,06-02-2020,428.2000122070313,438.0,424.0,430.6499938964844,410.358642578125,7745520,0.0,0.0,13-02-2020,0
209,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 04, 2020, titled ""sun pharma introduces absorica ld  (isotretinoin) capsules for management of severe recalcitrant nodular acne in the u.s."".",04-Feb-2020 16:05:00,2020-02-04 16:05:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_04022020160517_IntimationSE20200204.pdf,04-02-2020,416.9500122070313,426.8999938964844,412.8500061035156,425.6499938964844,405.59423828125,4848610,0.0,0.0,11-02-2020,0
210,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 20, 2020, titled ""sun pharma to announce third quarter results on february 06, 2020"".",20-Jan-2020 12:50:00,2020-01-20 12:50:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_20012020124829_IntimationSE20200120_075.pdf,20-01-2020,454.2000122070313,456.2000122070313,446.1499938964844,449.4500122070313,428.2728271484375,2824739,0.0,0.0,27-01-2020,0
211,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 15, 2020, titled ""sun pharma and rockwell medical enter into licensing agreement for triferic in india "".",15-Jan-2020 08:05:00,2020-01-15 08:05:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_15012020080509_IntimationSE20200115_002.pdf,15-01-2020,447.6000061035156,450.7000122070313,443.6499938964844,449.0499877929688,427.89166259765625,3054107,0.0,0.0,22-01-2020,0
212,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'certificate under regulation 74(5) of securities and exchange board of india (depositories and participants) regulations, 2018 for the quarter ended 31st december, 2019'.",13-Jan-2020 15:13:00,2020-01-13 15:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_13012020151315_SPILCertificateunderRegulation7431122019_098.pdf,13-01-2020,447.0,453.6499938964844,442.5499877929688,444.6000061035156,423.6513366699219,4823348,0.0,0.0,20-01-2020,0
213,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",26-Dec-2019 18:44:00,2019-12-26 18:44:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_26122019184017_SPILClosureofTradingWindowQ326122019_132.pdf,26-12-2019,430.8999938964844,431.3999938964844,420.6499938964844,422.1499938964844,402.2591247558594,5296867,0.0,0.0,02-01-2020,0
214,SUNPHARMA,Sun Pharmaceutical Industries Limited,related party transactions," regarding intimation under regulation 23(9) of the sebi (listing obligations and disclosure requirements) regulations, 2015",06-Dec-2019 18:07:00,2019-12-06 18:07:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_612201918525_IntimationtoStockExchange30092019_245.pdf,06-12-2019,440.2999877929688,444.2000122070313,427.0,428.6000061035156,408.4052429199219,5805588,0.0,0.0,13-12-2019,0
215,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 07, 2019, titled ""sun pharma reports q2fy20 results, q2 gross sales at rs. 7,949 crores up 16% yoy,q2 net profit at rs. 1,064 crores up 12.6% yoy"".",07-Nov-2019 14:59:00,2019-11-07 14:59:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_07112019145817_IntimationSE20191107_171.pdf,07-11-2019,431.7000122070313,444.0,423.3999938964844,440.6000061035156,419.83984375,14294406,0.0,0.0,15-11-2019,-1
216,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended september 30, 2019.",07-Nov-2019 14:50:10,2019-11-07 14:50:10,-,-,https://nsearchives.nseindia.com/corporate/Outcomequickresults071119_07112019145010.zip,07-11-2019,431.7000122070313,444.0,423.3999938964844,440.6000061035156,419.83984375,14294406,0.0,0.0,15-11-2019,-1
217,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 06, 2019, titled ""sun pharma and astrazeneca enter into license agreement for novel oncology products in china"".",06-Nov-2019 06:40:00,2019-11-06 06:40:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_06112019063920_IntimationSE20191106_002.pdf,06-11-2019,432.3999938964844,452.8999938964844,422.1000061035156,427.8999938964844,407.7381591796875,15917528,0.0,0.0,14-11-2019,0
218,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 24, 2019, titled ""sun pharma to announce second quarter results on november 07, 2019"".",24-Oct-2019 13:42:00,2019-10-24 13:42:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_24102019134033_IntimationSE20191024_109.pdf,24-10-2019,405.0,407.75,398.7000122070313,405.9500122070313,386.822509765625,3017220,0.0,0.0,31-10-2019,1
219,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'please find enclosed compliance certificate under regulation 74(5) of sebi (dp) regulations, 2018'.",18-Oct-2019 14:58:00,2019-10-18 14:58:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_18102019145715_StockEchangeIntimation_098.pdf,18-10-2019,401.0,406.5,397.5,401.6499938964844,382.72503662109375,4647037,0.0,0.0,27-10-2019,0
220,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 16, 2019, titled ""sun pharma launches drizalma sprinkle in the u.s.  "".",16-Oct-2019 08:46:00,2019-10-16 08:46:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_16102019084422_IntimationSE20191016_007.pdf,16-10-2019,398.0499877929688,402.2000122070313,394.25,399.7000122070313,380.866943359375,5503380,0.0,0.0,24-10-2019,0
221,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 14, 2019, titled ""launch of cequa for the treatment of dry eye disease in the us"".",14-Oct-2019 09:23:00,2019-10-14 09:23:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_14102019092226_IntimationSE20191014_016.pdf,14-10-2019,387.0,399.0,387.0,394.6499938964844,376.0548706054688,4372357,0.0,0.0,22-10-2019,0
222,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 09, 2019, titled ""press release presentation of long term follow up data for ilumya at eadv"".",09-Oct-2019 23:13:00,2019-10-09 23:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_09102019231227_IntimationSE20191009_319.pdf,09-10-2019,378.0,387.75,374.2000122070313,383.9500122070313,365.8590393066406,4991946,0.0,0.0,16-10-2019,0
223,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",01-Oct-2019 13:05:00,2019-10-01 13:05:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_01102019130436_SPILStockExchangeIntimation_197.pdf,01-10-2019,388.5,396.3999938964844,380.1000061035156,386.5499877929688,368.3365173339844,4308157,0.0,0.0,10-10-2019,0
224,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure under regulation 30 of the sebi (listing obligations and disclosurerequirements) regulations, 2015'.",09-Sep-2019 17:33:00,2019-09-09 17:33:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_09092019173231_StockExchangeIntimationSPIL_327.pdf,09-09-2019,426.0,432.5,426.0,428.7999877929688,408.5957946777344,5488753,0.0,0.0,17-09-2019,0
225,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned sun pharma slides 4% on report of sebi ordering forensic audit.  the response from the company is attached.,06-Sep-2019 11:00:00,2019-09-06 11:00:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_05092019201010_SPILClarification05092019_046.pdf,06-09-2019,416.7000122070313,427.2000122070313,414.4500122070313,425.1000061035156,405.0701293945313,12513040,0.0,0.0,16-09-2019,0
226,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting,"sun pharmaceutical industries limited has submitted the exchange a copy srutinizers report of  annual general meeting held on august 28, 2019. further, the company has informed the exchange regarding voting results.",29-Aug-2019 20:59:00,2019-08-29 20:59:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_29082019205656_SPIL27AGMVOTINGRESULTS_381.pdf,29-08-2019,428.0,438.6000061035156,421.1000061035156,434.6499938964844,414.170166015625,19967263,0.0,0.0,06-09-2019,0
227,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'chairman speech at the 27th agm held on august 28, 2019 at vadodara'.",28-Aug-2019 20:08:00,2019-08-28 20:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_28082019194115_27thAGMSpeech28Aug2019_467.pdf,28-08-2019,416.8999938964844,421.7000122070313,411.5,413.1000061035156,393.6355590820313,3441725,0.0,0.0,05-09-2019,0
228,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of annual general meeting held on august 28, 2019",28-Aug-2019 20:01:00,2019-08-28 20:01:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_28082019200053_OutcomeofAGM_459.pdf,28-08-2019,416.8999938964844,421.7000122070313,411.5,413.1000061035156,393.6355590820313,3441725,0.0,0.0,05-09-2019,0
229,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 16, 2019, titled ""sun pharma and china medical system holdings enter into licensing agreement for generic products in mainland china"".",16-Aug-2019 19:16:00,2019-08-16 19:16:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_16082019191543_IntimationSE20190816_374.pdf,16-08-2019,419.3999938964844,421.3999938964844,410.0,414.7000122070313,392.6092834472656,6536156,0.0,0.0,23-08-2019,0
230,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 14, 2019, titled ""sun pharma announces licensing agreement with csir-iict"".",14-Aug-2019 12:25:00,2019-08-14 12:25:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_14082019122502_IntimationSE20190814_109.pdf,14-08-2019,440.0,441.0,408.0499877929688,417.1499938964844,394.9287414550781,16173302,0.0,0.0,22-08-2019,0
231,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended june 30, 2019.",13-Aug-2019 19:33:33,2019-08-13 19:33:33,-,-,https://nsearchives.nseindia.com/corporate/SPILBMOutcome13082019_13082019193333.zip,13-08-2019,421.5,444.5,420.75,439.25,415.8515319824219,13211835,0.0,0.0,21-08-2019,-1
232,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 13, 2019, titled ""sun pharma reports q1fy20 results, "".",13-Aug-2019 15:41:00,2019-08-13 15:41:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_13082019154032_IntimationSE20190813_445.pdf,13-08-2019,421.5,444.5,420.75,439.25,415.8515319824219,13211835,0.0,0.0,21-08-2019,-1
233,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'submission of newspaper advertisement under regulation 30 read with regulation 47 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",06-Aug-2019 18:38:00,2019-08-06 18:38:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_06082019183726_LettertoSESPILNewspaperadvt_510.pdf,06-08-2019,416.0,422.4500122070313,414.5,418.2000122070313,395.9228210449219,3204070,0.0,0.0,14-08-2019,0
234,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned sun pharma shuts two clinical units in vadodara for cost efficiency.  the response from the company is attached.,06-Aug-2019 18:26:00,2019-08-06 18:26:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_06082019144735_SPILStockexchangereplyletterAug62019_489.pdf,06-08-2019,416.0,422.4500122070313,414.5,418.2000122070313,395.9228210449219,3204070,0.0,0.0,14-08-2019,0
235,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 05, 2019, titled ""sun pharma to announce first quarter results on august 13, 2019"".",05-Aug-2019 14:25:00,2019-08-05 14:25:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_05082019142407_IntimationSE20190805_198.pdf,05-08-2019,417.6499938964844,423.75,411.0499877929688,417.1499938964844,394.9287414550781,4784904,0.0,0.0,13-08-2019,1
236,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release (revised)," regarding a revised press release dated august 01, 2019, titled ""sun pharma announces regulatory filing of tildrakizumab in japan"".",01-Aug-2019 08:59:00,2019-08-01 08:59:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_01082019085908_IntimationSE20190801_011.pdf,01-08-2019,424.7999877929688,427.75,418.0,425.1000061035156,402.4552001953125,3635110,0.0,0.0,08-08-2019,0
237,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 01, 2019, titled ""sun pharma announces regulatory filing of tildrakizumab in japan"".",01-Aug-2019 08:11:00,2019-08-01 08:11:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_01082019081126_IntimationSE20190801_001.pdf,01-08-2019,424.7999877929688,427.75,418.0,425.1000061035156,402.4552001953125,3635110,0.0,0.0,08-08-2019,0
238,SUNPHARMA,Sun Pharmaceutical Industries Limited,agm/book closure," that the register of members and share transfer books of the company will be closed from august 22, 2019 to  august 28, 2019 (both days inclusive) for the purpose of holding of the annual general meeting of the company to be held on august 28, 2019 and declaration and payment of dividend.",26-Jul-2019 17:37:00,2019-07-26 17:37:00,-,-,https://nsearchives.nseindia.com/corporate/ketulj_26072019173738_SPILIntimationBookClosureAGM_338.pdf,26-07-2019,437.0,442.2000122070313,433.1000061035156,439.9500122070313,416.5141906738281,5094438,0.0,0.0,02-08-2019,0
239,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 15, 2019, titled ""sun pharma launches ezallor sprinkle (rosuvastatin) in the u.s. for people who have difficulty swallowing"".",15-Jul-2019 08:02:00,2019-07-15 08:02:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_15072019075502_IntimationSE20190715_013.pdf,15-07-2019,416.25,427.7000122070313,413.6499938964844,422.9500122070313,400.4197692871094,18269604,0.0,0.0,22-07-2019,0
240,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",27-Jun-2019 18:22:00,2019-06-27 18:22:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_27062019182110_WindowClosureSPIL_313.pdf,27-06-2019,399.0499877929688,405.3999938964844,394.75,402.7999877929688,381.3431701660156,7651785,0.0,0.0,04-07-2019,0
241,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 27, 2019, titled ""sun pharma and china medical system holdings enter into a license agreement for cyclosporine a eye drops in greater china"".",27-Jun-2019 14:53:00,2019-06-27 14:53:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_27062019145325_IntimationSE20190627_123.pdf,27-06-2019,399.0499877929688,405.3999938964844,394.75,402.7999877929688,381.3431701660156,7651785,0.0,0.0,04-07-2019,0
242,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 27, 2019, titled ""sun pharma and china medical system holdings enter into a license agreement for tildrakizumab in greater china "".",27-Jun-2019 14:46:00,2019-06-27 14:46:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_27062019144506_IntimationSE20190627_121.pdf,27-06-2019,399.0499877929688,405.3999938964844,394.75,402.7999877929688,381.3431701660156,7651785,0.0,0.0,04-07-2019,0
243,SUNPHARMA,Sun Pharmaceutical Industries Limited,related party transactions," regarding intimation under regulation 23(9) of the sebi (listing obligations and disclosure requirements) regulations, 2015",25-Jun-2019 16:01:00,2019-06-25 16:01:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract3_2562019154414_intimationunderreg29_197.pdf,25-06-2019,382.5,387.5,377.5499877929688,385.75,365.2013549804688,4480306,0.0,0.0,02-07-2019,0
244,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned sun pharmaceutical gets four observations for halol facility in gujarat. the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. sun pharmaceutical industries limited has submitted their response.",21-Jun-2019 20:44:00,2019-06-21 20:44:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_21062019193213_SPILStockexchangereplyletterJune212019_461.pdf,21-06-2019,388.8999938964844,391.7000122070313,381.0499877929688,382.7999877929688,362.4085083007813,5389874,0.0,0.0,28-06-2019,0
245,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 14, 2019, titled ""late-breaking phase 2 data showing potential of ilumya for of psoriatic arthritis "".",14-Jun-2019 11:24:00,2019-06-14 11:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_14062019112336_IntimationSE20190614_038.pdf,14-06-2019,390.0,394.8500061035156,376.5499877929688,392.5499877929688,371.6391906738281,9786375,0.0,0.0,21-06-2019,0
246,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 14, 2019, titled ""late-breaking phase 2 data showing potential of ilumya for of psoriatic arthritis "".",14-Jun-2019 11:24:00,2019-06-14 11:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_14062019112336_IntimationSE20190614_038.pdf,14-06-2019,390.0,394.8500061035156,376.5499877929688,392.5499877929688,371.6391906738281,9786375,0.0,0.0,21-06-2019,0
247,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of court convened general meeting held on jun 04, 2019",04-Jun-2019 15:37:00,2019-06-04 15:37:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_04062019153628_ProceedingofNCLTMeeting_155.pdf,04-06-2019,414.7999877929688,417.8999938964844,409.1000061035156,411.1499938964844,389.248291015625,3279047,0.0,0.0,12-06-2019,0
248,SUNPHARMA,Sun Pharmaceutical Industries Limited,change in director(s)," regarding change in director(s) of the company.change in designation of mr. sudhir v. valia : please note that mr. sudhir valia stepped down from the position of whole-time director of the company to non-executive director of the company, with effect from 29th may, 2019, therefore he shall continue as a non-executive and non-independent director of the company.",28-May-2019 20:29:00,2019-05-28 20:29:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_28052019202603_SPILResultsaudited2019outcome_535.pdf,28-05-2019,417.0,420.5,410.2000122070313,412.75,390.7630920410156,7987111,0.0,0.0,04-06-2019,0
249,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that the board of directors of the company at its meeting held on may 28, 2019 has recommended payment of dividend of rs 2.75/- ( rupees two and paise seventy five only ) per equity share of re 1/- each of the company for the year ended march 31, 2019 subject to the approval of the shareholders at the ensuing annual general meeting of the company.",28-May-2019 18:29:00,2019-05-28 18:29:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_28052019180726_Sunpharama_338.pdf,28-05-2019,417.0,420.5,410.2000122070313,412.75,390.7630920410156,7987111,0.0,0.0,04-06-2019,0
250,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 28, 2019, titled ""sun pharma reports q4fy19 results, "".",28-May-2019 17:40:00,2019-05-28 17:40:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_28052019173940_IntimationSE20190528_184.pdf,28-05-2019,417.0,420.5,410.2000122070313,412.75,390.7630920410156,7987111,0.0,0.0,04-06-2019,0
251,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended march 31, 2019.",28-May-2019 17:19:46,2019-05-28 17:19:46,-,-,https://nsearchives.nseindia.com/corporate/SPILResultsaudited2019_28052019171946.zip,28-05-2019,417.0,420.5,410.2000122070313,412.75,390.7630920410156,7987111,0.0,0.0,04-06-2019,0
252,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange had sought clarification from the company with respect to news item captioned- titled ""pharma stocks bleed as us states file lawsuit against generic drug firms"". in this regard, it was advised to provide clarification/confirmation on the news item in detail including the following: a) whether such event stated in published news were taking place? if so, it was advised to provide the said information along with the sequence of events in chronological order. b) the material impact of this article on the company. c) whether company was aware of any information that has not been announced to the exchanges under regulation 30 of listing regulations. if so, it was advised to provide the said information and the reasons for not disclosing the same to the exchange earlier as required under regulation 30 of the listing regulations. the response from the company is attached.",15-May-2019 08:45:00,2019-05-15 08:45:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract3_155201983612_SPILStockexchangereplyletterMay142019_015.pdf,15-05-2019,420.0,424.5,407.1000061035156,409.75,387.9229431152344,7581005,0.0,0.0,22-05-2019,0
253,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 14, 2019, titled ""sun pharma to announce fourth quarter results on may 28, 2019"".",14-May-2019 17:58:00,2019-05-14 17:58:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_14052019175640_IntimationSE20190514_121.pdf,14-05-2019,406.0499877929688,424.5,403.25,419.4500122070313,397.106201171875,18797497,0.0,0.0,21-05-2019,0
254,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'submission of copies of newspaper advertisement regarding notice of the national company law tribunal (ￂﾓncltￂﾔ) convened meetings of the sun pharmaceutical industries limited'.,13-May-2019 16:08:00,2019-05-13 16:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_13052019160613_StockExchangeIntimationmOfAdvertisement_281.pdf,13-05-2019,437.75,437.75,344.54998779296875,398.1000061035156,376.8934631347656,24079258,0.0,0.0,20-05-2019,0
255,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange had sought clarification from the company with respect to news item captioned ""us fda finds quality, data issues at dadra plant of sun pharma."" in this regard, exchange has advised the company to provide clarification/confirmation on the news item in detail including the following: a) whether such event/negotiations/article stated in published news were taking place? if so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the company. b) whether company is aware of any information that has not been announced to the exchanges under regulation 30 of listing regulations. the response from the company is attached.",26-Apr-2019 18:46:00,2019-04-26 18:46:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract3_26042019180017_SPIL__408.pdf,26-04-2019,464.0,469.3999938964844,462.6000061035156,464.1000061035156,439.3777160644531,2903286,0.0,0.0,07-05-2019,0
256,SUNPHARMA,Sun Pharmaceutical Industries Limited,disc. under reg.30 of sebi (sast) reg.2011,"the promoter along with pac has submitted to the exchange a copy of annual disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares and takeovers), regulations, 2011 as on march 31, 2019.",26-Apr-2019 16:44:00,2019-04-26 16:44:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_26042019102114_SunPharmaceutical_261.pdf,26-04-2019,464.0,469.3999938964844,462.6000061035156,464.1000061035156,439.3777160644531,2903286,0.0,0.0,07-05-2019,0
257,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'intimation under regulation 39(3) of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",16-Apr-2019 12:59:00,2019-04-16 12:59:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_16042019125911_stockexchangeintimation12042019_107.pdf,16-04-2019,459.4500122070313,464.5,458.6499938964844,462.5499877929688,437.9102478027344,2825105,0.0,0.0,25-04-2019,0
258,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'update on (a) transition of india domestic formulations distribution to sun pharmaￂﾒs wholly owned subsidiary and (b) completion of assignment from atlas global trading to sun pharmaￂﾒs wholly owned subsidiary'.,08-Apr-2019 20:02:00,2019-04-08 20:02:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_08042019200103_SPILIntimationtoSE08042019_550.pdf,08-04-2019,464.6000061035156,467.2000122070313,460.4500122070313,462.4500122070313,437.8156433105469,2274003,0.0,0.0,15-04-2019,0
259,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated april 08, 2019, titled ""sun pharma launches ready-to-infuse infugem in the u.s."".",08-Apr-2019 08:15:00,2019-04-08 08:15:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_08042019081414_IntimationSE20190408_012.pdf,08-04-2019,464.6000061035156,467.2000122070313,460.4500122070313,462.4500122070313,437.8156433105469,2274003,0.0,0.0,15-04-2019,0
260,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window," regarding the trading window closure pursuant to sebi (prohibition of insider trading) regulations, 2015",03-Apr-2019 18:13:00,2019-04-03 18:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_03042019181241_SPILIintimationToSEWindowClosure03042019_874.pdf,03-04-2019,471.0,473.8999938964844,459.1499938964844,462.0,437.38958740234375,4715586,0.0,0.0,10-04-2019,0
261,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure under sebi (prohibition of insider trading) regulations, 2015 as amended from time to time'.",01-Apr-2019 19:06:00,2019-04-01 19:06:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_01042019184935_FairDisclosureCode_626.pdf,01-04-2019,480.9500122070313,484.25,475.6000061035156,478.8500061035156,453.3420104980469,3583589,0.0,0.0,08-04-2019,0
262,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange had sought clarification from the company with respect to news item captioned- "" sun pharma falls 1% on usfda observation for baska facility "". in this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) whether such event stated in published news were taking place? if so, you are advised to provide the said information along with the sequence of events in chronological order. b) the material impact of this article on the company. c) whether company are aware of any information that has not been announced to the exchanges under regulation 30 of listing regulations. if so, you are advised to provide the said information and the reasons for not disclosing the same to the exchange earlier as required under regulation 30 of the listing regulations. the response from the company is attached.ￂﾠ",25-Mar-2019 14:45:00,2019-03-25 14:45:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_25032019144133_SPIL_115.pdf,25-03-2019,468.5,469.4500122070313,461.2000122070313,464.6499938964844,439.8984375,4043446,0.0,0.0,02-04-2019,0
263,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," that the wholly owned subsidiary of the company has increased its shareholding in pjsc biosintez, russia, by way of purchase of 33958 shares (30221 ordinary shares and 3737 preferred shares) equivalent to 11.86% of pjsc biosintez under mandatory tender offer. post completion of this purchase of shares, the total holding of wholly owned subsidiary company was increased from 85.10% to 96.96% in pjsc biosintez.",13-Mar-2019 16:21:00,2019-03-13 16:21:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_1332019161450_SPILReg30dislcosurePJSCBiosintez13Mar2019_113.pdf,13-03-2019,473.0,475.0,452.5,456.5,432.1825866699219,7156428,0.0,0.0,20-03-2019,0
264,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated march 01, 2019, titled ""ilumya (tildrakizumab-asmn) 3-year data demonstrates sustained skin clearance in patients with moderate-to-severe plaque psoriasis"".",01-Mar-2019 17:38:00,2019-03-01 17:38:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_01032019173631_IntimantionSE20190301_200.pdf,01-03-2019,447.8999938964844,451.0,445.0499877929688,447.3500061035156,423.5199890136719,5608805,0.0,0.0,11-03-2019,0
265,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release (revised)," regarding a revised press release dated february 12, 2019, titled ""revised press release sun pharma reports q3fy19 resultsq3 gross sales at rs. 7,657 crores up 16%q3 adjusted net profit at rs. 1,242 crores up 49%"".",12-Feb-2019 18:11:00,2019-02-12 18:11:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_12022019181005_IntimationSE20190212_406.pdf,12-02-2019,427.2000122070313,444.0,424.0499877929688,436.6000061035156,413.3426513671875,8559968,0.0,0.0,20-02-2019,0
266,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 12, 2019, titled ""sun pharma reports q3fy19 resultsq3 gross sales at rs. 7,657 crores up 16%q3 adjusted net profit at rs. 1,242 crores up 49%"".",12-Feb-2019 17:20:00,2019-02-12 17:20:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_12022019171843_IntimationSE20190212_334.pdf,12-02-2019,427.2000122070313,444.0,424.0499877929688,436.6000061035156,413.3426513671875,8559968,0.0,0.0,20-02-2019,0
267,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended december 31, 2018.",12-Feb-2019 16:28:59,2019-02-12 16:28:59,-,-,https://nsearchives.nseindia.com/corporate/OutcomeofBM12022019_12022019162859.zip,12-02-2019,427.2000122070313,444.0,424.0499877929688,436.6000061035156,413.3426513671875,8559968,0.0,0.0,20-02-2019,0
268,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 28, 2019, titled ""sun pharma to announce third quarter results on february 12, 2019"".",28-Jan-2019 18:36:00,2019-01-28 18:36:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_28012019183406_IntimationSE20190128_384.pdf,28-01-2019,424.0,424.75,410.1499938964844,411.75,389.81634521484375,5809082,0.0,0.0,04-02-2019,0
269,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'our letter to sebi on a media report regarding alleged second whistleblower complaint filed against our company'.,18-Jan-2019 15:40:00,2019-01-18 15:40:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_18012019153718_SPILStockexchangeintimationreglettertoSEBIwithannexJan182019_116.pdf,18-01-2019,424.0499877929688,424.1000061035156,370.2000122070313,390.75,369.9350280761719,82906214,0.0,0.0,25-01-2019,1
270,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned sun pharma plummets over 12% over buzz of fresh whistleblower complaint. the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. sun pharmaceutical industries limited has submitted their response.",18-Jan-2019 14:37:00,2019-01-18 14:37:00,-,-,https://nsearchives.nseindia.com/corporate/vkallianpur_18012019143601_SUNPHARMA_7848_reply_076.pdf,18-01-2019,424.0499877929688,424.1000061035156,370.2000122070313,390.75,369.9350280761719,82906214,0.0,0.0,25-01-2019,1
271,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," regarding agreement by one of the wholly owned subsidiaries of the company, to acquire 100% shares of pola pharma inc., japan, subject to completion of closing conditions.",03-Jan-2019 16:04:00,2019-01-03 16:04:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_312019155454_IntimationSE20190103_094.pdf,03-01-2019,442.0499877929688,443.6000061035156,434.0,436.1000061035156,412.8692932128906,9479511,0.0,0.0,10-01-2019,0
272,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated december 26, 2018, titled ""dusa pharmaceuticals, inc. awarded preliminary injunctive relief prohibiting biofrontera from using its trade secrets"".",26-Dec-2018 16:18:00,2018-12-26 16:18:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_26122018161729_IntimationSE20181226_081.pdf,26-12-2018,423.4500122070313,423.4500122070313,410.0,413.6499938964844,391.61517333984375,8406699,0.0,0.0,02-01-2019,1
273,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'receipt of us fda approval for elepsia xr 1000mg & elepsia xr 1500mg'.,21-Dec-2018 13:54:00,2018-12-21 13:54:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_21122018135331_IntimationSE20181221Elepsia_070.pdf,21-12-2018,429.5,433.0,423.0,425.2999877929688,402.6445617675781,7315242,0.0,0.0,31-12-2018,0
274,SUNPHARMA,Sun Pharmaceutical Industries Limited,clarification,sun pharmaceutical industries limited has informed about the clarification on recent media reports.,03-Dec-2018 20:53:00,2018-12-03 20:53:00,-,-,https://nsearchives.nseindia.com/corporate/Mchheda_3122018204225_IntimationSE20181203Clarification_386.pdf,03-12-2018,450.0,461.0,441.1499938964844,455.3999938964844,431.1411437988281,61492013,0.0,0.0,10-12-2018,-1
275,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated december 03, 2018, titled ""sun pharma announces us fda approval for generic ganirelix acetate injection"".",03-Dec-2018 08:44:00,2018-12-03 08:44:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_03122018084109_IntimationSE20181203GanirelixApproval_092.pdf,03-12-2018,450.0,461.0,441.1499938964844,455.3999938964844,431.1411437988281,61492013,0.0,0.0,10-12-2018,-1
276,SUNPHARMA,Sun Pharmaceutical Industries Limited,scheme of arrangement," regarding 'scheme of arrangement among sun pharma global fze and sun pharmaceutical industries limited (""the company"") and their respective members and creditors'.",03-Dec-2018 08:41:00,2018-12-03 08:41:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_312201873818_StockExchangeIntimation01122018_091.pdf,03-12-2018,450.0,461.0,441.1499938964844,455.3999938964844,431.1411437988281,61492013,0.0,0.0,10-12-2018,-1
277,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated december 03, 2018, titled ""sun pharma to hold an investor update call on december 03, 2018"".",03-Dec-2018 08:28:00,2018-12-03 08:28:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_03122018082644_IntimationSE20181203InvestorCall_083.pdf,03-12-2018,450.0,461.0,441.1499938964844,455.3999938964844,431.1411437988281,61492013,0.0,0.0,10-12-2018,-1
278,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned ""governance cloud over sun, stock at 6-mth low."". the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. sun pharmaceutical industries limited has submitted their response.",29-Nov-2018 16:26:00,2018-11-29 16:26:00,-,-,https://nsearchives.nseindia.com/corporate/siddhantg_29112018162415_SUNPHARMA_7704_reply_147.pdf,29-11-2018,489.0,491.4500122070313,478.7000122070313,484.3999938964844,458.5963745117188,7391256,0.0,0.0,06-12-2018,-1
279,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"raksha valia has submitted to the exchange a copy of disclosure under regulation 31(1) of sebi (sast) regulations, 2011.",28-Nov-2018 09:11:00,2018-11-28 09:11:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_28112018090734_Sunpharama_013.pdf,28-11-2018,489.0,502.3999938964844,481.5,486.0,460.1111450195313,11393583,0.0,0.0,05-12-2018,-1
280,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'intimation of settlement in the in re modafinil antitrust litigation matter in us with certain plaintiffs'.,26-Nov-2018 18:40:00,2018-11-26 18:40:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_26112018183752_Stockexchangeintimation_226.pdf,26-11-2018,527.0,528.1500244140625,506.3999938964844,510.75,483.5427551269531,5189359,0.0,0.0,03-12-2018,-1
281,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure under regulation 30 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",26-Nov-2018 16:12:00,2018-11-26 16:12:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract3_26112018155725_LODRIntimationSE20181126_138.pdf,26-11-2018,527.0,528.1500244140625,506.3999938964844,510.75,483.5427551269531,5189359,0.0,0.0,03-12-2018,-1
282,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 26, 2018, titled ""sun pharma to acquire pola pharma in japan"".",26-Nov-2018 15:50:00,2018-11-26 15:50:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_26112018154938_IntimationSE20181126_117.pdf,26-11-2018,527.0,528.1500244140625,506.3999938964844,510.75,483.5427551269531,5189359,0.0,0.0,03-12-2018,-1
283,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"shanghvi finance private limited, has submitted to the exchange a copy of regulation 10(7) of sebi (substantial acquisition of shares and takeovers) regulations, 2011 (""takeover regulations 2011"").",26-Nov-2018 09:16:00,2018-11-26 09:16:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_26112018085637_SPIL_02_028.pdf,26-11-2018,527.0,528.1500244140625,506.3999938964844,510.75,483.5427551269531,5189359,0.0,0.0,03-12-2018,-1
284,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended september 30, 2018.",13-Nov-2018 16:31:08,2018-11-13 16:31:08,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_13112018153802_BMOutcome13112018_624_13112018163108.zip,13-11-2018,589.5,592.9000244140625,556.25,561.75,531.8259887695312,9176639,0.0,0.0,20-11-2018,-1
285,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 13, 2018, titled ""sun pharma reports q2fy19 results"".",13-Nov-2018 15:57:00,2018-11-13 15:57:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_13112018155613_IntimationSE20181113_636.pdf,13-11-2018,589.5,592.9000244140625,556.25,561.75,531.8259887695312,9176639,0.0,0.0,20-11-2018,-1
286,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"shanghvi finance private limited has submitted to the exchange disclosure under regulation 10(6) of sebi (substantial acquisition of shares and takeovers) regulations, 2011 (the ""takeover regulations"").",30-Oct-2018 10:41:00,2018-10-30 10:41:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_30102018100338_Sunpharma_010.pdf,30-10-2018,571.9000244140625,575.9000244140625,559.6500244140625,562.0499877929688,532.1099853515625,2783468,0.0,0.0,06-11-2018,0
287,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'intimation for inter-se change in the shareholding of certain promoter group entities on account of scheme of amalgamation'.,24-Oct-2018 21:44:00,2018-10-24 21:44:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_24102018214302_SPILintimationLetterforSFPL_407.pdf,24-10-2018,583.0,584.0,561.4500122070312,570.7000122070312,540.29931640625,5820242,0.0,0.0,31-10-2018,0
288,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 23, 2018, titled ""sun pharma to announce second quarter results on november 13, 2018"".",23-Oct-2018 17:36:00,2018-10-23 17:36:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_23102018173442_IntimationSE20181023_223.pdf,23-10-2018,605.0,605.5999755859375,572.75,575.8499755859375,545.1748657226562,4538253,0.0,0.0,30-10-2018,0
289,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 23, 2018, titled ""sun pharma announces the availability of ilumyatm (tildrakizumab-asmn) in the united states for the treatment of moderate-to-severe plaque psoriasis"".",23-Oct-2018 15:59:00,2018-10-23 15:59:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_23102018155629_IntimationSE20181023_140.pdf,23-10-2018,605.0,605.5999755859375,572.75,575.8499755859375,545.1748657226562,4538253,0.0,0.0,30-10-2018,0
290,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting,"sun pharmaceutical industries limited has submitted the exchange a copy srutinizers report of  annual general meeting held on september 26, 2018. further, the company has informed the exchange regarding voting results.",27-Sep-2018 22:04:00,2018-09-27 22:04:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_27092018215644_SPILAGMVotingResults2018_056.pdf,27-09-2018,641.7000122070312,643.9500122070312,625.2000122070312,631.25,597.6237182617188,4070395,0.0,0.0,05-10-2018,-1
291,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'text of the speech delivered by mr. israel makov, chairman at the annual general meeting of the company held on september 26, 2018.'.",27-Sep-2018 14:28:00,2018-09-27 14:28:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract3_2792018142521_TwentysixthAGMSpeechSept18_749.pdf,27-09-2018,641.7000122070312,643.9500122070312,625.2000122070312,631.25,597.6237182617188,4070395,0.0,0.0,05-10-2018,-1
292,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of annual general meeting held on september 26, 2018",26-Sep-2018 19:37:00,2018-09-26 19:37:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_26092018193255_SPILOutcomeof26thAGM_587.pdf,26-09-2018,649.7999877929688,649.7999877929688,632.5499877929688,639.8499755859375,605.765625,4850782,0.0,0.0,04-10-2018,-1
293,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 21, 2018, titled ""sun pharma announces australian tga approval of ilumyaￂﾙ "".",21-Sep-2018 11:33:00,2018-09-21 11:33:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_21092018113232_IntimationSE20180921_709.pdf,21-09-2018,650.0,655.0,614.5,634.9000244140625,601.079345703125,9635852,0.0,0.0,28-09-2018,0
294,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 18, 2018, titled ""sun pharma announces receipt of european commission approval for ilumetriￂﾮ "".",18-Sep-2018 16:43:00,2018-09-18 16:43:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_18092018163928_IntimationSE20180918_121.pdf,18-09-2018,646.4000244140625,655.7000122070312,640.5,642.5,608.2744750976562,5780144,0.0,0.0,26-09-2018,0
295,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 14, 2018, titled ""sun pharma and sparc announce us fda approval of xelpros"".",14-Sep-2018 07:21:00,2018-09-14 07:21:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_14092018071824_IntimationSE20180914_566.pdf,14-09-2018,665.0,670.9000244140625,658.0,665.25,627.9192504882812,7444874,0.0,0.0,24-09-2018,-1
296,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,the exchange had sought clarification from the company with respect to news item captioned-sun pharma mohali plant on fda radar. the response from the company is attached.,11-Sep-2018 19:08:00,2018-09-11 19:08:00,-,-,https://nsearchives.nseindia.com/corporate/dhamals_119201819431_SPILStockExchangereplyletterMohaliSep112018_226.pdf,11-09-2018,643.0,649.4000244140625,627.5499877929688,630.4000244140625,595.0247192382812,8273963,0.0,0.0,19-09-2018,0
297,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," that one of the wholly owned subsidiaries of the company has agreed to acquire shares of tarsius pharma ltd, (ￂﾓtarsiusￂﾔ), israel, by way of subscription of 345,622 ordinary shares of nominal value of nis 0.01 each, representing 18.75% of shares of tarsius, on a fully diluted basis.",10-Sep-2018 16:04:00,2018-09-10 16:04:00,-,-,https://nsearchives.nseindia.com/corporate/listcontract1_1092018155837_SPILDisclosuretoSE10Sept2018CoveringletterwithAnnexA_397.pdf,10-09-2018,656.5,667.25,635.3499755859375,638.0,602.1982421875,9930755,0.0,0.0,18-09-2018,0
298,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned ""sun pharma falls 5% on report of co getting 6 observations by us fda for halol unit"". the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. sun pharmaceutical industries limited has submitted their response.",07-Sep-2018 14:52:00,2018-09-07 14:52:00,-,-,https://nsearchives.nseindia.com/corporate/deepak_07092018144953_SUNPHARMA_7615_reply_280.pdf,07-09-2018,650.0,670.0,640.0,664.25,626.975341796875,22074525,0.0,0.0,17-09-2018,0
299,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'submission of newspaper advertisement under regulation 30 read with regulation 47 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",05-Sep-2018 14:52:00,2018-09-05 14:52:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_05092018144509_CoveringLetter_275.pdf,05-09-2018,654.0999755859375,671.7999877929688,653.75,663.75,626.5032958984375,9140409,0.0,0.0,12-09-2018,0
300,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of annual general meeting to be held on september 26, 2018",31-Aug-2018 16:57:00,2018-08-31 16:57:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA123_31082018164513_SPILsubmissionofNoticeof26thAGM2018_342.pdf,31-08-2018,643.4500122070312,659.4000244140625,643.2999877929688,652.8499755859375,616.2149047851562,12972927,0.0,0.0,07-09-2018,0
301,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 29, 2018, titled ""sun pharma launches volini maxx, indiaￂﾒs strongest pain relief spray"".",29-Aug-2018 14:08:00,2018-08-29 14:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA456_29082018140651_IntimationSE20180829_120.pdf,29-08-2018,623.9000244140625,631.0,616.7999877929688,621.25,586.38818359375,4435825,0.0,0.0,05-09-2018,1
302,SUNPHARMA,Sun Pharmaceutical Industries Limited,agm/book closure," thatￂﾠthe register of members and share transfer books of the company shall remain closed from september 19, 2018 to september 26, 2018ￂﾠ(both days inclusive)ￂﾠ for the purpose ofￂﾠannual general meeting of the company is scheduled to be held on september 26, 2018 and payment of dividend",20-Aug-2018 20:09:00,2018-08-20 20:09:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_AGMBOOK.pdf,20-08-2018,625.0,630.9500122070312,620.25,626.3499755859375,591.2020263671875,9494515,0.0,0.0,28-08-2018,0
303,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 16, 2018, titled ""sun pharma announces u.s. fda approval of cequaￂﾙ to treat dry eye disease "".",16-Aug-2018 08:32:00,2018-08-16 08:32:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180816_16082018083257_961.zip,16-08-2018,610.0,621.7000122070312,602.2000122070312,619.7000122070312,584.9251708984375,25169096,0.0,0.0,24-08-2018,0
304,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 14, 2018, titled ""sun pharma reports q1fy19 results, gross sales at rs.7,139 crores up 16%,adjusted net profit at rs.983 crores up 87%"".",14-Aug-2018 14:30:00,2018-08-14 14:30:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180814_14082018143028_242.zip,14-08-2018,565.5,610.0,560.0999755859375,601.7999877929688,568.0296020507812,25001972,0.0,0.0,23-08-2018,1
305,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended june 30, 2018.",14-Aug-2018 14:20:45,2018-08-14 14:20:45,-,-,https://nsearchives.nseindia.com/corporate/OutcomeBM14082018_14082018142045.zip,14-08-2018,565.5,610.0,560.0999755859375,601.7999877929688,568.0296020507812,25001972,0.0,0.0,23-08-2018,1
306,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 06, 2018, titled ""sun pharma launches novel drug kapspargo sprinkleￂﾙ in usa"".",06-Aug-2018 15:47:00,2018-08-06 15:47:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180806_06082018154759_256.zip,06-08-2018,586.5,593.4000244140625,575.0999755859375,576.1500244140625,543.8190307617188,3867267,0.0,0.0,13-08-2018,0
307,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 27, 2018, titled ""sun pharma to announce first quarter results on august 14, 2018"".",27-Jul-2018 15:30:00,2018-07-27 15:30:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180727_27072018153008_189.zip,27-07-2018,555.9000244140625,561.0,553.25,557.0499877929688,525.7908935546875,2638153,0.0,0.0,03-08-2018,1
308,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 25, 2018, titled ""sun pharma announces launch of generic glumetzaￂﾮ tablets in us"".",25-Jul-2018 13:01:00,2018-07-25 13:01:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180725_25072018130139_416.zip,25-07-2018,566.4000244140625,567.3499755859375,555.5,558.1500244140625,526.8291625976562,2161490,0.0,0.0,01-08-2018,0
309,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 18, 2018, titled ""sun pharma announces u.s. fda approval of infugemￂﾙ injection"".",18-Jul-2018 11:09:00,2018-07-18 11:09:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180718_18072018110954_023.zip,18-07-2018,554.9500122070312,559.2000122070312,542.8499755859375,549.9000244140625,519.0421752929688,5720388,0.0,0.0,25-07-2018,0
310,SUNPHARMA,Sun Pharmaceutical Industries Limited,reply to clarification sought,"sunpharma:the exchange had sought clarification from sun pharmaceutical industries limited with respect to announcement dated 11-jul-2018, regarding ""  regarding a press release dated july 11, 2018, titled ""dusa pharmaceuticals, inc. files lawsuit against biofrontera inc. for patent infringement, trade secret misappropriation, and tortious interference""."".on basis of above the company is required to clarify following:1. quantum of claims, if any<br>2. expected financial implications, if any, due to compensation, penalty etc;<br>3. brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is filed, brief details of dispute/litigation;the response of the company is enclosed.",12-Jul-2018 19:23:00,2018-07-12 19:23:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockexchangereplyClarificationonpressreleaseDUSA12July2018_12072018192327_592.zip,12-07-2018,563.0,570.7000122070312,558.0,564.4500122070312,532.775634765625,3736611,0.0,0.0,19-07-2018,0
311,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'submission of advertisement published in newspapers regarding notice for transfer of equity shares and unclaimed dividend to the investor education and protection fund (iepf) suspense account'.,12-Jul-2018 19:04:00,2018-07-12 19:04:00,-,-,https://nsearchives.nseindia.com/corporate/Intimationtostockexchange_12072018190432_582.zip,12-07-2018,563.0,570.7000122070312,558.0,564.4500122070312,532.775634765625,3736611,0.0,0.0,19-07-2018,0
312,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 11, 2018, titled ""dusa pharmaceuticals, inc. files lawsuit against biofrontera inc. for patent infringement, trade secret misappropriation, and tortious interference"".",11-Jul-2018 18:04:00,2018-07-11 18:04:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180711_11072018180437_244.zip,11-07-2018,564.9500122070312,569.7000122070312,559.5999755859375,560.75,529.283203125,3519985,0.0,0.0,18-07-2018,0
313,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 09, 2018, titled ""sun pharma signs akshay kumar as revital h brand ambassador"".",09-Jul-2018 14:38:00,2018-07-09 14:38:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180709_09072018143853_213.zip,09-07-2018,560.5999755859375,572.5999755859375,560.5999755859375,568.7999877929688,536.881591796875,4117856,0.0,0.0,16-07-2018,-1
314,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 12, 2018, titled ""sun pharma receives eir for halol facility"".",12-Jun-2018 17:15:00,2018-06-12 17:15:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180612_12062018171523_152.zip,12-06-2018,535.7000122070312,544.9500122070312,531.3499755859375,540.4500122070312,510.1223754882813,8140874,0.0,0.0,19-06-2018,0
315,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceutical industries limited with respect to recent news item captioned ""no re-inspection at sun pharma's halol unit sends stock soaring 9%"". the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. sun pharmaceutical industries limited has submitted their response.",08-Jun-2018 21:13:00,2018-06-08 21:13:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockexchangereplyletterforClarificationonnewsitem8June2018_08062018211348.zip,08-06-2018,487.0,533.6500244140625,486.25,528.25,498.6070861816406,29224236,0.0,0.0,15-06-2018,1
316,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 05, 2018, titled ""sun pharma receives prestigious csr award"".",05-Jun-2018 15:59:00,2018-06-05 15:59:00,-,-,https://nsearchives.nseindia.com/corporate/SPILPressReleaseCSRAwardJune52018_05062018155924_877.zip,05-06-2018,476.1499938964844,483.25,470.1499938964844,473.5,446.9292907714844,3076737,0.0,0.0,12-06-2018,1
317,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of court convened general meeting held on jun 01, 2018",01-Jun-2018 15:00:00,2018-06-01 15:00:00,-,-,https://nsearchives.nseindia.com/corporate/NCLTMeetingProceedings01062018_01062018150023_175.zip,01-06-2018,485.0,489.5499877929688,479.1000061035156,484.3500061035156,457.1705017089844,3793797,0.0,0.0,08-06-2018,1
318,SUNPHARMA,Sun Pharmaceutical Industries Limited,scheme of arrangement," that the board of directors of the company at its meeting held on may 25, 2018 - approved the composite scheme of arrangement among sun pharmaceutical industries limited (ￂﾓtransferor companyￂﾔ) and sun pharma (netherlands) b.v. (ￂﾓtransferee company 1ￂﾔ) and sun pharmaceutical holdings usa inc. (ￂﾓtransferee company 2ￂﾔ) and their respective members and creditors",25-May-2018 17:14:00,2018-05-25 17:14:00,-,-,https://nsearchives.nseindia.com/corporate/Outomemay252018BM_25052018171426_360.zip,25-05-2018,465.5,469.3999938964844,456.0,466.4500122070313,440.2749633789063,4971624,0.0,0.0,01-06-2018,0
319,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 25, 2018, relating to fourth quarter & full year fy18 financials.",25-May-2018 17:05:00,2018-05-25 17:05:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180525_25052018170521_343.zip,25-05-2018,465.5,469.3999938964844,456.0,466.4500122070313,440.2749633789063,4971624,0.0,0.0,01-06-2018,0
320,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended march 31, 2018.",25-May-2018 16:32:13,2018-05-25 16:32:13,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_25052018163213.zip,25-05-2018,465.5,469.3999938964844,456.0,466.4500122070313,440.2749633789063,4971624,0.0,0.0,01-06-2018,0
321,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that board of directors at its meeting held on may 25, 2018, recommended final dividend of 2 per equity share.",25-May-2018 15:44:00,2018-05-25 15:44:00,-,-,https://nsearchives.nseindia.com/corporate/Outomemay252018BM_25052018154429_242.zip,25-05-2018,465.5,469.3999938964844,456.0,466.4500122070313,440.2749633789063,4971624,0.0,0.0,01-06-2018,0
322,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting," regarding  outcome of board meeting held on may 25, 2018 for approval of audited financial results.",25-May-2018 15:41:00,2018-05-25 15:41:00,-,-,https://nsearchives.nseindia.com/corporate/Outomemay252018BM_25052018154116_237.zip,25-05-2018,465.5,469.3999938964844,456.0,466.4500122070313,440.2749633789063,4971624,0.0,0.0,01-06-2018,0
323,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 23, 2018, titled ""sun pharma announces usfda approval of yonsa"".",23-May-2018 07:56:00,2018-05-23 07:56:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180523_23052018075616_652.zip,23-05-2018,454.0,461.5,449.4500122070313,452.25,426.8717346191406,4549341,0.0,0.0,30-05-2018,1
324,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial results updates, that the company will be additionally submitting quarterly / year-to-date consolidated financial results along with standalone financial results during the financial year 2018-19.,18-May-2018 08:26:00,2018-05-18 08:26:00,-,-,https://nsearchives.nseindia.com/corporate/SPIL_Reg33_18052018082625_019.zip,18-05-2018,488.9500122070313,488.9500122070313,462.8500061035156,464.8999938964844,438.8118591308594,8722402,0.0,0.0,25-05-2018,0
325,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 17, 2018, titled ""sun pharma announces us launch of authorized generic for welcholￂﾮ tablets"".",17-May-2018 22:57:00,2018-05-17 22:57:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170517_17052018225723_012.zip,17-05-2018,473.0,486.0,468.3500061035156,479.8500061035156,452.9229431152344,5939278,0.0,0.0,24-05-2018,0
326,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 11, 2018, titled ""sun pharma to announce fourth quarter results on may 25, 2018"".",11-May-2018 10:47:00,2018-05-11 10:47:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180511_11052018104708_464.zip,11-05-2018,494.0,496.1499938964844,467.75,472.0499877929688,445.5606384277344,9906203,0.0,0.0,18-05-2018,0
327,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated april 30, 2018, titled ""sun pharma chc enters anti-fungal powder otc category with abzorb"".",30-Apr-2018 12:25:00,2018-04-30 12:25:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180430_30042018122503_546.zip,30-04-2018,528.0,530.9500122070312,525.0999755859375,528.4000244140625,498.7485656738281,1689385,0.0,0.0,08-05-2018,0
328,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of court convened general meeting to be held on jun 01, 2018",26-Apr-2018 15:48:00,2018-04-26 15:48:00,-,-,https://nsearchives.nseindia.com/corporate/SPILIntimationforadvertisement_26042018154854_138.zip,26-04-2018,514.0,522.7000122070312,511.2999877929688,512.5999755859375,483.8351745605469,3304748,0.0,0.0,04-05-2018,0
329,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure under regulation 30 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",18-Apr-2018 18:55:00,2018-04-18 18:55:00,-,-,https://nsearchives.nseindia.com/corporate/SPILReg30DisclosureRanbaxyMalaysiaSdnBhd18Apr2018_18042018185549_258.zip,18-04-2018,514.3499755859375,517.4000244140625,510.6499938964844,512.0,483.2689208984375,2412444,0.0,0.0,25-04-2018,0
330,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of court convened general meeting to be held on jun 01, 2018",17-Apr-2018 18:31:00,2018-04-17 18:31:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationNCLTMeetingJune012018_17042018183115_575.zip,17-04-2018,521.9000244140625,521.9000244140625,510.5,512.1500244140625,483.4104919433594,3104869,0.0,0.0,24-04-2018,0
331,SUNPHARMA,Sun Pharmaceutical Industries Limited,disc. under reg.30 of sebi (sast) reg.2011,"promoter of the company has submitted to the exchange a copy of disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",10-Apr-2018 15:09:00,2018-04-10 15:09:00,-,-,https://nsearchives.nseindia.com/corporate/Sun_DSS_10042018150926.zip,10-04-2018,512.4000244140625,515.9000244140625,507.5,508.25,479.7293090820313,2645876,0.0,0.0,17-04-2018,0
332,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated march 21, 2018, titled ""sun pharma announces u.s. fda approval ofilumyaￂﾙ (tildrakizumab-asmn)"".",21-Mar-2018 17:55:00,2018-03-21 17:55:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180321_21032018175502_332.zip,21-03-2018,513.9500122070312,515.5999755859375,502.5499877929688,504.5,476.189697265625,3986735,0.0,0.0,28-03-2018,0
333,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure under regulation 30 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",19-Feb-2018 19:23:00,2018-02-19 19:23:00,-,-,https://nsearchives.nseindia.com/corporate/SPILReg30DisclosureRanbaxyMalaysiaSdnBhd19Feb2018_19022018192350_667.zip,19-02-2018,575.0,577.25,553.5499877929688,561.4000244140625,529.8967895507812,3518880,0.0,0.0,26-02-2018,0
334,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 14, 2018, titled ""sun pharma reports q3fy18 results"".",14-Feb-2018 16:37:00,2018-02-14 16:37:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180214_14022018163728_856.zip,14-02-2018,590.9500122070312,591.7999877929688,571.2000122070312,574.7999877929688,542.5447387695312,6630066,0.0,0.0,21-02-2018,-1
335,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended december 31, 2017.",14-Feb-2018 15:54:36,2018-02-14 15:54:36,-,-,https://nsearchives.nseindia.com/corporate/SPILRESULTS31122017_14022018155436.zip,14-02-2018,590.9500122070312,591.7999877929688,571.2000122070312,574.7999877929688,542.5447387695312,6630066,0.0,0.0,21-02-2018,-1
336,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange had sought clarification from the company with respect to news item captioned ""fire at sun pharma's ankleshwar plant, company says no casualties . in this regard, exchange has advised the company to provide clarification/confirmation on the news item in detail including the following: a) whether such event/negotiations/article stated in published news were taking place? if so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the company. b) whether company is aware of any information that has not been announced to the exchanges under regulation 30 of listing regulations. the response from the company is enclosed.",06-Feb-2018 08:51:00,2018-02-06 08:51:00,-,-,https://nsearchives.nseindia.com/corporate/SPILReplytoNSEonNewsClarificationAnkleshwarunitFeb52018_06022018085123_021.zip,06-02-2018,537.0,554.5,531.2000122070312,551.7999877929688,520.8353881835938,6325143,0.0,0.0,14-02-2018,0
337,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated february 02, 2018, titled ""sun pharma to announce third quarter results on february 14, 2018"".",02-Feb-2018 17:36:00,2018-02-02 17:36:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180202_02022018173652_449.zip,02-02-2018,552.0,567.3499755859375,544.6500244140625,551.2000122070312,520.26904296875,10873325,0.0,0.0,09-02-2018,1
338,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated january 16, 2018, titled ""sun pharma announces settlement of patent litigation for generic linzessￂﾮ in us"".",16-Jan-2018 18:59:00,2018-01-16 18:59:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20180116_16012018185928_646.zip,16-01-2018,577.3499755859375,583.9500122070312,572.1500244140625,577.7000122070312,545.2820434570312,4868363,0.0,0.0,23-01-2018,0
339,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'disclosure under regulation 30 of the sebi (listing obligations and disclosure requirements) regulations, 2015'.",08-Jan-2018 19:25:00,2018-01-08 19:25:00,-,-,https://nsearchives.nseindia.com/corporate/Reg30DisclosureRanbaxyMalaysiaSdnBhd_08012018192508_675.zip,08-01-2018,588.0,604.5999755859375,586.1500244140625,591.5999755859375,558.402099609375,10475190,0.0,0.0,15-01-2018,0
340,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release (revised)," regarding a revised press release dated december 27, 2017, titled ""sun pharma announces us fda acceptance of nda for otx-101"".",27-Dec-2017 08:56:00,2017-12-27 08:56:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20121227_27122017085627_635.zip,27-12-2017,543.7999877929688,581.7000122070312,543.0499877929688,576.2999877929688,543.9605712890625,23356359,0.0,0.0,03-01-2018,0
341,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated december 27, 2017, titled ""sun pharma announces us fda acceptance of nda for otx-101"".",27-Dec-2017 08:27:00,2017-12-27 08:27:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20121227_27122017082712_629.zip,27-12-2017,543.7999877929688,581.7000122070312,543.0499877929688,576.2999877929688,543.9605712890625,23356359,0.0,0.0,03-01-2018,0
342,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 24, 2017, titled ""sun pharmaceutical industries inc. issues voluntary nationwide recall of riometￂﾮ (metformin hydrochloride oral solution) manufactured by a contract manufacturer due to microbial contamination"".",24-Nov-2017 19:58:00,2017-11-24 19:58:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20171124_24112017195821_915.zip,24-11-2017,545.75,551.0,541.7000122070312,549.5,518.66455078125,4099139,0.0,0.0,01-12-2017,0
343,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," regarding update on disclosure under regulation 30 of the sebi ( listing obligations and disclosure requirements) regulations, 2015.",22-Nov-2017 20:03:00,2017-11-22 20:03:00,-,-,https://nsearchives.nseindia.com/corporate/DisclosureReg30Scpharmaceuticals_22112017200347_425.zip,22-11-2017,539.75,544.6500244140625,530.1500244140625,535.25,505.2142333984375,4294740,0.0,0.0,29-11-2017,0
344,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated november 14, 2017, titled ""sun pharma reports q2fy18 results, q2 gross sales at rs. 6,590 crores, q2 net profit at rs. 912 crores "".",14-Nov-2017 17:03:00,2017-11-14 17:03:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20171114_14112017170342_871.zip,14-11-2017,533.4000244140625,537.9000244140625,517.0999755859375,526.0499877929688,496.5304260253906,5853721,0.0,0.0,21-11-2017,0
345,SUNPHARMA,Sun Pharmaceutical Industries Limited,scheme of arrangement," regarding scheme of arrangement approved at board meeting held on november 14, 2017.",14-Nov-2017 16:09:00,2017-11-14 16:09:00,-,-,https://nsearchives.nseindia.com/corporate/Reg30_14112017160959_785.zip,14-11-2017,533.4000244140625,537.9000244140625,517.0999755859375,526.0499877929688,496.5304260253906,5853721,0.0,0.0,21-11-2017,0
346,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended september 30, 2017.",14-Nov-2017 15:53:04,2017-11-14 15:53:04,-,-,https://nsearchives.nseindia.com/corporate/outcomesept202017_14112017155304.zip,14-11-2017,533.4000244140625,537.9000244140625,517.0999755859375,526.0499877929688,496.5304260253906,5853721,0.0,0.0,21-11-2017,0
347,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 31, 2017, titled ""sun pharma to announce second quarter results on november 14, 2017"".",31-Oct-2017 16:40:00,2017-10-31 16:40:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20171031_31102017164037_748.zip,31-10-2017,553.0,558.7000122070312,545.9000244140625,552.9000244140625,521.8738403320312,2907328,0.0,0.0,07-11-2017,0
348,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated october 26, 2017, titled ""sun pharma announces us fda approval for generic coreg crￂﾮ "".",26-Oct-2017 13:36:00,2017-10-26 13:36:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20171026_26102017133606_125.zip,26-10-2017,525.4000244140625,538.9000244140625,519.0,530.1500244140625,500.40032958984375,3566575,0.0,0.0,02-11-2017,1
349,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," that  one of the wholly owned subsidiaries of the company has agreed to increase its shareholding in ranbaxy malaysia sdn bhd, malaysia, by way of purchase of 666,985 shares of face value of myr 1.00 each (equivalent to 8.3%) of ranbaxy malaysia sdn bhd.",12-Oct-2017 16:05:00,2017-10-12 16:05:00,-,-,https://nsearchives.nseindia.com/corporate/DisclosureRegulation30_12102017160527_186.zip,12-10-2017,543.0,545.0,532.0,539.5499877929688,509.2728271484375,8970339,0.0,0.0,19-10-2017,0
350,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding 'this is with reference to our letters dated april 21, 2017 to the stock exchanges providing our clarification on the us fda inspection at the companyￂﾒs dadra facility wherein interalia we had indicated that we were then in the process of responding to the form-483 observation letter issued by the us fda post the inspection completed on april 13, 2017. we had further stated that if there are any material developments related to this inspection, we will promptly inform the stock exchanges.we are now pleased to inform you that the above referred inspection is closed. in this respect ,we have received a communication from the us fda releasing a copy of the establishment inspection report (eir) in respect of the above inspection based upon our responses to the said observation letter. please note eir is issued to the entity when the us fda concludes that an inspection is closed under title 21 section 20.64 (d) (3) of code of federal regulation.  this is for your information and necessary dissemination.'.",11-Oct-2017 17:21:00,2017-10-11 17:21:00,-,-,https://nsearchives.nseindia.com/corporate/Update_11102017172101_615.zip,11-10-2017,530.7999877929688,533.1500244140625,521.1500244140625,526.0499877929688,496.5304260253906,4031497,0.0,0.0,18-10-2017,0
351,SUNPHARMA,Sun Pharmaceutical Industries Limited,credit rating, regarding credit rating of commercial paper of the company by crisil,04-Oct-2017 19:50:00,2017-10-04 19:50:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStkexchangeintimationCRISILfornewCPrating04Oct2017_04102017195043_280.zip,04-10-2017,504.1000061035156,522.0,502.0,517.9000244140625,488.8377990722656,6203591,0.0,0.0,11-10-2017,0
352,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting,"sun pharmaceutical industries limited has submitted the exchange a copy srutinizers report of  annual general meeting held on september 26, 2017. further, the company has informed the exchange regarding voting results.",27-Sep-2017 20:36:00,2017-09-27 20:36:00,-,-,https://nsearchives.nseindia.com/corporate/VotingResults25thAGM_27092017203640_002.zip,27-09-2017,503.9500122070313,503.9500122070313,489.5,494.7000122070313,466.9396667480469,7594880,0.0,0.0,05-10-2017,0
353,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding 'chairman speech made at 25th agm as on 26 september 2017 enclosed.'.,26-Sep-2017 15:40:00,2017-09-26 15:40:00,-,-,https://nsearchives.nseindia.com/corporate/TwentyfifthAGMSpeechSept17_26092017154036_221.zip,26-09-2017,506.0,515.0,505.1499938964844,507.6000061035156,479.1157531738281,3615167,0.0,0.0,04-10-2017,0
354,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding proceedings of annual general meeting held on september 26, 2017",26-Sep-2017 15:15:00,2017-09-26 15:15:00,-,-,https://nsearchives.nseindia.com/corporate/Outcome25thAGM_26092017151541_201.zip,26-09-2017,506.0,515.0,505.1499938964844,507.6000061035156,479.1157531738281,3615167,0.0,0.0,04-10-2017,0
355,SUNPHARMA,Sun Pharmaceutical Industries Limited,meeting updates," that the committee of directors (allotment) at its meeting held on september 26, 2017 allotted 1,106 (one thousand one hundred and six) equity shares of the company of re 1/- each, on exercise of stock options under the sun employee stock option plan-2015. accordingly, post the above allotment the paid-up equity share capital of the company is rs. 2,39,93,08,086/- (rupees two hundred and thirty nine crores ninety three lakhs eight thousand and eighty six only) divided into 2,39,93,08,086/- (two hundred and thirty nine crores ninety three lakhs eight thousand and eighty six only) equity shares of re.1/- each.",26-Sep-2017 10:13:00,2017-09-26 10:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26092017101306.zip,26-09-2017,506.0,515.0,505.1499938964844,507.6000061035156,479.1157531738281,3615167,0.0,0.0,04-10-2017,0
356,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated september 20, 2017, titled ""sun pharma odomzoￂﾮ (sonidegib) new label approval showssustained duration of response of 26 months in treatment of locally advanced basal cell carcinoma"".",20-Sep-2017 08:42:00,2017-09-20 08:42:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170920_20092017084212_039.zip,20-09-2017,518.7999877929688,519.4000244140625,503.6000061035156,505.5,477.1335754394531,5024973,0.0,0.0,27-09-2017,0
357,SUNPHARMA,Sun Pharmaceutical Industries Limited,amalgamation/merger," regarding approval of scheme of arrangement among sun pharma medisales private limited, ranbaxy drugs limited, gufic pharma limited, vidyut investments limited and sun pharmaceutical industries limited and their respective members and creditors and filing of e-form inc-28 with registrar of companies",08-Sep-2017 20:03:00,2017-09-08 20:03:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationforfilingofINC28_08092017200348_481.zip,08-09-2017,478.9500122070313,484.2999877929688,467.25,471.3500061035156,441.929931640625,3557040,0.0,0.0,15-09-2017,1
358,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding submission of newspaper advertisement under regulation 30 read with regulation 47 of the sebi (listing obligations and disclosure requirements) regulations, 2015",06-Sep-2017 17:23:00,2017-09-06 17:23:00,-,-,https://nsearchives.nseindia.com/corporate/CoveringLetterandpublications_06092017172332_128.zip,06-09-2017,486.9500122070313,486.9500122070313,473.0,474.25,444.6490173339844,7344173,0.0,0.0,13-09-2017,1
359,SUNPHARMA,Sun Pharmaceutical Industries Limited,agm/book closure," that the register of members and share transfer books of the company shall remain closed from september 20, 2017 to september 26 , 2017(both days inclusive) for the purpose of annual general meeting of the company is scheduled to be held on september 26, 2017.and payment of dividend",01-Sep-2017 08:34:00,2017-09-01 08:34:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_AGMBOOK_01092017083456.zip,01-09-2017,481.0,492.0,480.7999877929688,486.2000122070313,455.8530883789063,3998817,0.0,0.0,08-09-2017,0
360,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of annual general meeting to be held on september 26, 2017",31-Aug-2017 17:16:00,2017-08-31 17:16:00,-,-,https://nsearchives.nseindia.com/corporate/SPILIntimationforAGMBookClosure_31082017171629_901.zip,31-08-2017,487.1499938964844,487.3500061035156,476.6499938964844,481.1499938964844,451.1183166503906,4398132,0.0,0.0,07-09-2017,0
361,SUNPHARMA,Sun Pharmaceutical Industries Limited,amalgamation/merger," regarding ""approval of scheme of arrangement among sun pharma medisales private limited, ranbaxy drugs limited, gufic pharma limited, vidyut investments limited and the company and their respective members and creditors"".",14-Aug-2017 20:33:00,2017-08-14 20:33:00,-,-,https://nsearchives.nseindia.com/corporate/approvalmerger_14082017203312_328.zip,14-08-2017,433.0,476.9500122070313,432.7000122070313,471.7999877929688,442.3518981933594,20846332,0.0,0.0,22-08-2017,0
362,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding update on acquisition of 203,135 series a preferred stock of krystal biotech inc., usa completion of transaction",11-Aug-2017 19:53:00,2017-08-11 19:53:00,-,-,https://nsearchives.nseindia.com/corporate/SPILIntimationtoStkExchangeKrystalBiotechcompletionoftransaction_11082017195303_921.zip,11-08-2017,458.0,462.9500122070313,444.6000061035156,450.0,421.91259765625,7851424,0.0,0.0,21-08-2017,0
363,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated august 11, 2017, titled ""sun pharma reports q1fy18 results"".",11-Aug-2017 16:04:00,2017-08-11 16:04:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170811_11082017160447_495.zip,11-08-2017,458.0,462.9500122070313,444.6000061035156,450.0,421.91259765625,7851424,0.0,0.0,21-08-2017,0
364,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended june 30, 2017.",11-Aug-2017 15:36:07,2017-08-11 15:36:07,-,-,https://nsearchives.nseindia.com/corporate/outcome_11082017153607.zip,11-08-2017,458.0,462.9500122070313,444.6000061035156,450.0,421.91259765625,7851424,0.0,0.0,21-08-2017,0
365,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition," that  one of the wholly owned subsidiaries of the company has agreed to acquire by way of allotment to it, 203,135 series a preferred stock (equivalent to 15.91% fully diluted equity stake on conversion) of krystal biotech inc., united states of america, a biopharmaceutical company using gene therapy to develop treatments for patients suffering from rare debilitating disorders.",08-Aug-2017 17:04:00,2017-08-08 17:04:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockExchangeIntimation8Aug2017_08082017170436_381.zip,08-08-2017,509.0,509.0,498.0,500.3500061035156,469.1199035644531,3042569,0.0,0.0,16-08-2017,0
366,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding disclosure under regulation 30 of sebi (listing obligations and disclosure requirements) regulations, 2015.",27-Jul-2017 18:08:00,2017-07-27 18:08:00,-,-,https://nsearchives.nseindia.com/corporate/Disclosureunderregulation30_27072017180817_439.zip,27-07-2017,580.0,582.2000122070312,567.5,572.0999755859375,536.3914184570312,5119717,0.0,0.0,03-08-2017,-1
367,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 26, 2017, titled ""sun pharma to announce first quarter results on august 11, 2017"".",26-Jul-2017 17:59:00,2017-07-26 17:59:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170726_26072017175910_367.zip,26-07-2017,568.5,580.2999877929688,566.5,579.5,543.32958984375,1896905,0.0,0.0,02-08-2017,-1
368,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," that pursuant to the company s policy on determining materiality of events/information, and consequent to the appointment of mr. kalyansundaram subramanian as the whole-time director of the company w.e.f. february 14, 2017 and consequent to the resignation of mr. uday baldota as the cfo of the company and appointment of mr. c. s. muralidharan as the cfo of the company w.e.f. june 19, 2017, mr. kalyansundaram subramanian and mr. c s muralidharan in place of mr. uday baldota be and are hereby additionally authorised to determine materiality of an event or information and for making disclosures to stock exchanges (s).",12-Jul-2017 16:22:00,2017-07-12 16:22:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockexchangeIntimationchangeinKMP_12072017162209_197.zip,12-07-2017,566.0,567.0,560.0,562.4000244140625,527.2970581054688,1383094,0.0,0.0,19-07-2017,0
369,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates, regarding intimation of settlement in re modafinil antitrust litigation matter in us.,10-Jul-2017 07:57:00,2017-07-10 07:57:00,-,-,https://nsearchives.nseindia.com/corporate/LettertoStockExchangesSPIL07072017_10072017075725_959.zip,10-07-2017,557.75,570.0,557.75,563.7000122070312,528.5159301757812,1025468,0.0,0.0,17-07-2017,0
370,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated july 04, 2017, titled ""sun pharma & samsung biologics announce strategic manufacturing tie-up for tildrakizumab"".",04-Jul-2017 07:33:00,2017-07-04 07:33:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170704_04072017073331_673.zip,04-07-2017,556.0,556.7000122070312,545.7000122070312,552.4500122070312,517.968017578125,1980453,0.0,0.0,11-07-2017,0
371,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 27, 2017, titled ""sun pharma & niv sign agreement to fight zika, chikungunya and dengue "".",27-Jun-2017 08:00:00,2017-06-27 08:00:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170627_27062017080025_862.zip,27-06-2017,547.0,549.4000244140625,537.25,544.0499877929688,510.09228515625,4675855,0.0,0.0,04-07-2017,0
372,SUNPHARMA,Sun Pharmaceutical Industries Limited,court convened meeting updates," that voting results of national company law tribunal ( nclt"") convened meeting of the equity shareholders of the company held on june 20, 2017 along with scrutinizers' report.",22-Jun-2017 08:23:00,2017-06-22 08:23:00,-,-,https://nsearchives.nseindia.com/corporate/TCMvotingresult_22062017082315_023.zip,22-06-2017,529.5,539.9500122070312,529.0,538.7000122070312,505.0763549804688,5201690,0.0,0.0,30-06-2017,0
373,SUNPHARMA,Sun Pharmaceutical Industries Limited,court convened meeting updates," regarding proceedings of national company law tribunal ( nclt"") convened separate meetings of the equity shareholders and unsecured creditors of sun pharmaceutical industries limited ( the company ) held on june 20, 2017",20-Jun-2017 18:12:00,2017-06-20 18:12:00,-,-,https://nsearchives.nseindia.com/corporate/TCMProceedings20062017_20062017181255_494.zip,20-06-2017,526.0999755859375,533.7999877929688,519.75,523.7999877929688,491.1062316894531,4464038,0.0,0.0,28-06-2017,0
374,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated jun 13, 2017, titled ""sun pharma announces us fda approval for generic zetia  tablets"".",13-Jun-2017 08:06:00,2017-06-13 08:06:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170613_13062017080647_537.zip,13-06-2017,551.1500244140625,552.0,536.2000122070312,537.2000122070312,503.669921875,9578458,0.0,0.0,20-06-2017,0
375,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," regarding a small correction in the profile of the chief financial officer of the company sent to the exchanges on may 26, 2017 along with the outcome of the board meeting held on may 26, 2017",30-May-2017 20:55:00,2017-05-30 20:55:00,-,-,https://nsearchives.nseindia.com/corporate/SPILCorrectionletter_30052017205546_635.zip,30-05-2017,502.0,510.5499877929688,502.0,508.0,476.2924499511719,10937265,0.0,0.0,06-06-2017,0
376,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,", the financial results for the period ended march 31, 2017.",29-May-2017 13:08:33,2017-05-29 13:08:33,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29052017130833.zip,29-05-2017,529.0,529.0,492.6499938964844,502.6000061035156,471.2295227050781,42138319,0.0,0.0,05-06-2017,0
377,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend," that the board of directors of the company at its meeting held on may 26, 2017, has recommended payment of dividend of rs. 3.5/- (rupees three and fifty paise only) per equity share of re.1/- each of the company for the year ended march 31, 2017, subject to approval of the members at the ensuing annual general meeting of the company.",26-May-2017 17:00:00,2017-05-26 17:00:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_26052017170009.zip,26-05-2017,590.5999755859375,597.8499755859375,564.0,567.6500244140625,532.2193603515625,10814562,0.0,0.0,02-06-2017,-1
378,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 26, 2017, titled ""fourth quarter & full year fy17 financials, "".",26-May-2017 16:58:00,2017-05-26 16:58:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170526_26052017165823_808.zip,26-05-2017,590.5999755859375,597.8499755859375,564.0,567.6500244140625,532.2193603515625,10814562,0.0,0.0,02-06-2017,-1
379,SUNPHARMA,Sun Pharmaceutical Industries Limited,allotment of securities," regarding allotment of 15000 securities pursuant to esop/esps at its meeting held on may 26, 2017",26-May-2017 11:00:00,2017-05-26 11:00:00,-,-,https://nsearchives.nseindia.com/corporate/Outcome_26052017110040_459.zip,26-05-2017,590.5999755859375,597.8499755859375,564.0,567.6500244140625,532.2193603515625,10814562,0.0,0.0,02-06-2017,-1
380,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 24, 2017, titled ""us fda filing acceptance of biologics license application (bla) for tildrakizumab"".",24-May-2017 10:24:00,2017-05-24 10:24:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170524_24052017102407_200.zip,24-05-2017,615.9500122070312,616.2999877929688,599.5,603.5,565.8318481445312,3751856,0.0,0.0,31-05-2017,-1
381,SUNPHARMA,Sun Pharmaceutical Industries Limited,corrigendum," regarding corrigendum to notice of court convened meeting to be held on may 21, 2017",16-May-2017 08:51:00,2017-05-16 08:51:00,-,-,https://nsearchives.nseindia.com/corporate/Soft_copy_of_NCLT_conveyed_meeting-_Sun_Pharmaceutical_Industries_16052017084347.zip,16-05-2017,655.0,656.5499877929688,648.0,652.3499755859375,611.632568359375,2325051,0.0,0.0,23-05-2017,-1
382,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated may 15, 2017, titled ""sun pharma to announce fourth quarter results on may 26, 2017"".",15-May-2017 16:21:00,2017-05-15 16:21:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170515_15052017162133_323.zip,15-05-2017,655.4000244140625,656.8499755859375,649.5,654.4500122070312,613.6016845703125,1224004,0.0,0.0,22-05-2017,0
383,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates," a copy of corrigendum to the notice of the national company law tribunal (""nclt"") convened meeting of the sun pharmaceutical industries limited (""the company"").",12-May-2017 14:13:00,2017-05-12 14:13:00,-,-,https://nsearchives.nseindia.com/corporate/corrigendumNCLTnotice_12052017141307_195.zip,12-05-2017,650.0,656.7000122070312,643.8499755859375,655.0999755859375,614.2109985351562,1992719,0.0,0.0,19-05-2017,0
384,SUNPHARMA,Sun Pharmaceutical Industries Limited,shareholders meeting," regarding notice of tribunal convened meeting of equity shareholder of the company to be held on june 20, 2017",11-May-2017 17:16:00,2017-05-11 17:16:00,-,-,https://nsearchives.nseindia.com/corporate/NCLTnoticeshareholdersandcreditors_11052017171617_782.zip,11-05-2017,644.8499755859375,649.9000244140625,640.1500244140625,648.4500122070312,607.97607421875,1674209,0.0,0.0,18-05-2017,0
385,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated april 28, 2017, titled ""press release sun pharma science foundation award"".",28-Apr-2017 16:31:00,2017-04-28 16:31:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170428_28042017163117_276.zip,28-04-2017,637.25,644.2000122070312,637.25,641.9500122070312,601.8817749023438,1903299,0.0,0.0,08-05-2017,0
386,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release," regarding a press release dated april 25, 2017, titled ""press release fdec commences roll-out of malaria demonstration project"".",25-Apr-2017 13:39:00,2017-04-25 13:39:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170425_25042017133943_148.zip,25-04-2017,645.25,649.0,639.9000244140625,642.5499877929688,602.4442138671875,1825996,0.0,0.0,03-05-2017,0
387,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange has sought clarification from the company with respect to news item captioned ""fda issues 11 observations for dadra unit"". the response from the company is enclosed.",21-Apr-2017 19:52:00,2017-04-21 19:52:00,-,-,https://nsearchives.nseindia.com/corporate/DADRA_21042017195232.zip,21-04-2017,659.4500122070312,659.4500122070312,636.5999755859375,639.5999755859375,599.678466796875,6091210,0.0,0.0,28-04-2017,0
388,SUNPHARMA,Sun Pharmaceutical Industries Limited,disc. under reg.30 of sebi (sast) reg.2011,"dilip s shanghvi has submitted to the exchange vide letter dated april 04, 2017 a copy of disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",06-Apr-2017 15:23:00,2017-04-06 15:23:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_30_06042017152311.zip,06-04-2017,692.9500122070312,692.9500122070312,683.1500244140625,686.9000244140625,644.0261840820312,2015425,0.0,0.0,13-04-2017,0
389,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 24, 2017, titled ""almirall and sun pharma announce regulatory filing of tildrakizumab in europe"".",24-Mar-2017 12:30:00,2017-03-24 12:30:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170324_24032017123022_069.zip,24-03-2017,703.5,709.6500244140625,700.2000122070312,703.9000244140625,659.9651489257812,1357525,0.0,0.0,31-03-2017,0
390,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"shanghvi finance private limited has submitted to the exchange, vide its letter dated march 22, 2017 a copy of disclosures under regulation 10(5) in respect of acquisition under regulation 10(1)(a) of sebi (substantial acquisition of shares and takeovers) regulations, 2011.",23-Mar-2017 08:54:00,2017-03-23 08:54:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23032017085438.zip,23-03-2017,704.0,705.0,699.25,703.1500244140625,659.261962890625,1294418,0.0,0.0,30-03-2017,0
391,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that one of the indirect subsidiaries of the company namely, taro pharmaceuticals inc. (canada) has entered into an agreement to acquire all of the issued and outstanding shares of thallion pharmaceuticals inc., a canadian pharmaceutical corporation.",17-Mar-2017 14:53:00,2017-03-17 14:53:00,-,-,https://nsearchives.nseindia.com/corporate/Disclosureunderregulation30_17032017145331_500.zip,17-03-2017,715.0,716.4000244140625,702.0,707.5,663.34033203125,3067000,0.0,0.0,24-03-2017,0
392,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 14, 2017, titled ""update on mohali facility"".",14-Mar-2017 13:44:00,2017-03-14 13:44:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170314_14032017134415_962.zip,14-03-2017,693.5,729.0499877929688,677.0999755859375,708.2000122070312,663.9967041015625,9857280,0.0,0.0,21-03-2017,0
393,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 01, 2017, titled ""press release tildrakizumab 2017 american academy of dermatology meeting"".",01-Mar-2017 19:46:00,2017-03-01 19:46:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170301_01032017194620_444.zip,01-03-2017,681.0999755859375,697.4000244140625,679.0,694.6500244140625,651.2923583984375,4972108,0.0,0.0,08-03-2017,0
394,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceuticals industries limited with respect to recent news item captioned ""uk regulator approves sun pharma's generic drug of tobramycin."". the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. sun pharmaceuticals industries limited has submitted their response.",16-Feb-2017 14:54:00,2017-02-16 14:54:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_6636_reply_16022017145441.zip,16-02-2017,624.0,652.0,623.4500122070312,649.2999877929688,608.7730102539062,6158072,0.0,0.0,23-02-2017,0
395,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange, the financial results for the period ended december 31, 2016.",14-Feb-2017 16:30:58,2017-02-14 16:30:58,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_14022017163058.zip,14-02-2017,659.0,662.8499755859375,640.9000244140625,649.2999877929688,608.7730102539062,3393607,0.0,0.0,21-02-2017,0
396,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 14, 2017, titled ""sun pharma reports q3fy17 results"".",14-Feb-2017 15:54:00,2017-02-14 15:54:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170214_14022017155426_135.zip,14-02-2017,659.0,662.8499755859375,640.9000244140625,649.2999877929688,608.7730102539062,3393607,0.0,0.0,21-02-2017,0
397,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange regarding the outcome of board meeting held on february 14, 2017.",14-Feb-2017 15:21:00,2017-02-14 15:21:00,-,-,https://nsearchives.nseindia.com/corporate/Appointmentofkalsundaram_14022017152156_085.zip,14-02-2017,659.0,662.8499755859375,640.9000244140625,649.2999877929688,608.7730102539062,3393607,0.0,0.0,21-02-2017,0
398,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange that the meeting of the board of directors of the company held , on february 14, 2017 and the board has inter-alia approved the following; 1.i appointment of mr. kalyanasundaram subramanian as an additional director :the board of directors of the company appointed mr. kalyanasundaram subramanian as an additional director of the company with immediate effect. ii. appointment of mr. kalyanasundaram subramanian as the wholetime director the board of directors of the company have, subject to the approval of the members of the company at the ensuing general meeting of the company, appointed mr. kalyanasundaram subramanian as the wholetime director of the company, without any remuneration, for a period of two (2) years from february 14, 2017 to february 13, 2019. mr. kalyanasundaram subramanian is not related to any of the directors of the company.",14-Feb-2017 15:14:00,2017-02-14 15:14:00,-,-,https://nsearchives.nseindia.com/corporate/Outcome_14022017151434_068.zip,14-02-2017,659.0,662.8499755859375,640.9000244140625,649.2999877929688,608.7730102539062,3393607,0.0,0.0,21-02-2017,0
399,SUNPHARMA,Sun Pharmaceutical Industries Limited,allotment of securities,"sun pharmaceuticals industries limited has informed the exchange that the allotment committee of directors at its meeting held on february 14, 2017, allotted 20,993(twenty thousand nine hundred and ninety three) equity shares of the company of re. 1/- (rupee one only) each, on exercise of stock options under the sun employee stock option scheme - 2015. accordingly, post the above allotment the paid-up equity share capital of the company is rs. 2,39,92,91,181/- (rupees two hundred and thirty nine crore ninety two lakhs ninety one thousand one hundred and eighty one only) divided into 2,39,92,91,181/- (two hundred and thirty nine crore ninety two lakhs ninety one thousand one hundred and eighty one only) equity shares of re.1/- each.",14-Feb-2017 11:05:00,2017-02-14 11:05:00,-,-,https://nsearchives.nseindia.com/corporate/Outcome_14022017110544_833.zip,14-02-2017,659.0,662.8499755859375,640.9000244140625,649.2999877929688,608.7730102539062,3393607,0.0,0.0,21-02-2017,0
400,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated january 31, 2017, titled ""sun pharma q3 fy17 financial result on february 14, 2017"".",31-Jan-2017 15:00:00,2017-01-31 15:00:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170131_31012017150056_001.zip,31-01-2017,644.5,649.0,630.0,631.5,592.0840454101562,1926978,0.0,0.0,07-02-2017,1
401,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange has sought clarification from the company with respect to recent news item captioned  ""sun pharma to sell ohm labs site at new jersey in the us; ohm labs site could fetch co up to $100 m."" the response from the company is enclosed.",24-Jan-2017 09:19:00,2017-01-24 09:19:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockExchangereplyonNewsclarificationJan232017NSE_24012017091926_030.zip,24-01-2017,636.0,644.5,636.0,641.4000244140625,601.3660888671875,2187797,0.0,0.0,01-02-2017,0
402,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated january 04, 2017, titled ""sun pharma announces positive topline results of confirmatory phase-3 clinical trial for seciera  for treatment of dry eye "".",04-Jan-2017 17:57:00,2017-01-04 17:57:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20170104_04012017175722_589.zip,04-01-2017,638.0,643.7999877929688,634.7999877929688,637.3499755859375,597.5687866210938,2500456,0.0,0.0,11-01-2017,0
403,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange has sought clarification from sun pharmaceuticals industries limited with respect to recent news item captioned ""blast at sun pharma unit''. the response from the company is enclosed.",29-Dec-2016 15:51:00,2016-12-29 15:51:00,-,-,https://nsearchives.nseindia.com/corporate/SPILReplytoNSEonnewsclarificationAhmednagarunitDec292016_29122016155158_100.zip,29-12-2016,621.5,624.9500122070312,611.8499755859375,614.7000122070312,576.3326416015625,4788982,0.0,0.0,05-01-2017,0
404,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that one of the wholly owned subsidiaries of the company has acquired 13,000,000 series b preferred stock of. scpharmaceuticals inc. (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment. scpharmaceuticals inc., is a united states pharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.",23-Dec-2016 08:31:00,2016-12-23 08:31:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockExchangeIntimation2312016scPharmaceuticalsInc_23122016083124_598.zip,23-12-2016,614.0,629.5,611.2000122070312,623.5,584.583251953125,6105681,0.0,0.0,30-12-2016,0
405,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 22, 2016, titled ""press release sun pharma to acquire branded oncology product odomzo  for global markets"".",22-Dec-2016 08:20:00,2016-12-22 08:20:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161222_22122016082031_311.zip,22-12-2016,616.25,625.0,608.0,609.1500244140625,571.1289672851562,5479188,0.0,0.0,29-12-2016,0
406,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange regarding update on acquisition of 85.1% of jsc biosintez, a russian pharmaceutical company.",20-Dec-2016 19:15:00,2016-12-20 19:15:00,-,-,https://nsearchives.nseindia.com/corporate/STOCKEXCHNAGEINTIMATION_20122016191501_034.zip,20-12-2016,635.0,638.0,622.0999755859375,627.9000244140625,588.7086181640625,3984283,0.0,0.0,27-12-2016,0
407,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has informed the exchange that one of the company s wholly-owned subsidiaries has voluntarily requested the usfda to withdraw approval for 28 abbreviated new drug applications (andas).these older drug products belong to erstwhile ranbaxy laboratories ltd. and are not being marketed in the us since 2008.,20-Dec-2016 08:24:00,2016-12-20 08:24:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_20122016082440.zip,20-12-2016,635.0,638.0,622.0999755859375,627.9000244140625,588.7086181640625,3984283,0.0,0.0,27-12-2016,0
408,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange vide letter dated december 15, 2016 that ""we refer to our letter and press release dated october 26, 2016 regarding agreement to acquire 100% equity stake of ocular technologies, sarl.further to the above, we wish to inform you that all the necessary formalities for closure of the said transaction have been concluded and we have successfully completed the acquisition of ocular technologies, sarl, today"".",16-Dec-2016 08:42:00,2016-12-16 08:42:00,-,-,https://nsearchives.nseindia.com/corporate/SPILIntimationtoStkExDec152016closureoftransactionOccularTechnologies_16122016084247_374.zip,16-12-2016,650.8499755859375,651.9000244140625,633.5999755859375,647.3499755859375,606.9446411132812,10780836,0.0,0.0,23-12-2016,0
409,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 12, 2016, titled ""press release sun pharma & moebius medical sign deal to develop novel liposomal non-opiod pain product for osteoarthritis"".",12-Dec-2016 16:48:00,2016-12-12 16:48:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161212_12122016164837_685.zip,12-12-2016,673.2000122070312,681.9000244140625,670.0,676.4000244140625,634.1815185546875,2155130,0.0,0.0,19-12-2016,-1
410,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has informed the exchange regarding update on usfda inspection for halol facility.,08-Dec-2016 14:36:00,2016-12-08 14:36:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockexchangeletterDec82016_08122016143658_117.zip,08-12-2016,664.0,679.5999755859375,658.8499755859375,675.7000122070312,633.5252075195312,6865033,0.0,0.0,15-12-2016,0
411,SUNPHARMA,Sun Pharmaceutical Industries Limited,news verification,"the exchange has sought clarification from sun pharmaceuticals industries limited with respect to recent news item captioned ""usfda informs that haloi issued 14 page form 483 post inspection."". the exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. sun pharmaceuticals industries limited has submitted their response.",07-Dec-2016 13:28:00,2016-12-07 13:28:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_6545_reply_07122016132808.zip,07-12-2016,700.0,700.0,660.0,664.0,622.5554809570312,12922300,0.0,0.0,14-12-2016,0
412,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 28, 2016, titled ""announcement of launches first branded ophthalmic product bromsite in usa,"".",28-Nov-2016 18:29:00,2016-11-28 18:29:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161128_28112016182925_807.zip,28-11-2016,713.6500244140625,720.2000122070312,710.0499877929688,715.1500244140625,670.5128784179688,2607872,0.0,0.0,05-12-2016,0
413,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition,"sun pharmaceuticals industries limited has informed the exchange that the company (including its subsidiaries and/or associate companies), has entered into an agreement to acquire 85.1% of jsc biosintez, a russian pharmaceutical company engaged in manufacture and marketing of pharmaceutical products in russia and cis region. further the company has submitted a copy of press release dated november 23, 2016, titled ""sun pharma to acquire biosintez in russia"".",23-Nov-2016 08:32:00,2016-11-23 08:32:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockExchangeIntimationacquisitionofBiosintez23112016withPR_23112016083236_746.zip,23-11-2016,696.0,704.9000244140625,691.0499877929688,701.2999877929688,657.52734375,4496512,0.0,0.0,30-11-2016,0
414,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the company have received a letter intimating to the company from our chief financial officer (cfo), mr. uday baldota that he would be tendering his resignation as the cfo of sun pharmaceutical industries limited to be effective with effect from in and around april, 2017 due to his shifting to united states of america in and around april, 2017 to look after the business of taro pharmaceutical industries ltd, a subsidiary of sun pharmaceutical industries limited as its chief executive officer.",22-Nov-2016 19:08:00,2016-11-22 19:08:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationtoStockExchangeCFOintentiontoresign22112016_22112016190838_699.zip,22-11-2016,699.0,699.4000244140625,685.0,689.9000244140625,646.8389892578125,3359143,0.0,0.0,29-11-2016,0
415,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange that the allotment committee of directors at its meeting held on november 22, 2016, allotted 16,229 (sixteen thousand two hundred and twenty nine) equity shares of the company of re. 1/- (rupee one only) each, on exercise of stock options under the sun employee stock option scheme - 2015.",22-Nov-2016 17:34:00,2016-11-22 17:34:00,-,-,https://nsearchives.nseindia.com/corporate/OUTCOME_22112016173457_658.zip,22-11-2016,699.0,699.4000244140625,685.0,689.9000244140625,646.8389892578125,3359143,0.0,0.0,29-11-2016,0
416,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 15, 2016, titled ""press release sun pharma signing tri-party agreement to launch malaria free india"".",15-Nov-2016 14:03:00,2016-11-15 14:03:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161115_15112016140308_369.zip,15-11-2016,697.9500122070312,705.5499877929688,674.6500244140625,682.4500122070312,639.8538818359375,5816519,0.0,0.0,22-11-2016,0
417,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange regarding outcome of meeting of the board of directors of the company held on november 10, 2016.",11-Nov-2016 11:45:00,2016-11-11 11:45:00,-,-,https://nsearchives.nseindia.com/corporate/outcomebm10112016merger_11112016114527_674.zip,11-11-2016,690.0,708.0,680.0,688.0,645.057373046875,13184334,0.0,0.0,21-11-2016,0
418,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 10, 2016, titled ""please find enclosed herewith our press release relating to second quarter & first half fy17 financials, which we shall be releasing after sending this letter to you. this is for your information and record."".",10-Nov-2016 16:03:00,2016-11-10 16:03:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161110_10112016160327_313.zip,10-11-2016,680.0,693.5999755859375,664.0999755859375,666.2000122070312,624.6180419921875,9357587,0.0,0.0,18-11-2016,0
419,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange regarding outcome of board meeting held on november 10, 2016.",10-Nov-2016 15:52:00,2016-11-10 15:52:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_OBM_10112016155217.zip,10-11-2016,680.0,693.5999755859375,664.0999755859375,666.2000122070312,624.6180419921875,9357587,0.0,0.0,18-11-2016,0
420,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange, the financial results for the period ended september 30, 2016.",10-Nov-2016 15:47:28,2016-11-10 15:47:28,-,-,https://nsearchives.nseindia.com/corporate/RESULTS_10112016154728.zip,10-11-2016,680.0,693.5999755859375,664.0999755859375,666.2000122070312,624.6180419921875,9357587,0.0,0.0,18-11-2016,0
421,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that please find herewith the shareholding pattern of the company as on october 21, 2016 after giving effect to the below mentioned:- 1. receipt of approval from national stock exchange of india limited on october 7, 2016 and bse limited on october 10, 2016, for reclassification of shares under regulation 31a(7) of the sebi (listing obligation & disclosure requirements) regulations, 2015; 2. buyback of 75,00,000 (seventy five lakhs) fully paid up equity shares of the company of face value of re. 1/- (rupee one only) each completed on october 18, 2016 after giving effect to the above re-classification and buyback, the shareholding of the promoter and promoter group have changed from 1,323,022,812 equity shares (54.97 %) held by 34 promoter & promoter group persons/entities to 1,304,855,381 equity shares (54.39%) held by 25 promoter & promoter group persons/entities",28-Oct-2016 17:46:00,2016-10-28 17:46:00,-,-,https://nsearchives.nseindia.com/corporate/shareholdingpattern_28102016174617_653.zip,28-10-2016,747.0,752.0,741.9500122070312,743.4000244140625,696.9996337890625,1900094,0.0,0.0,07-11-2016,-1
422,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 27, 2016 titled ""sun pharma announces us launch of authorized generics for benicar, benicar hct, azor and tribenzor"".",27-Oct-2016 08:25:00,2016-10-27 08:25:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161027_27102016082529_338.zip,27-10-2016,742.0,750.7000122070312,737.2000122070312,746.9000244140625,700.2811279296875,2686399,0.0,0.0,04-11-2016,-1
423,SUNPHARMA,Sun Pharmaceutical Industries Limited,acquisition,"sun pharmaceuticals industries limited has informed the exchange that the company has entered into an agreement to acquire 100% equity stake on ocular technologies, sarl. further the company has submitted a copy of press release dated october 26, 2016, titled ""sun pharma to acquire ocular technologies"".",27-Oct-2016 08:20:00,2016-10-27 08:20:00,-,-,https://nsearchives.nseindia.com/corporate/STOCKEXCHANGEINTIMATION26102016_27102016082051_332.zip,27-10-2016,742.0,750.7000122070312,737.2000122070312,746.9000244140625,700.2811279296875,2686399,0.0,0.0,04-11-2016,-1
424,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 26, 2016 titled ""sun pharma to announce second quarter results on november 10, 2016 "".",26-Oct-2016 12:19:00,2016-10-26 12:19:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161026_26102016121935_822.zip,26-10-2016,749.0,749.0,736.0999755859375,738.7000122070312,692.5929565429688,1206610,0.0,0.0,03-11-2016,0
425,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window,sun pharmaceuticals industries limited has informed the exchange regarding change in window closure date for trading by designated persons.,25-Oct-2016 13:48:00,2016-10-25 13:48:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_25102016134820.zip,25-10-2016,749.0999755859375,759.0,746.25,747.4000244140625,700.7499389648438,1924646,0.0,0.0,02-11-2016,0
426,SUNPHARMA,Sun Pharmaceutical Industries Limited,corrigendum,vivro financial services private limited has submitted to the exchange a copy of corrigendum to the post buyback public announcement of the company,24-Oct-2016 09:06:00,2016-10-24 09:06:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_CORR_02.zip,24-10-2016,749.9000244140625,753.7000122070312,745.25,747.1500244140625,700.515625,1014731,0.0,0.0,01-11-2016,0
427,SUNPHARMA,Sun Pharmaceutical Industries Limited,post buyback public announcement,vivro financial services private limited has submitted to the exchange a copy of post buyback public announcement for the attention of equity shareholders/ beneficial owners of equity shares of the company.,24-Oct-2016 09:02:00,2016-10-24 09:02:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_Corr01.zip,24-10-2016,749.9000244140625,753.7000122070312,745.25,747.1500244140625,700.515625,1014731,0.0,0.0,01-11-2016,0
428,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has informed the exchange regarding update on divestment of seven prescription brands of the company to rpg life sciences ltd - closure of transaction.,21-Oct-2016 19:15:00,2016-10-21 19:15:00,-,-,https://nsearchives.nseindia.com/corporate/SPILANNOUNCEMENT_21102016191501_556.zip,21-10-2016,747.0,749.0,740.5499877929688,747.75,701.0780639648438,1807639,0.0,0.0,28-10-2016,0
429,SUNPHARMA,Sun Pharmaceutical Industries Limited,post buyback public announcement,sun pharmaceuticals industries limited has informed the exchange regarding corrigendum to the post buyback public announcement of company.,21-Oct-2016 17:58:00,2016-10-21 17:58:00,-,-,https://nsearchives.nseindia.com/corporate/SPILCORRIGENDUMSEPOSTBUYBACKPA_21102016175818_472.zip,21-10-2016,747.0,749.0,740.5499877929688,747.75,701.0780639648438,1807639,0.0,0.0,28-10-2016,0
430,SUNPHARMA,Sun Pharmaceutical Industries Limited,post buyback public announcement,sun pharmaceuticals industries limited has submitted to the exchange a copy of post buyback public announcement for the attention of equity shareholders/ beneficial owners of equity shareholders.,21-Oct-2016 08:21:00,2016-10-21 08:21:00,-,-,https://nsearchives.nseindia.com/corporate/SPILSEPOSTBUYBACKPUBLICANNOUNCEMENT_21102016082111_035.zip,21-10-2016,747.0,749.0,740.5499877929688,747.75,701.0780639648438,1807639,0.0,0.0,28-10-2016,0
431,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 19, 2016, titled ""sun pharma & icgeb announce new exclusive collaboration to develop novel dengue vaccine for india & global markets"".",19-Oct-2016 11:56:00,2016-10-19 11:56:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161019_19102016115631_738.zip,19-10-2016,748.4000244140625,759.0,747.0499877929688,750.25,703.4220581054688,2267328,0.0,0.0,26-10-2016,0
432,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the company has received the approval of the national stock exchange of india limited and bse limited for reclassification of shares held by the below mentioned persons/entities from promoter category to public category under regulation 31a of sebi (listing obligation & disclosure requirements) regulations, 2015: 1. mr. jayant shantilal sanghvi 2. pratham investments 3. mr. ajay vrundavandas valia 4. mr. kirit valia 5. kirit v. valia (huf) 6. mr. jitendra vrundavandas valia 7. jitendra v valia (huf) 8. ms. dipti modi 9. ms. varsha doshi",10-Oct-2016 18:41:00,2016-10-10 18:41:00,-,-,https://nsearchives.nseindia.com/corporate/PromoterReclassification_10102016184149_491.zip,10-10-2016,752.9500122070312,758.0,750.0,755.4500122070312,708.2975463867188,1365905,0.0,0.0,19-10-2016,0
433,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 3, 2016 titled ""revital h woman launches healthy conversations initiative to bring the health of indian women in focus"".",03-Oct-2016 15:41:00,2016-10-03 15:41:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20161003_03102016154135_238.zip,03-10-2016,750.0,761.0,750.0,757.0499877929688,709.7975463867188,1856097,0.0,0.0,10-10-2016,0
434,SUNPHARMA,Sun Pharmaceutical Industries Limited,amendments to memorandum & articles of association,"sun pharmaceuticals industries limited has informed the exchange regarding ""submission of new set of articles of association of the company"".",22-Sep-2016 08:26:00,2016-09-22 08:26:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_22092016082615_052.zip,22-09-2016,786.0499877929688,788.8499755859375,783.2999877929688,786.75,737.6438598632812,1730313,0.0,0.0,29-09-2016,-1
435,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the speech delivered by mr. israel makov, chairman & mr. dilip shanghvi, managing director of the company at the annual general meeting held on september 17, 2016.",19-Sep-2016 19:08:00,2016-09-19 19:08:00,-,-,https://nsearchives.nseindia.com/corporate/ChairmanSpeechwithcoveringletter_19092016190813_659.zip,19-09-2016,784.5499877929688,789.7000122070312,780.5499877929688,782.5,733.6591186523438,1283403,0.0,0.0,26-09-2016,0
436,SUNPHARMA,Sun Pharmaceutical Industries Limited,"regulation 44(3) of sebi (lodr), reg., 2015","sun pharmaceuticals industries limited has submitted to the exchange a copy of voting results of annual general meeting of the company held on september 17, 2016.",19-Sep-2016 12:37:00,2016-09-19 12:37:00,-,-,https://nsearchives.nseindia.com/corporate/SPIL24thAGMVOTINGRESULTS_19092016123743_371.zip,19-09-2016,784.5499877929688,789.7000122070312,780.5499877929688,782.5,733.6591186523438,1283403,0.0,0.0,26-09-2016,0
437,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of proceedings of annual general meeting of the company held on september 17, 2016.",19-Sep-2016 08:01:00,2016-09-19 08:01:00,-,-,https://nsearchives.nseindia.com/corporate/SPILProceedingsAGM17092016_19092016080155_158.zip,19-09-2016,784.5499877929688,789.7000122070312,780.5499877929688,782.5,733.6591186523438,1283403,0.0,0.0,26-09-2016,0
438,SUNPHARMA,Sun Pharmaceutical Industries Limited,buyback,"sun pharmaceuticals industries limited has informed the exchange about the updates regarding offer to buyback not exceeding 75,00,000 (seventy five lakhs) fully paid up equity shares of the company of face value of re.1/- (rupee one only) each at a price of rs.900/- (rupees nine hundred only) per equity share on a proportionate basis through the tender offer process using stock exchange mechanism (""buyback"").",14-Sep-2016 09:12:00,2016-09-14 09:12:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_14092016091209_898.zip,14-09-2016,795.0,796.2000122070312,774.4000244140625,779.8499755859375,731.1744995117188,3858523,0.0,0.0,21-09-2016,0
439,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 06, 2016 titled ""sun pharma announces distribution alliance with mitsubishi tanabe pharma corporation in japan"".",06-Sep-2016 07:40:00,2016-09-06 07:40:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE06092016_06092016074000_398.zip,06-09-2016,786.0,789.0,778.2999877929688,782.6500244140625,732.8580322265625,1556462,0.0,0.0,14-09-2016,0
440,SUNPHARMA,Sun Pharmaceutical Industries Limited,agm/book closure,"sun pharmaceuticals industries limited has informed the exchange that the register of members & share transfer books of the company will remain closed from september 10, 2016 to september 17, 2016 (both days inclusive) for the purpose of annual general meeting (agm) of the company to be held on september 17, 2016 and payment of dividend.",17-Aug-2016 18:41:00,2016-08-17 18:41:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_17082016184111.zip,17-08-2016,778.75,790.7999877929688,772.7999877929688,785.0,735.05859375,3550406,0.0,0.0,24-08-2016,0
441,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of notice of annual general meeting of the members of the company to be held on september 17, 2016.",17-Aug-2016 18:33:00,2016-08-17 18:33:00,-,-,https://nsearchives.nseindia.com/corporate/SPILNoticewithcoveringletterandbookclosure_17082016183306_456.zip,17-08-2016,778.75,790.7999877929688,772.7999877929688,785.0,735.05859375,3550406,0.0,0.0,24-08-2016,0
442,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results along with the limited review report for the period ended june 30, 2016.",12-Aug-2016 14:14:47,2016-08-12 14:14:47,-,-,https://nsearchives.nseindia.com/corporate/SPILRESUTSQ1201617_12082016141447.zip,12-08-2016,816.7999877929688,825.9000244140625,790.5499877929688,800.5499877929688,749.6193237304688,8732728,0.0,0.0,22-08-2016,0
443,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 8, 2016 titled ""sun pharma extends imatinib mesylate savings card program benefits for patients in usa"".",08-Aug-2016 18:01:00,2016-08-08 18:01:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE08082016_08082016180143_848.zip,08-08-2016,842.0499877929688,844.8499755859375,830.4000244140625,832.7999877929688,779.8175048828125,3382787,0.0,0.0,16-08-2016,-1
444,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 02, 2016, titled ""sun pharma announces us fda approval for generic glumetza "".",02-Aug-2016 09:11:00,2016-08-02 09:11:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE02082016_02082016091155_061.zip,02-08-2016,839.0,847.5,826.8499755859375,828.9000244140625,776.1656494140625,2135409,0.0,0.0,09-08-2016,0
445,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated  august 01, 2016  titled "" sun pharma to announce first quarter results on august 12, 2016"".",01-Aug-2016 20:06:00,2016-08-01 20:06:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160801_01082016200648_836.zip,01-08-2016,837.9000244140625,840.0,822.7000122070312,835.6500244140625,782.486328125,2052236,0.0,0.0,08-08-2016,0
446,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 27, 2016 titled ""almirall and sun pharma enter into a licence agreement for tildrakizumab in europe for psoriasis"".",28-Jul-2016 08:49:00,2016-07-28 08:49:00,-,-,https://nsearchives.nseindia.com/corporate/20160727IntimationSE_28072016084932_021.zip,28-07-2016,810.4000244140625,828.0,809.5,825.4500122070312,772.9351196289062,3981433,0.0,0.0,04-08-2016,0
447,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the company july 27, 2016  signed an agreement with rpg life sciences ltd to divest seven prescription brands in india, owned by sun pharmaceutical industries limited and its subsidiary, for a consideration of inr 41 crores.the 7 (seven) divested brands include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment. this divestment is subject to receipt of competition commission of india s (cci) approval.",27-Jul-2016 16:32:00,2016-07-27 16:32:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockexchangeIntimationforsaleofbrandstoRPG270716_27072016163228_074.zip,27-07-2016,797.0499877929688,810.0,791.25,807.9000244140625,756.501708984375,2447955,0.0,0.0,03-08-2016,0
448,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 20, 2016, titled ""sun pharma announces us fda approval for generic crestor "".",20-Jul-2016 11:52:00,2016-07-20 11:52:00,-,-,https://nsearchives.nseindia.com/corporate/20160720IntimationSE_20072016115222_054.zip,20-07-2016,785.4000244140625,798.2999877929688,781.5499877929688,797.25,746.5291137695312,4592908,0.0,0.0,27-07-2016,0
449,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press releae dated july 18, 2016 titled ""sparc licenses elepsia xr (levetiracetam er tablets) to sun pharma"".",18-Jul-2016 08:03:00,2016-07-18 08:03:00,-,-,https://nsearchives.nseindia.com/corporate/20160718IntimationSE_18072016080328_838.zip,18-07-2016,774.2999877929688,781.0,770.9000244140625,776.7000122070312,727.28662109375,3096502,0.0,0.0,25-07-2016,0
450,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange vide letter dated july 12, 2016 regarding ""sun pharma's leadership update for india, north america and emerging markets"".",13-Jul-2016 08:44:00,2016-07-13 08:44:00,-,-,https://nsearchives.nseindia.com/corporate/SPILStockExchangeIntimationLeadershipAnnouncement12July2016_13072016084458_038.zip,13-07-2016,786.8499755859375,794.8499755859375,775.0,778.5499877929688,729.0189819335938,3546248,0.0,0.0,20-07-2016,0
451,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 11, 2016, titled ""sun pharma  launches gemcitabine infusmart, world's first licensed ready-to--administer bag for oncology treatment"".",11-Jul-2016 09:51:00,2016-07-11 09:51:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE_11072016095139_244.zip,11-07-2016,789.0,793.9000244140625,781.5,789.0,738.8040771484375,4771555,0.0,0.0,18-07-2016,0
452,SUNPHARMA,Sun Pharmaceutical Industries Limited,public announcement - buyback of shares,"sun pharmaceuticals industries limited has submitted to the exchange the public announcement pursuant to the provisions of regulation 8(2) of sebi(buy-back of securities) regulations, 1998.",27-Jun-2016 18:53:00,2016-06-27 18:53:00,-,-,https://nsearchives.nseindia.com/corporate/spilpublicannouncementrevised_27062016185322_821.zip,27-06-2016,757.0,775.5999755859375,753.2999877929688,773.75,724.5243530273438,4493497,0.0,0.0,04-07-2016,0
453,SUNPHARMA,Sun Pharmaceutical Industries Limited,record date,"sun pharmaceuticals industries limited has informed the exchange that the company has fixed record date as july 15, 2016 for the purpose of buyback",24-Jun-2016 08:29:00,2016-06-24 08:29:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_24062016082958.zip,24-06-2016,747.7000122070312,765.0,734.0,754.75,706.7330322265625,7640809,0.0,0.0,01-07-2016,0
454,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 23, 2016 titled ""sun pharma announces buyback of equity shares"".",23-Jun-2016 20:28:00,2016-06-23 20:28:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160623_23062016202832_879.zip,23-06-2016,743.9500122070312,757.7999877929688,743.0,752.5999755859375,704.7197875976562,3909660,0.0,0.0,30-06-2016,0
455,SUNPHARMA,Sun Pharmaceutical Industries Limited,buyback,"sun pharmaceuticals industries limited has informed the exchange that the board of directors of the company at its meeting held on june 23, 2016 has, inter-alia, approved the buyback by the company of its fully paid up equity shares of face value of re. 1/- (rupee one only) each (""equity shares"") not exceeding 75,00,000 (seventy five lakhs) equity shares (representing up to 0.31% of the total paid-up equity share capital of the company) at a price of rs. 900/- (rupees nine hundred only) per equity share payable in cash for an aggregate amount of up to rs. 675,00,00,000 (rupees six hundred and seventy five crores only) excluding transaction costs viz. brokerage, securities transaction tax, service tax, stamp duty, etc., which is approximately 3.79% of the fully paid-up equity share capital and free reserves (including securities premium account) as per the latest audited standalone balance sheet of the company for the financial year ended march 31, 2016 on a proportionate basis through the ""tender offer"" route using stock exchange mechanism as prescribed under securities and exchange board of india (buy back of securities) regulations, 1998 (the ""buyback regulations"") and the companies act, 2013 (the ""act"") and rules made thereunder from the equity shareholders of the company who hold equity shares as on the record date (""buyback"").",23-Jun-2016 20:27:00,2016-06-23 20:27:00,-,-,https://nsearchives.nseindia.com/corporate/OutcomeJune232016_23062016202742_878.zip,23-06-2016,743.9500122070312,757.7999877929688,743.0,752.5999755859375,704.7197875976562,3909660,0.0,0.0,30-06-2016,0
456,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 08, 2016 titled ""sun pharma focuses on dermatology as additional engine of growth for global consumer healthcare (gch) business"".",08-Jun-2016 13:05:00,2016-06-08 13:05:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160608_08062016130514_129.zip,08-06-2016,744.0,744.9500122070312,734.4000244140625,738.0,691.0486450195312,3384926,0.0,0.0,15-06-2016,0
457,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial results updates,"sun pharmaceuticals industries limited has informed the exchange regarding declaration on audit report with unmodified opinion for the year ended march 31, 2016.",06-Jun-2016 18:28:00,2016-06-06 18:28:00,-,-,https://nsearchives.nseindia.com/corporate/SPILCFODeclarationonAuditedfinancials_06062016182802_981.zip,06-06-2016,748.9000244140625,750.0,721.8499755859375,724.4000244140625,678.3137817382812,6330743,0.0,0.0,13-06-2016,0
458,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding press release dated june 04, 2016 title "" sun pharma announces divestment of us manufacturing units.""",06-Jun-2016 08:26:00,2016-06-06 08:26:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160604_06062016082600_609.zip,06-06-2016,748.9000244140625,750.0,721.8499755859375,724.4000244140625,678.3137817382812,6330743,0.0,0.0,13-06-2016,0
459,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 30, 2016 titled ""sun pharma reports q4 & fy16 results"".",30-May-2016 22:42:00,2016-05-30 22:42:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160530_30052016224240_439.zip,30-05-2016,831.0,842.0,808.25,812.0999755859375,760.4344482421875,4888391,0.0,0.0,06-06-2016,-1
460,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window,"sun pharmaceuticals industries limited has informed the exchange that window closure for trading by designated persons as per insider trading rules of the company will be from june 14, 2016 to june 27, 2016 (both days inclusive), pursuant to evaluation of the proposal of buy back of equity shares of the company.",30-May-2016 22:22:00,2016-05-30 22:22:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30052016222256.zip,30-05-2016,831.0,842.0,808.25,812.0999755859375,760.4344482421875,4888391,0.0,0.0,06-06-2016,-1
461,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend,"sun pharmaceuticals industries limited has informed the exchange that the board of directors of the company at their meeting held on may 30, 2016, has recommended payment of dividend of re. 1/- (rupee one only) per equity share of re. 1/- each of the company for the year ended march 31, 2016, subject to the approval of the members at the ensuing annual general meeting of the company.the dividend will be paid on or about last week of september, 2016.",30-May-2016 22:11:00,2016-05-30 22:11:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30052016221109.zip,30-05-2016,831.0,842.0,808.25,812.0999755859375,760.4344482421875,4888391,0.0,0.0,06-06-2016,-1
462,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange regarding outcome of board meeting of the company held on may 30, 2016.",30-May-2016 22:07:00,2016-05-30 22:07:00,-,-,https://nsearchives.nseindia.com/corporate/SPILOUTCOMEOFBOARDMEETINGANDRESULTS_30052016220719_414.zip,30-05-2016,831.0,842.0,808.25,812.0999755859375,760.4344482421875,4888391,0.0,0.0,06-06-2016,-1
463,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results along with the auditors report for the period ended march 31, 2016.",30-May-2016 22:03:09,2016-05-30 22:03:09,-,-,https://nsearchives.nseindia.com/corporate/SPILOUTCOMEOFBOARDMEETINGANDRESULTS_30052016220309.zip,30-05-2016,831.0,842.0,808.25,812.0999755859375,760.4344482421875,4888391,0.0,0.0,06-06-2016,-1
464,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the parties have terminated the umbrella agreement as well as the transaction agreements executed between daiichi sankyo company limited., daiichi sankyo (thailand) ltd. ranbaxy, ranbaxy (netherlands) b.v., ranbaxy unichem company ltd., ranbaxy (thailand) company ltd. due to divestment of ranbaxy by daiichi sankyo company limited.",26-May-2016 20:16:00,2016-05-26 20:16:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationaboutTerminationofUmbrellaAgreement_26052016201651_712.zip,26-05-2016,781.0999755859375,788.0,774.0499877929688,779.3499755859375,729.76806640625,1900809,0.0,0.0,02-06-2016,0
465,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 19, 2016 titled ""sun pharma to announce fourth quarter results on may 30, 2016"".",19-May-2016 15:34:00,2016-05-19 15:34:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160519_19052016153442_991.zip,19-05-2016,797.0,797.7000122070312,790.0,792.5,742.0813598632812,3114189,0.0,0.0,26-05-2016,0
466,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window,"sun pharmaceuticals industries limited has informed the exchange that window closure for trading by designated persons as per insider trading rules of the company will be from may 19, 2016 to june 01, 2016 (both days inclusive).",13-May-2016 19:56:00,2016-05-13 19:56:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_tw_13052016195635.zip,13-05-2016,805.3499755859375,805.3499755859375,792.5,795.0499877929688,744.46923828125,2454738,0.0,0.0,20-05-2016,0
467,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 4, 2016 titled ""sun pharma announces positive results of two pivotal phase-3 clinical trials of tildrakizumab in patients with moderate-to-severe plaque psoriasis"".",04-May-2016 15:33:00,2016-05-04 15:33:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160504-2_04052016153323_702.zip,04-05-2016,799.0,806.4000244140625,787.0499877929688,804.2000122070312,753.0372314453125,2523074,0.0,0.0,11-05-2016,0
468,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 04,2016, titled ""icgeb & sun pharma sign an exclusive agreement to develop novel botanical drug for treatment of dengue"".",04-May-2016 11:22:00,2016-05-04 11:22:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160504_04052016112250_550.zip,04-05-2016,799.0,806.4000244140625,787.0499877929688,804.2000122070312,753.0372314453125,2523074,0.0,0.0,11-05-2016,0
469,SUNPHARMA,Sun Pharmaceutical Industries Limited,esops/esos/esps,"sun pharmaceuticals industries limited has informed the exchange that the allotment committee of directors at its meeting held on monday, may 02, 2016, allotted 25,460 (twenty five thousand four hundred and sixty) equity shares of the company of re. 1/- (rupee one only) each, on exercise of stock options under the sun employee stock option scheme - 2015. accordingly, post the above allotment the paid-up equity share capital of the company is rs. 2,40,67,53,959/- (rupees two hundred and forty crore sixty seven lakh fifty three thousand nine hundred and fifty nine only) divided into 2,40,67,53,959 (two hundred and forty crore sixty seven lakh fifty three thousand nine hundred and fifty nine only) equity shares of re.1/- (rupee one only) each.",02-May-2016 17:01:00,2016-05-02 17:01:00,-,-,https://nsearchives.nseindia.com/corporate/OUTCOMEOFALLOTMENTCOMMITEEMEETING02052016_02052016170129_157.zip,02-05-2016,813.75,816.1500244140625,804.5,811.7999877929688,760.153564453125,1083227,0.0,0.0,09-05-2016,0
470,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 25, 2016 titled "" public-private-partnership for malaria free india."".",25-Apr-2016 19:26:00,2016-04-25 19:26:00,-,-,https://nsearchives.nseindia.com/corporate/SE25042016_25042016192645_056.zip,25-04-2016,820.0,821.1500244140625,802.0,808.8499755859375,757.3912963867188,3644370,0.0,0.0,02-05-2016,0
471,SUNPHARMA,Sun Pharmaceutical Industries Limited,disc. under reg.30 of sebi (sast) reg.2011,"dilip shanghvi has submitted to the exchange vide letter dated april 05, 2016 a copy of disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",11-Apr-2016 13:05:00,2016-04-11 13:05:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticals_dilip_11042016130503.zip,11-04-2016,823.0,826.0,809.2000122070312,817.2999877929688,765.3036499023438,2757166,0.0,0.0,21-04-2016,0
472,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 09, 2016 titled ""sun pharma receives usfda approval for bromsite"".",11-Apr-2016 09:09:00,2016-04-11 09:09:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharam_pr02.zip,11-04-2016,823.0,826.0,809.2000122070312,817.2999877929688,765.3036499023438,2757166,0.0,0.0,21-04-2016,0
473,SUNPHARMA,Sun Pharmaceutical Industries Limited,credit rating,"sun pharmaceuticals industries limited has informed the exchange that at the company s request, credit analysis & research ltd., (care) has withdrawn the ratings assigned to the non-convertible debenture (ncd) issue and bank facilities of the company. the company had voluntarily requested for such withdrawal since the company has fully repaid the amounts under the said ncd issue and the bank facilities of the company continue to be rated aaa / a1+ by crisil ltd., and icra ltd.",06-Apr-2016 17:23:00,2016-04-06 17:23:00,-,-,https://nsearchives.nseindia.com/corporate/intimationofwithdrawalofcreditrating_06042016172303_568.zip,06-04-2016,804.5,811.0999755859375,798.0499877929688,809.5499877929688,758.0468139648438,1809628,0.0,0.0,13-04-2016,0
474,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 29, 2016 titled ""sun pharma enters japanese prescription market"".",30-Mar-2016 08:20:00,2016-03-30 08:20:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE29032016_30032016082051_448.zip,30-03-2016,811.9000244140625,815.5499877929688,801.0499877929688,811.7000122070312,760.0599975585938,3020735,0.0,0.0,06-04-2016,0
475,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 23, 2016 titled ""sun pharma and astrazeneca india enter partnership in type 2 diabetes"".",23-Mar-2016 14:04:00,2016-03-23 14:04:00,-,-,https://nsearchives.nseindia.com/corporate/Pressrelease_23032016140410_106.zip,23-03-2016,844.7000122070312,852.0,834.5999755859375,846.2000122070312,792.3650512695312,2331768,0.0,0.0,01-04-2016,0
476,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has informed the exchange regarding wind down / termination of the collaboration established in 2011 between affiliates of merck sharp & dohme and sun pharmaceuticals industries limited to develop and commercialize novel formulations and combinations of medicines for emerging markets.,12-Feb-2016 19:12:00,2016-02-12 19:12:00,-,-,https://nsearchives.nseindia.com/corporate/Announcement_12022016191245_608.zip,12-02-2016,845.0,884.7000122070312,802.4500122070312,847.3499755859375,793.4418334960938,5260215,0.0,0.0,19-02-2016,0
477,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 12, 2016 titled "" sun pharma reports q3 results "".",12-Feb-2016 15:58:00,2016-02-12 15:58:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160212_12022016155840_321.zip,12-02-2016,845.0,884.7000122070312,802.4500122070312,847.3499755859375,793.4418334960938,5260215,0.0,0.0,19-02-2016,0
478,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results along with the limited review report for the period ended december 31, 2015.",12-Feb-2016 14:46:40,2016-02-12 14:46:40,-,-,https://nsearchives.nseindia.com/corporate/SPILOutcomeofBoardMeetingResultsfor31Dec2015February122016_12022016144640.zip,12-02-2016,845.0,884.7000122070312,802.4500122070312,847.3499755859375,793.4418334960938,5260215,0.0,0.0,19-02-2016,0
479,SUNPHARMA,Sun Pharmaceutical Industries Limited,esops/esos/esps,"sun pharmaceuticals industries limited has informed the exchange that the allotment committee of directors at its meeting held today i.e. on february 12, 2016, allotted:a) 32,449 (thirty two thousand four hundred and forty nine) equity shares of the company of re 1/- each, on exercise of stock options under the sun employee stock option scheme - 2015. b) 30,000 (thirty thousand) equity shares of the company of re 1/- each, to sun pharma esop trust under sun employee stock option plan - 2015 for further allocation to employees. accordingly, post the above allotments the paid-up equity share capital of the company is now rs.240,67,28,499 (rupees two hundred and forty crore sixty seven lakh twenty eight thousand four hundred and ninety nine only) divided into 240,67,28,499 (rupees two hundred and forty crore sixty seven lakh twenty eight thousand four hundred and ninety nine) equity shares of re.1/-each.",12-Feb-2016 11:55:00,2016-02-12 11:55:00,-,-,https://nsearchives.nseindia.com/corporate/OutcomeAllotmentCommiteeMeeting12022016_12022016115551_100.zip,12-02-2016,845.0,884.7000122070312,802.4500122070312,847.3499755859375,793.4418334960938,5260215,0.0,0.0,19-02-2016,0
480,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange regarding ""update on sale of cns divisions of erstwhile ranbaxy to strides shasun limited (formerly known as strides arcolab ltd) closure of transaction"".",01-Feb-2016 17:31:00,2016-02-01 17:31:00,-,-,https://nsearchives.nseindia.com/corporate/SPILSEFeb12016closureoftransactionsaleofCNSdivisiontoStrides_01022016173141_542.zip,01-02-2016,880.7999877929688,888.2999877929688,861.9000244140625,872.2999877929688,816.8046264648438,3252050,0.0,0.0,08-02-2016,0
481,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed regarding a press release dated february 01, 2016, titled ""sun pharma launch of imatinib mesylate in usa"".",01-Feb-2016 16:52:00,2016-02-01 16:52:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE20160201_01022016165226_449.zip,01-02-2016,880.7999877929688,888.2999877929688,861.9000244140625,872.2999877929688,816.8046264648438,3252050,0.0,0.0,08-02-2016,0
482,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window,"sun pharmaceuticals industries limited has informed the exchange that the window closure for trading by designated persons as per insider trading rules of the company will be from february 03, 2016 to february 16, 2016 (both days inclusive).",28-Jan-2016 16:51:00,2016-01-28 16:51:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_28012016165111.zip,28-01-2016,817.0,836.7999877929688,817.0,834.1500244140625,781.0816650390625,4368190,0.0,0.0,04-02-2016,0
483,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange vide letter dated january 22, 2016 regarding ""update on sale of cns divisions of erstwhile ranbaxy to strides shasun limited (formerly known as strides arcolab ltd) - receipt of order from competition commission of india approving the proposed transaction"".",22-Jan-2016 08:24:00,2016-01-22 08:24:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharama_22012016082446.zip,22-01-2016,779.0,794.0,773.2999877929688,789.2000122070312,738.9913330078125,1970106,0.0,0.0,01-02-2016,1
484,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange regarding raising of rs. 10,000,000,000/- (rupees one thousand crores only) by sun pharma laboratories limited, a wholly-owned subsidiary of the company, by allotment of 10000 (ten thousand) rated listed unsecured redeemable non-convertible debentures of a face value of rs. 10,00,000/- (rupees ten lakh only) each.",24-Dec-2015 08:37:00,2015-12-24 08:37:00,-,-,https://nsearchives.nseindia.com/corporate/Stkexchangeintimation_24122015083755_275.zip,24-12-2015,797.0,798.4000244140625,786.4000244140625,790.8499755859375,740.536376953125,2053955,0.0,0.0,01-01-2016,0
485,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 19, 2015 titled ""sun pharma receives warning letter for halol facility"".",21-Dec-2015 10:05:00,2015-12-21 10:05:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press_21122015100532.zip,21-12-2015,738.0,756.7999877929688,731.0,754.2000122070312,706.2181396484375,12310649,0.0,0.0,29-12-2015,1
486,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 14, 2015 titled ""sun pharma announces divestment of us manufacturing unit"".",14-Dec-2015 17:15:00,2015-12-14 17:15:00,-,-,https://nsearchives.nseindia.com/corporate/IntimationSE_14122015171505_551.zip,14-12-2015,758.8499755859375,773.0,753.6500244140625,768.5999755859375,719.701904296875,2629235,0.0,0.0,21-12-2015,0
487,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 10, 2015, titled ""sun pharma announces research collaboration with weizmann institute of science, israel & health research institute of santiago, spain for brain therapies"".",10-Dec-2015 08:04:00,2015-12-10 08:04:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_Pr_10122015080407.zip,10-12-2015,769.8499755859375,769.8499755859375,733.2999877929688,756.7999877929688,708.6526489257812,4496091,0.0,0.0,17-12-2015,1
488,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 04, 2015, titled""sun pharma announces us fda approval for generic gleevec "".",04-Dec-2015 10:26:00,2015-12-04 10:26:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_04122015102641.zip,04-12-2015,722.5,773.9000244140625,721.5,755.4000244140625,707.341796875,24605807,0.0,0.0,11-12-2015,0
489,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that pursuant to regulation 30(5) of the securities and exchange board of india (listing obligations and disclosure requirements) regulations, 2015, mr. dilip shanghvi , managing director, mr. sudhir v valia, whole time director, mr. sailesh desai whole time director, mr. uday baldota ,cfo and mr.sunil ajmera, company secretary have been authorised severally to determine materiality of an event or information and for making disclosures to stock exchange(s).",01-Dec-2015 08:44:00,2015-12-01 08:44:00,-,-,https://nsearchives.nseindia.com/corporate/Regulation30(5)intimation_01122015084410_015.zip,01-12-2015,732.0,733.7999877929688,727.0,729.25,682.8553466796875,3183165,0.0,0.0,08-12-2015,1
490,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that some of company's subsidiaries were contemplating an investment in a wind energy project in the us. subsequent to a further evaluation, these subsidiaries have decided not to proceed with this potential project.",24-Nov-2015 16:49:00,2015-11-24 16:49:00,-,-,https://nsearchives.nseindia.com/corporate/Update_on_Wind_Energy_Project_24112015164908.zip,24-11-2015,717.0,719.5499877929688,704.0,706.2000122070312,661.271728515625,9846509,0.0,0.0,02-12-2015,0
491,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the company has made payment of interest on and redemption amount pertaining to 5,000 secured rated redeemable non-convertible debentures (ncd) of the face value of rs.10,00,000 each aggregating to rs. 500 crores (listed on national stock exchange of india ltd), on november 23, 2015 to the ncd holders of the company whose names stand registered on the register of beneficial owners maintained by depositories in respect of the ncds held in electronic form on november 10, 2015.",23-Nov-2015 19:46:00,2015-11-23 19:46:00,-,-,https://nsearchives.nseindia.com/corporate/RedemptionofNCDs_23112015194638_430.zip,23-11-2015,726.0,728.9000244140625,713.5,717.0999755859375,671.478271484375,5781403,0.0,0.0,01-12-2015,0
492,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 7, 2015 titled ""sun pharma reports q2 & h1 fy16 results"".",09-Nov-2015 10:35:00,2015-11-09 10:35:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA02.zip,09-11-2015,761.0,771.8499755859375,744.9500122070312,756.9500122070312,708.7931518554688,7903526,0.0,0.0,18-11-2015,0
493,SUNPHARMA,Sun Pharmaceutical Industries Limited,postal ballot updates,sun pharmaceuticals industries limited has submitted to the exchange a copy of results of the postal ballot along with a copy of scrutinizer's report pursuant to clause 35a of the listing agreement.,06-Nov-2015 17:30:00,2015-11-06 17:30:00,-,-,https://nsearchives.nseindia.com/corporate/SPIL-Result_of_Postal_Ballot_as_per_Clause_35A_06_06112015173014.zip,06-11-2015,816.0499877929688,822.3499755859375,800.5499877929688,803.4000244140625,752.2879638671875,3763950,0.0,0.0,17-11-2015,-1
494,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 03, 2015, titled ""sun pharma successfully acquires insite vision"".",03-Nov-2015 08:56:00,2015-11-03 08:56:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharama_03112015085604.zip,03-11-2015,870.0,877.7999877929688,862.7999877929688,868.5499877929688,813.2932739257812,1547053,0.0,0.0,10-11-2015,-1
495,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure of voting pattern - clause 35a,"sun pharmaceuticals industries limited has informed the exchange regarding outcome and voting results of annual general meeting of the company held on october 31, 2015, alongwith consolidated scuritnizer's report.",02-Nov-2015 09:03:00,2015-11-02 09:03:00,-,-,https://nsearchives.nseindia.com/corporate/ATTF8EBK_02112015090325.zip,02-11-2015,875.0499877929688,878.1500244140625,857.5499877929688,865.3499755859375,810.296630859375,1982404,0.0,0.0,09-11-2015,-1
496,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 28, 2015 titled ""sun pharma completes tender offer for insite vision"".",28-Oct-2015 18:15:00,2015-10-28 18:15:00,-,-,https://nsearchives.nseindia.com/corporate/20151028_Press_Release_Sun_Pharma_InSite_Vision_tender_offer_upda_28102015181554.zip,28-10-2015,903.0,907.5,895.0499877929688,901.5499877929688,844.1937255859375,1939812,0.0,0.0,04-11-2015,-1
497,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 26, 2015 titled ""sun pharma to announce second quarter results on november 07, 2015""",26-Oct-2015 17:41:00,2015-10-26 17:41:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press.zip,26-10-2015,890.0,894.0999755859375,886.0999755859375,888.7999877929688,832.2546997070312,1770689,0.0,0.0,02-11-2015,0
498,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window,"sun pharmaceuticals industries limited has informed the exchange that window closure for trading by designated persons as per insider trading rules of the company will be from october 29, 2015 to november 10, 2015 (both days inclusive).",23-Oct-2015 18:23:00,2015-10-23 18:23:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_23102015182352.zip,23-10-2015,901.9500122070312,903.8499755859376,883.0499877929688,884.5999755859375,828.3220825195312,1916780,0.0,0.0,30-10-2015,0
499,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that sun pharmaceutical industries ltd, along with its subsidiary ( sun pharma) has entered into a settlement agreement with acorda therapeutics, inc. to resolve the pending patent litigation involving ampyra (dalfampridine) extended-release tablets in the us. the pending patent litigation was filed by acorda therapeutics in the u.s. district court for the district of delaware in response to sun pharma's submission of an abbreviated new drug application ( anda ) to the u.s. food and drug administration ( fda ), seeking marketing approval for a generic version of ampyra . as a result of the settlement agreement, sun pharma will be permitted to market a generic version of ampyra in the united states at a specified date in 2027, or potentially earlier under certain circumstances. details of the settlement are confidential, and the parties will submit the agreement to the federal trade commission and the department of justice, as required by federal law. as per ims mat july 2015, ampyra recorded annual sales of approximately us$ 325 million in the us.",21-Oct-2015 19:12:00,2015-10-21 19:12:00,-,-,https://nsearchives.nseindia.com/corporate/patent_21102015191259_173.zip,21-10-2015,901.9000244140624,902.25,886.5,889.0,832.442138671875,1272841,3.0,0.0,29-10-2015,0
500,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has informed the exchange that the company has withdrawn its appeal in the lawsuit filed by erstwhile ranbant laboratories limited ( ranbaxy) in november 2014 in a u.s. district court against u.s. food and drug administration (fda). this lawsuit challenged fda's revocation of ranbaxy's tentative approvals for its generic versions of nexium and valcyte in the us. the company do not believe that the withdrawal of said lawsuit by the company will have any materially adverse financial impact on the company.,08-Oct-2015 20:19:00,2015-10-08 20:19:00,-,-,https://nsearchives.nseindia.com/corporate/SPIL-Intimation_about_the_withdrawal_of_the_lawsuit_filed_against_08102015201936.zip,08-10-2015,930.0,933.9500122070312,910.5999755859376,915.6500244140624,854.5466918945312,2018360,0.0,0.0,15-10-2015,0
501,SUNPHARMA,Sun Pharmaceutical Industries Limited,postal ballot updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of notice of postal ballot pursuant to section 110 of the companies act, 2013.",06-Oct-2015 08:25:00,2015-10-06 08:25:00,-,-,https://nsearchives.nseindia.com/corporate/NoticeofPostalBallotwithcoverletter_06102015082526_406.zip,06-10-2015,905.9500122070312,915.9000244140624,902.25,909.9500122070312,849.2271118164062,2368600,0.0,0.0,13-10-2015,0
502,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 05, 2015 titled ""sun pharma announces absorica patent litigation settlement"".",05-Oct-2015 18:13:00,2015-10-05 18:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press.zip,05-10-2015,899.0,902.2000122070312,880.2000122070312,897.9500122070312,838.0279541015625,3142118,0.0,0.0,12-10-2015,0
503,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of notice of annual general meeting of the members of the company to be held on october 31, 2015.",05-Oct-2015 12:23:00,2015-10-05 12:23:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharmaceutical0001_05102015122316.zip,05-10-2015,899.0,902.2000122070312,880.2000122070312,897.9500122070312,838.0279541015625,3142118,0.0,0.0,12-10-2015,0
504,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 29, 2015 titled "" sun pharma commences tender offer for acquisition of insite vision"".",29-Sep-2015 18:43:00,2015-09-29 18:43:00,-,-,https://nsearchives.nseindia.com/corporate/Press_Release_Sun_Pharma_commences_Tender_Offer_for_Insite_Vision_29092015184304.zip,29-09-2015,861.0,861.0,840.25,848.25,791.6445922851562,2137288,0.0,0.0,07-10-2015,1
505,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 19, 2015 titled ""strides arcolab acquires cns divisions of erstwhile ranbaxy""",21-Sep-2015 09:27:00,2015-09-21 09:27:00,-,-,https://nsearchives.nseindia.com/corporate/Pressrelease_21092015092713_154.zip,21-09-2015,908.2999877929688,912.9500122070312,895.0999755859375,899.9500122070312,839.8944702148438,3137037,0.0,0.0,29-09-2015,-1
506,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 15, 2015 titled ""sun pharma to acquire insite vision"".",16-Sep-2015 08:51:00,2015-09-16 08:51:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_1.zip,16-09-2015,879.2000122070312,891.7999877929688,875.6500244140625,887.2000122070312,827.9952392578125,5674983,0.0,0.0,24-09-2015,0
507,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 1, 2015 titled ""sun pharma announces successful completion of opiates business acquisition in australia"".",01-Sep-2015 08:28:00,2015-09-01 08:28:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_01092015082827.zip,01-09-2015,883.7000122070312,916.0,882.0,901.9500122070312,841.7610473632812,4315484,0.0,0.0,08-09-2015,-1
508,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 19, 2015 titled ""sun pharma announces us fda approval for ximino tm""",19-Aug-2015 19:38:00,2015-08-19 19:38:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_press1.zip,19-08-2015,897.0,930.0,896.25,927.75,865.8392944335938,5294282,0.0,0.0,26-08-2015,-1
509,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 11, 2015 titled ""sun pharma reports q1fy16 results"".",11-Aug-2015 17:39:00,2015-08-11 17:39:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press_11082015173936.zip,11-08-2015,843.0,846.5999755859375,831.2999877929688,841.75,785.578369140625,2135240,0.0,0.0,18-08-2015,1
510,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange regarding consideration of revised annual accounts for the year ended march 31, 2015.",11-Aug-2015 17:24:00,2015-08-11 17:24:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_11082015172445.zip,11-08-2015,843.0,846.5999755859375,831.2999877929688,841.75,785.578369140625,2135240,0.0,0.0,18-08-2015,1
511,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange that the board of directors of the company at their meeting held on august 11, 2015 recorded the approval of the scheme of amalgamation of sun pharma global inc., wholly owned subsidiary of the company, into sun pharmaceutical industries limited (spil) with effect from the appointed date of january 1, 2015 as per the order of the hon'ble high court of gujarat, at ahmedabad at its hearing held on july 30, 2015 and accordingly after taking into effect the above scheme and recommendation of the payment of dividend, approved the revised annual accounts for the year ended march 31, 2015.",11-Aug-2015 17:20:00,2015-08-11 17:20:00,-,-,https://nsearchives.nseindia.com/corporate/sun_out_11082015172041.zip,11-08-2015,843.0,846.5999755859375,831.2999877929688,841.75,785.578369140625,2135240,0.0,0.0,18-08-2015,1
512,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend,"sun pharmaceuticals industries limited has informed the exchange that the board of directors of the company at their meeting held on august 11, 2015 recommended payment of dividend of rs. 3 (rupees three only) per equity share of re.1/- each of the company for the year ended march 31, 2015, subject to the approval of the members at the ensuing annual general meeting of the company to be held in around end of october 2015.",11-Aug-2015 17:10:00,2015-08-11 17:10:00,-,-,https://nsearchives.nseindia.com/corporate/sun_11082015171048.zip,11-08-2015,843.0,846.5999755859375,831.2999877929688,841.75,785.578369140625,2135240,0.0,0.0,18-08-2015,1
513,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results along with the limited review report for the period ended 30-jun-2015.,11-Aug-2015 17:05:34,2015-08-11 17:05:34,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_11082015170534.zip,11-08-2015,843.0,846.5999755859375,831.2999877929688,841.75,785.578369140625,2135240,0.0,0.0,18-08-2015,1
514,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the report of proceedings of the annual general meeting of the company held on august 1, 2015.",03-Aug-2015 13:07:00,2015-08-03 13:07:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_03082015130716.zip,03-08-2015,822.0,832.0,820.0,830.9500122070312,775.4990844726562,2029186,0.0,0.0,10-08-2015,0
515,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 29, 2015 titled "" sun pharma to announce first quarter results on august 11, 2015"".",29-Jul-2015 17:21:00,2015-07-29 17:21:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_29072015172131.zip,29-07-2015,823.0,834.0499877929688,819.6500244140625,829.75,774.3790283203125,2301293,0.0,0.0,05-08-2015,0
516,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window,"sun pharmaceuticals industries limited has informed the exchange that window closure for trading by designated persons as per insider trading rules of the company will be from july 31, 2015 to august 13, 2015 (both days inclusive).",28-Jul-2015 13:12:00,2015-07-28 13:12:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_28072015131248.zip,28-07-2015,825.0,834.5,810.0499877929688,820.1500244140625,765.4197387695312,2689656,0.0,0.0,04-08-2015,0
517,SUNPHARMA,Sun Pharmaceutical Industries Limited,allotment of securities,"sun pharmaceuticals industries limited has informed the exchange regarding ""allotment of 72,789 equity shares under sun employee stock option scheme - 2015"".",23-Jul-2015 16:31:00,2015-07-23 16:31:00,-,-,https://nsearchives.nseindia.com/corporate/STOCKEXCHANGEINTIMATION_23072015163122_182.zip,23-07-2015,839.0,839.0999755859375,821.5,828.8499755859375,773.5390625,3645770,0.0,0.0,30-07-2015,0
518,SUNPHARMA,Sun Pharmaceutical Industries Limited,allotment of securities,"sun pharmaceuticals industries limited has informed the exchange that the allotment committee of directors at its meeting held on july 23, 2015, allotted 72,789 (seventy two thousand seven hundred and eighty nine) equity shares of the company of re 1/- each on exercise of stock options under the sun employee stock option scheme - 2015. the paid-up equity share capital of the company post allotment is rs. 24,064,96,137/- (rupees two hundred and forty crore sixty four lakh ninety six thousand one hundred and thirty seven only) divided into 24,064,96,137 (two hundred and forty crore sixty four lakh ninety six thousand one hundred and thirty seven) equity shares of re.1/-.",23-Jul-2015 16:31:00,2015-07-23 16:31:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_allot_23072015163126.zip,23-07-2015,839.0,839.0999755859375,821.5,828.8499755859375,773.5390625,3645770,0.0,0.0,30-07-2015,0
519,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 20, 2015 titled ""sun pharma provides business update"".",20-Jul-2015 17:25:00,2015-07-20 17:25:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press_20072015172526.zip,20-07-2015,952.8499755859376,953.7000122070312,945.0,948.0,884.7378540039062,1378923,0.0,0.0,27-07-2015,-1
520,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 09, 2015, titled ""sparc licenses xelprostm (latanoprost bak-free) to sun pharma"".",10-Jun-2015 17:17:00,2015-06-10 17:17:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press_10062015171610.zip,10-06-2015,811.2000122070312,830.9000244140625,811.2000122070312,823.0999755859375,768.1727294921875,4205596,0.0,0.0,17-06-2015,0
521,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure of voting pattern - clause 35a,"sun pharmaceuticals industries limited has submitted to the exchange a copy proceeding of court convened meeting of equity shareholders of the company held on the june 03, 2015 and disclosure of voting results along with report of scrutinizer pursuant to clause 35a of the listing agreement.",05-Jun-2015 08:19:00,2015-06-05 08:19:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_dis35a_06052015081901_1.zip,05-06-2015,831.5499877929688,860.5999755859375,830.0,847.9000244140625,791.3179321289062,4696506,0.0,0.0,12-06-2015,0
522,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 02, 2015, titled ""sun pharma and astrazeneca enter into distribution agreement for ticagrelor in india"".",02-Jun-2015 08:46:00,2015-06-02 08:46:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_pressrelease_06022015084601_1.zip,02-06-2015,887.2000122070312,888.4000244140625,856.8499755859375,860.75,803.3104248046875,7192196,0.0,0.0,09-06-2015,-1
523,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-mar-2015.,29-May-2015 18:47:03,2015-05-29 18:47:03,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_result_05292015184702_.zip,29-05-2015,964.4500122070312,979.0,960.0,966.0999755859376,901.6300659179688,7065774,0.0,0.0,05-06-2015,-1
524,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 29, 2015 titled ""sun pharma reports q4 & fy15 results"".",29-May-2015 17:31:00,2015-05-29 17:31:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press_29052015173017.zip,29-05-2015,964.4500122070312,979.0,960.0,966.0999755859376,901.6300659179688,7065774,0.0,0.0,05-06-2015,-1
525,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under insider trading regulation,"sun pharmaceuticals industries limited has submitted to the exchange vide letter dated may 26, 2015 a copy of disclosure pursuant to regulation 7(2) read with regulation 6(2) of the sebi (prohibition of insider trading) regulations, 2015. ",27-May-2015 11:25:00,2015-05-27 11:25:00,-,-,https://nsearchives.nseindia.com/corporate/SUN_PHARMA_27052015112450.zip,27-05-2015,996.0999755859376,1004.0,971.0999755859376,975.5499877929688,910.4495849609376,2738544,0.0,0.0,03-06-2015,-1
526,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under insider trading regulation,"sun pharmaceuticals industries limited has submitted to the exchange vide letter dated may 22, 2015 a copy of disclosure pursuant to regulation 7(2) read with regulation 6(2) of the sebi (prohibition of insider trading) regulations, 2015. ",26-May-2015 12:32:00,2015-05-26 12:32:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_26052015_26052015123146.zip,26-05-2015,999.9500122070312,1000.0,982.0,994.8499755859376,928.4614868164062,2570872,0.0,0.0,02-06-2015,-1
527,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 15, 2015 titled ""sun pharma to announce fourth quarter results on may 29, 2015"".",15-May-2015 13:00:00,2015-05-15 13:00:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_press_15052015125915.zip,15-05-2015,927.4000244140624,952.0,926.25,946.3499755859376,883.197998046875,2563043,0.0,0.0,22-05-2015,1
528,SUNPHARMA,Sun Pharmaceutical Industries Limited,trading window,"sun pharmaceuticals industries limited has informed the exchange that window closure for trading by designated persons as per insider trading rules of the company will be from may 20, 2015 to june 2, 2015 (both days inclusive).",14-May-2015 15:55:00,2015-05-14 15:55:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_05142015155502_1.zip,14-05-2015,952.7999877929688,953.2000122070312,939.0,944.4000244140624,881.3782958984375,2701006,0.0,0.0,21-05-2015,0
529,SUNPHARMA,Sun Pharmaceutical Industries Limited,court convened meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of notice of court convened meeting of shareholders of the company to be held on june 03, 2015. ",05-May-2015 17:43:00,2015-05-05 17:43:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMACEUTICAL_05052015_05052015174301_1.zip,05-05-2015,954.9000244140624,960.0,950.0499877929688,958.4500122070312,894.4906616210938,4329997,0.0,0.0,12-05-2015,0
530,SUNPHARMA,Sun Pharmaceutical Industries Limited,allotment of securities,"sun pharmaceuticals industries limited has informed the exchange that the allotment committee of directors at its meeting held on april 29, 2015, allotted 302,674 (three lakh two thousand six hundred and seventy four) equity shares of the company of re 1/- each on exercise of stock options under the sun employee stock option scheme - 2015. the paid-up equity share capital of the company post allotment is rs. 2,406,423,348 (two hundred and forty crore sixty four lakh twenty three thousand three hundred and forty eight only) divided into 2,406,423,348 (two hundred and forty crore sixty four lakh twenty three thousand three hundred and forty eight) equity shares of re.1/-. ",29-Apr-2015 17:05:00,2015-04-29 17:05:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_04292015170502_1.zip,29-04-2015,934.2000122070312,947.0,929.0,940.5,877.7384033203125,7229944,0.0,0.0,07-05-2015,0
531,SUNPHARMA,Sun Pharmaceutical Industries Limited,disc. under reg.30 of sebi (sast) reg.2011,"dilip shanghvi has submitted to the exchange vide letter dated april 06, 2015 a copy of disclosure under regulation 30(1) and 30(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",27-Apr-2015 12:36:00,2015-04-27 12:36:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharamceuticals_dilipshanghvi_04272015123602_1.zip,27-04-2015,951.5,957.2999877929688,921.8499755859376,926.4000244140624,864.5794677734375,7641311,0.0,0.0,05-05-2015,0
532,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"daiichi sankyo company, limited has submitted to the exchange vide letter dated april 23, 2015 a copy of disclosure under regulation 29(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011",23-Apr-2015 12:07:00,2015-04-23 12:07:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPPHAM_REG29_04232015120702_1.zip,23-04-2015,980.0,980.7999877929688,936.0,942.0,879.138427734375,9450660,0.0,0.0,30-04-2015,0
533,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"daiichi sankyo company, limited has submitted to the exchange vide letter dated april 16, 2015 a copy of disclosure under regulation 29(1) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",16-Apr-2015 13:10:00,2015-04-16 13:10:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29_04162015131001_1.zip,16-04-2015,1122.199951171875,1127.25,1082.5,1087.949951171875,1015.3489990234376,2725037,0.0,0.0,23-04-2015,-1
534,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"dilip shanghvi has submitted to the exchange vide letter dated april 14, 2015 a copy of disclosure under regulation 29(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",15-Apr-2015 19:21:00,2015-04-15 19:21:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_dilip_04152015192102_1.zip,15-04-2015,1161.4000244140625,1161.4000244140625,1112.3499755859375,1117.300048828125,1042.740478515625,3103257,0.0,0.0,22-04-2015,-1
535,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 15, 2015, titled ""sun pharma and the technion form research collaboration to develop new class of oncology drugs"".",15-Apr-2015 16:53:00,2015-04-15 16:53:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_04152015165301_1.zip,15-04-2015,1161.4000244140625,1161.4000244140625,1112.3499755859375,1117.300048828125,1042.740478515625,3103257,0.0,0.0,22-04-2015,-1
536,SUNPHARMA,Sun Pharmaceutical Industries Limited,meeting updates,"sun pharmaceuticals industries limited has informed the exchange that the allotment committee of the board of directors has approved the following at their meeting held on april 10, 2015. 1. allotment of 334,956,764 (thirty three crore forty nine lakh fifty six thousand seven hundred and sixty four) equity shares of re.1 each to the shareholders of erstwhile ranbaxy in the ratio of 8 (eight) equity shares of re. 1 each of the company for every 10 (ten) equity shares of rs.5 each of erstwhile ranbaxy held, after allotment, the total number of issued and paid up equity shares of the company has aggregated to 2,406,120,674 of re. 1 each, 2. allotment of 5,000 secured rated redeemable 9,20% non-convertible debentures of the face value of rs. 10,00.000/- each to the ncd holders of erstwhile ranbaxy.",10-Apr-2015 17:50:00,2015-04-10 17:50:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_04102015175001_1.zip,10-04-2015,1113.0,1128.5999755859375,1098.3499755859375,1119.75,1045.0269775390625,2880186,0.0,0.0,20-04-2015,-1
537,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has informed the exchange regarding settlement of litigation for generic angiomax in us.,01-Apr-2015 17:10:00,2015-04-01 17:10:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_update_04012015171002_2.zip,01-04-2015,1023.9000244140624,1094.0,1018.9500122070312,1081.1500244140625,1009.0026245117188,4104961,0.0,0.0,10-04-2015,0
538,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the company has fixed record date as april 7, 2015 to determine the names of the shareholders of erstwhile ranbaxy laboratories limited who would be entitled to receive 8 ( eight) equity shares of re.1 each of the company for every 10 (ten) equity shares of rs.5 each of erstwhile ranbaxy laboratories limited held and to determine the names of the ncd holders who would be entitled to 1 (one) ncd of rs.1 lac each of the company for every 1 (one) ncd of rs.1 lac each held in erstwhile ranbaxy laboratories limited pursuant to amalgamation of erstwhile ranbaxy into the company.",25-Mar-2015 13:23:00,2015-03-25 13:23:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_03252015132302_1.zip,25-03-2015,1058.0,1067.800048828125,1042.0999755859375,1052.050048828125,981.8445434570312,4242685,0.0,0.0,01-04-2015,0
539,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 25, 2015 titled ""sun pharma announces closure of merger deal with ranbaxy"", along with a copy of investor presentation - march 2015.",25-Mar-2015 12:13:00,2015-03-25 12:13:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA03_25032015121258.zip,25-03-2015,1058.0,1067.800048828125,1042.0999755859375,1052.050048828125,981.8445434570312,4242685,0.0,0.0,01-04-2015,0
540,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the all the requisite approvals have been received for scheme of arrangement between ranbaxy laboratories limited (""ranbaxy"") into sun pharmaceutical industries ltd (""sun pharma"") which is in the nature of merger of ranbaxy into sun pharma effective from the appointed date i.e. april 1, 2014.  further, the company has inform that the approvals received from the respective hon'ble high courts have been filed in e-forms inc-28 by ranbaxy and sun pharma with the respective registrar of companies on march 24, 2015 and with these filings the merger of ranbaxy into sun pharma has been consummated. ",24-Mar-2015 17:04:00,2015-03-24 17:04:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_update00000_03242015170402_1.zip,24-03-2015,1034.0,1049.800048828125,1030.0,1037.1500244140625,967.9388427734376,2573597,0.0,0.0,31-03-2015,0
541,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange regarding ""intimation about the approval received from reserve bank of india and competition commission of india in respect of the scheme of arrangement between ranbaxy laboratories limited and sun pharmaceutical industries ltd"".",24-Mar-2015 12:42:00,2015-03-24 12:42:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_update_03242015124202_1.zip,24-03-2015,1034.0,1049.800048828125,1030.0,1037.1500244140625,967.9388427734376,2573597,0.0,0.0,31-03-2015,0
542,SUNPHARMA,Sun Pharmaceutical Industries Limited,scheme of arrangement,"sun pharmaceuticals industries limited has informed the exchange that the hon'ble high court of punjab & haryana has on march 9, 2015 orally pronounced an order, approving the scheme of arrangement involving merger of ranbaxy laboratories ltd. with the company,sun pharmaceutical industries ltd. under sections 391 to 394, sections 78 and 100 of the companies act, 1956 and section 52 of the companies act, 2013.",09-Mar-2015 13:35:00,2015-03-09 13:35:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_03092015133502_1.zip,09-03-2015,1024.3499755859375,1049.9000244140625,1008.0,1041.0,971.5319213867188,3154190,0.0,0.0,16-03-2015,0
543,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 03, 2015, titled ""sun pharma to buy gsk's opiates business in australia"".",03-Mar-2015 08:15:00,2015-03-03 08:15:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_PR1_03032015081500.zip,03-03-2015,937.4500122070312,951.4000244140624,933.0999755859376,943.0499877929688,880.1182861328125,2114707,0.0,0.0,11-03-2015,1
544,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant sanghvi has submitted to the exchange, vide letter dated february 14, 2015 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",16-Feb-2015 19:01:00,2015-02-16 19:01:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmceticalsindustriesltd_160220150001_02162015190101_2.zip,16-02-2015,918.0,930.9000244140624,907.2999877929688,914.75,853.706787109375,2869370,0.0,0.0,24-02-2015,0
545,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 09, 2015 titled ""sun pharma to announce third quarter results on february 14, 2015"".",09-Feb-2015 20:02:00,2015-02-09 20:02:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_02092015200201_1.zip,09-02-2015,926.7999877929688,948.2000122070312,915.8499755859376,941.4500122070312,878.6251220703125,1350099,0.0,0.0,16-02-2015,0
546,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant sanghvi has submitted to the exchange, vide letter dated february 05, 2015 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",09-Feb-2015 16:36:00,2015-02-09 16:36:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharamaceuticalsindustiresltd_090220150001_09022015163601.zip,09-02-2015,926.7999877929688,948.2000122070312,915.8499755859376,941.4500122070312,878.6251220703125,1350099,0.0,0.0,16-02-2015,0
547,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 02, 2015 titled ""sun pharma receives us ftc clearance for ranbaxy acquisition"".",02-Feb-2015 09:06:00,2015-02-02 09:06:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_02022015090601_1.zip,02-02-2015,925.0,943.5499877929688,922.0,929.0999755859376,867.0989990234375,1750030,0.0,0.0,09-02-2015,0
548,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange that the competition commission of india (cci) has, as per its order dated december 5, 2014 approved the proposed combination in the nature of merger of ranbaxy laboratories limited with sun pharmaceutical industries limited under sub-section (7) of section 31 of the competition act, 2002, subject to inter alia divestment of certain products. in this respect, the company has also submitted to the exchange a copy of press release dated december 8, 2014 titled ""cci approves ranbaxy acquisition by sun pharma"".",08-Dec-2014 20:58:00,2014-12-08 20:58:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_08122014205741.zip,08-12-2014,821.0,839.5499877929688,820.0499877929688,827.7999877929688,772.55908203125,1706311,0.0,0.0,15-12-2014,0
549,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant sanghvi has submitted to the exchange, vide letter dated december 3, 2014 a copy of disclosure under regulation 31(1) & 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",04-Dec-2014 21:13:00,2014-12-04 21:13:00,-,-,https://nsearchives.nseindia.com/corporate/Sun_31_04122014211244.zip,04-12-2014,840.0,844.25,836.0,839.4000244140625,783.3850708007812,1007007,0.0,0.0,11-12-2014,0
550,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has informed the exchange regarding clarification with respect to cci approval to the scheme of arrangement between ranbaxy laboratories limited and sun pharmaceutical industries limited.,01-Dec-2014 20:14:00,2014-12-01 20:14:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_12012014201401_1.zip,01-12-2014,853.9000244140625,856.5,829.0,835.6500244140625,779.8854370117188,2948295,0.0,0.0,08-12-2014,0
551,SUNPHARMA,Sun Pharmaceutical Industries Limited,scheme of arrangement,"sun pharmaceuticals industries limited has informed the exchange, vide letter dated november 24, 2014 regarding the approval of scheme of arrangement between ranbaxy laboratories limited with sun pharmaceutical industries ltd in the nature of merger of ranbaxy laboratories limited with the company.",24-Nov-2014 13:54:00,2014-11-24 13:54:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_11242014135401_1.zip,24-11-2014,840.0,853.7000122070312,833.3499755859375,835.7999877929688,780.0252685546875,2455772,0.0,0.0,01-12-2014,0
552,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange, vide letter dated november 13, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",18-Nov-2014 10:26:00,2014-11-18 10:26:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma00001_18112014102535.zip,18-11-2014,882.9000244140625,896.9000244140625,865.0,866.9000244140625,809.0499267578125,2217575,0.0,0.0,25-11-2014,0
553,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release (revised),"sun pharmaceuticals industries limited has informed the exchange regarding a revised press release dated november 13, 2014 titled ""sun pharma reports a strong quarter"". further, the company has stated that ""the previous version had an error wherein on page no. 1, h1fy15 was erroneously written as h1fy14"".",13-Nov-2014 17:50:00,2014-11-13 17:50:00,-,-,https://nsearchives.nseindia.com/corporate/Sun_Revised_13112014174946.zip,13-11-2014,904.25,924.75,900.75,908.2999877929688,847.6871948242188,2563302,0.0,0.0,20-11-2014,-1
554,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-sep-2014.,13-Nov-2014 16:19:03,2014-11-13 16:19:03,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30Sep14_B_11132014161902_.zip,13-11-2014,904.25,924.75,900.75,908.2999877929688,847.6871948242188,2563302,0.0,0.0,20-11-2014,-1
555,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 13, 2014 titled ""sun pharma reports a strong quarter"".",13-Nov-2014 16:09:00,2014-11-13 16:09:00,-,-,https://nsearchives.nseindia.com/corporate/sun01_13112014160841.zip,13-11-2014,904.25,924.75,900.75,908.2999877929688,847.6871948242188,2563302,0.0,0.0,20-11-2014,-1
556,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange, vide letter dated november 08, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",11-Nov-2014 11:29:00,2014-11-11 11:29:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticals_11112014_11112014112901_1.zip,11-11-2014,911.0,924.0,910.0999755859376,917.2999877929688,856.0866088867188,3176824,0.0,0.0,18-11-2014,-1
557,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 30, 2014, titled "" sun pharma to announce second quarter results on november 13, 2014"".",30-Oct-2014 12:37:00,2014-10-30 12:37:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARAMA_01_10302014123702_1.zip,30-10-2014,824.5,838.7999877929688,823.5,828.6500244140625,773.3524780273438,2576515,0.0,0.0,10-11-2014,1
558,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated october 22, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",29-Oct-2014 18:03:00,2014-10-29 18:03:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharamceutical_jayant_291020140002_29102014180244.zip,29-10-2014,848.0,849.5,826.0,830.4000244140625,774.9857177734375,2776661,0.0,0.0,07-11-2014,1
559,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure of voting pattern - clause 35a,sun pharmaceuticals industries limited has informed the exchange regarding outcome of annual general meeting and disclosure of voting results along with scrutinizer report as per clause 35a of listing agreement.,01-Oct-2014 08:26:00,2014-10-01 08:26:00,-,-,https://nsearchives.nseindia.com/corporate/SPILOutcomeof22ndAGM2014VotingResultsasper35AandScrutinizerReports_01102014082655.zip,01-10-2014,860.0,865.4000244140625,849.4500122070312,860.7999877929688,803.3571166992188,2624246,0.0,0.0,13-10-2014,-1
560,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the chairman speech at the annual general meeting of the company held on september 27, 2014.",29-Sep-2014 13:42:00,2014-09-29 13:42:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_01_29092014134214.zip,29-09-2014,808.0,839.7999877929688,808.0,835.7999877929688,780.0252685546875,3873334,0.0,0.0,09-10-2014,0
561,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 17, 2014, titled ""sun pharma and merck & co. inc. enter into licensing agreement for tildrakizumab"".",17-Sep-2014 18:12:00,2014-09-17 18:12:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_09172014181202_2.zip,17-09-2014,804.9000244140625,811.7999877929688,786.7999877929688,792.4000244140625,739.5216064453125,2736588,0.0,0.0,24-09-2014,0
562,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant sanghvi has submitted to the exchange vide letter dated september 11, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",15-Sep-2014 16:08:00,2014-09-15 16:08:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticak_15092014_09152014160802_4.zip,15-09-2014,804.0,814.75,792.5,795.2999877929688,742.2279052734375,3131125,0.0,0.0,22-09-2014,0
563,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated september 02, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",05-Sep-2014 19:12:00,2014-09-05 19:12:00,-,-,https://nsearchives.nseindia.com/corporate/jayant_05092014_09052014191202_2.zip,05-09-2014,869.0,869.9000244140625,852.6500244140625,857.8499755859375,799.2064208984375,1179280,0.0,0.0,12-09-2014,-1
564,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of notice of the annual general meeting of the company to be held on september 27, 2014.",03-Sep-2014 17:12:00,2014-09-03 17:12:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticalindustriesltd_03092014_09032014171201_1.zip,03-09-2014,866.4000244140625,878.4000244140625,857.0499877929688,863.2999877929688,804.2837524414062,2005404,0.0,0.0,10-09-2014,0
565,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange that the company in receipt of direction under section 29(2) of the competition act, 2002 from cci directing sun pharma to publish the details of the proposed combination within 10 working days from august 27 , 2014 in form iv contained in schedule ii to the combination regulations.",28-Aug-2014 08:40:00,2014-08-28 08:40:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_01_08282014084001_1.zip,28-08-2014,861.0,866.4000244140625,849.8499755859375,855.25,796.7841186523438,2416622,0.0,0.0,05-09-2014,0
566,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure of voting pattern - clause 35a,"sun pharmaceuticals industries limited has informed the exchange regarding report of proceedings of court convened meeting of equity shareholders of the company held on august 22, 2014 and disclosure of voting results under clause 35a of the listing agreement.",26-Aug-2014 08:12:00,2014-08-26 08:12:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_01_08262014081204_2.zip,26-08-2014,849.2000122070312,875.4500122070312,849.2000122070312,864.9500122070312,805.821044921875,1767734,0.0,0.0,03-09-2014,0
567,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"sun pharmaceuticals industries limited has submitted to the exchange vide letter dated august 18, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi ( substantial acquisition of shares & takeovers ) regulations, 2011.",22-Aug-2014 12:16:00,2014-08-22 12:16:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticals_22082014_08222014121602_2.zip,22-08-2014,853.0499877929688,864.0,844.6500244140625,856.6500244140625,798.0884399414062,2090452,0.0,0.0,01-09-2014,0
568,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 12, 2014, titled ""sun pharma reports a strong quarter"".",13-Aug-2014 08:24:00,2014-08-13 08:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_08132014082401_1.zip,13-08-2014,777.5,805.0,777.5,802.5999755859375,747.7333984375,3490582,0.0,0.0,21-08-2014,1
569,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results along with the limited review report for the period ended 30-jun-2014.,13-Aug-2014 08:07:03,2014-08-13 08:07:03,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30June14_B.zip,13-08-2014,777.5,805.0,777.5,802.5999755859375,747.7333984375,3490582,0.0,0.0,21-08-2014,1
570,SUNPHARMA,Sun Pharmaceutical Industries Limited,meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of notice of court convened meeting of the shareholders of the company to be held on august 22, 2014.",05-Aug-2014 20:32:00,2014-08-05 20:32:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_CourtConvened_05082013_08052014203202_1.zip,05-08-2014,766.3499755859375,779.9000244140625,762.5,773.7999877929688,720.9020385742188,1194951,0.0,0.0,12-08-2014,0
571,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 30, 2014, titled ""sun pharma to announce first quarter results on august 12, 2014"".",30-Jul-2014 13:12:00,2014-07-30 13:12:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_PR_07302014131202_1.zip,30-07-2014,785.0,800.0,780.4500122070312,790.4500122070312,736.4140625,2397895,0.0,0.0,06-08-2014,0
572,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated july 16, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",21-Jul-2014 20:24:00,2014-07-21 20:24:00,-,-,https://nsearchives.nseindia.com/corporate/sun_jayant_21072014202232.zip,21-07-2014,750.7999877929688,751.4500122070312,741.0999755859375,743.7000122070312,692.85986328125,1201953,0.0,0.0,28-07-2014,1
573,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated july 16, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",21-Jul-2014 20:24:00,2014-07-21 20:24:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticalindustriesltd_jayantsanghvi_21072014_21072014202108.zip,21-07-2014,750.7999877929688,751.4500122070312,741.0999755859375,743.7000122070312,692.85986328125,1201953,0.0,0.0,28-07-2014,1
574,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 16, 2014, titled ""sun pharma acquires pharmalucence"".",16-Jul-2014 08:36:00,2014-07-16 08:36:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_07162014083602_2.zip,16-07-2014,746.0,753.0,737.5,744.9000244140625,693.9777221679688,1970017,0.0,0.0,23-07-2014,0
575,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated july 11, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",15-Jul-2014 17:32:00,2014-07-15 17:32:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticalindustriesltd_jayantsanghvi_15072014_15072014173011.zip,15-07-2014,737.25,747.5999755859375,733.0,739.7000122070312,689.1331787109375,1205297,0.0,0.0,22-07-2014,0
576,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated july 03, 2014 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",08-Jul-2014 17:16:00,2014-07-08 17:16:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticalindustriesltd_08072014_08072014171411.zip,08-07-2014,732.0,744.9000244140625,719.4500122070312,726.0499877929688,676.4163818359375,4496355,0.0,0.0,15-07-2014,0
577,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange about the outcome of board meeting held on may 29, 2014.",29-May-2014 16:08:00,2014-05-29 16:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMa_05292014160801_1.zip,29-05-2014,585.0,591.0999755859375,581.8499755859375,586.5999755859375,546.4993286132812,3306080,0.0,0.0,05-06-2014,0
578,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 29, 2014, titled ""sun pharma reports a strong quarter"".",29-May-2014 15:32:00,2014-05-29 15:32:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_29052014_05292014153202_1.zip,29-05-2014,585.0,591.0999755859375,581.8499755859375,586.5999755859375,546.4993286132812,3306080,0.0,0.0,05-06-2014,0
579,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-mar-2014.,29-May-2014 15:15:03,2014-05-29 15:15:03,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_05292014151502_.zip,29-05-2014,585.0,591.0999755859375,581.8499755859375,586.5999755859375,546.4993286132812,3306080,0.0,0.0,05-06-2014,0
580,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",27-May-2014 12:48:00,2014-05-27 12:48:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharamceuticalindustriesltd_jayantsanghvi_27052014_27052014124501.zip,27-05-2014,591.3499755859375,597.9000244140625,584.2000122070312,592.5,551.9960327148438,1672637,0.0,0.0,03-06-2014,0
581,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 16, 2014, titled ""sun pharma to announce q4 and fy14 results on may 29, 2014"".",16-May-2014 18:44:00,2014-05-16 18:44:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharama_pr_05162014184401_1.zip,16-05-2014,622.2000122070312,634.5499877929688,611.0,613.5,571.5604248046875,2621959,0.0,0.0,23-05-2014,0
582,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 15, 2014, titled ""sun pharma announces settlement of litigation for generic gleevec  in us"".",15-May-2014 08:40:00,2014-05-15 08:40:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_15052014_05152014084002_1.zip,15-05-2014,620.0,629.7999877929688,613.25,621.4000244140625,578.9203491210938,2847444,0.0,0.0,22-05-2014,-1
583,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure of voting pattern - clause 35a,"sun pharmaceuticals industries limited has informed the exchange regarding a proceedings of the court convened meeting of equity shareholders of the company held on may 05, 2014, under clause 35a.",12-May-2014 09:04:00,2014-05-12 09:04:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHAR_CLAUSE35A_12052014090055.zip,12-05-2014,624.0,624.0999755859375,610.0999755859375,613.3499755859375,571.4205932617188,2231158,0.0,0.0,19-05-2014,0
584,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 02, 2014 titled ""sun pharma announces manufacturing consolidation"".",02-May-2014 17:00:00,2014-05-02 17:00:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_05022014170002_1.zip,02-05-2014,631.5999755859375,641.4000244140625,628.5999755859375,629.9000244140625,586.8394165039062,1531545,0.0,0.0,09-05-2014,0
585,SUNPHARMA,Sun Pharmaceutical Industries Limited,court convened meeting updates,"sun pharmaceuticals industries limited  has submitted to the exchange  a copy of the notice of court convened meeting of the shareholders of the company to be held on may 05, 2014.",21-Apr-2014 13:56:00,2014-04-21 13:56:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_21042014_04212014135602_1.zip,21-04-2014,628.7000122070312,629.25,619.4000244140625,621.25,578.7805786132812,1324788,0.0,0.0,28-04-2014,0
586,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 09, 2014, titled ""clarification on silverstreet investment in ranbaxy"".",09-Apr-2014 15:24:00,2014-04-09 15:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_pr_09042014_04092014152401_1.zip,09-04-2014,597.0,634.9000244140625,593.0,630.0,586.9324951171875,13263006,0.0,0.0,17-04-2014,0
587,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,sun pharmaceuticals industries limited has submitted to the exchange a copy of investor presentation related to the merger of sun pharmaceutical industries ltd. and ranbaxy laboratories ltd.,07-Apr-2014 09:44:00,2014-04-07 09:44:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_update_07042014_04072014094402_1.zip,07-04-2014,580.0,594.7999877929688,573.75,588.0999755859375,547.8967895507812,10031924,0.0,0.0,16-04-2014,0
588,SUNPHARMA,Sun Pharmaceutical Industries Limited,outcome of board meeting,"sun pharmaceuticals industries limited has informed the exchange that (1) the board of directors of the company at their meeting held on april 06, 2014 has approved the scheme of arrangement between ranbaxy laboratories limited and the company (sun pharmaceutical industries limited) under the provisions of the sections 391 to 394 and other applicable provisions of the companies act, 1956 and corresponding provisions of the companies act, 2013 subject to receipt of necessary approvals, consents and filings. (2) the board of directors has recommended the share exchange ratio of 8 fully paid up equity shares of rs. 1/ - each of the company for every 10 equity shares of rs. 5/- each of ranbaxy laboratories limited. further, the company has submitted a copy of press release dated april 06, 2014 titled ""sun pharma to acquire ranbaxy in a us$ 4 billion landmark transaction"".",07-Apr-2014 08:24:00,2014-04-07 08:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_07042014_04072014082402_1.zip,07-04-2014,580.0,594.7999877929688,573.75,588.0999755859375,547.8967895507812,10031924,0.0,0.0,16-04-2014,0
589,SUNPHARMA,Sun Pharmaceutical Industries Limited,news clarification,"the exchange had sought clarification from sun pharmaceuticals industries limited with respect to a news item captioned ""sun pharma to buy stan chartered mumbai tower for rs. 280 crore"". the company has clarified that ""in this connection, please note that that we have entered into a preliminary understanding with standard chartered bank for purchase of the property referred into the above media report, subject to successful outcome of our due diligence and compliance/satisfaction of other conditions. you may further note that ours is a pharmaceutical company having our corporate office at mumbai and purchase of any property for our official use does not directly affect the earnings/earning capacity of the company and further the amount which may be paid by the company for the purchase of the said property will amount to minor percentage of our net worth/our asset base. in view thereof, the above information did not/ does not constitute price sensitive information of the company and therefore there was no need to report the same to the exchanges. we may hereby clarify that other than above statements regarding the property, we are neither denying nor confirming any other information published in the said news paper"".",02-Apr-2014 15:28:00,2014-04-02 15:28:00,-,-,https://nsearchives.nseindia.com/corporate/sun_04022014152801_1.zip,02-04-2014,572.0,581.5,570.0999755859375,575.25,535.9252319335938,3765317,0.0,0.0,10-04-2014,1
590,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 13, 2014, titled ""import alert for karkhadl unit from us fda"".",13-Mar-2014 13:08:00,2014-03-13 13:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHAR_Pr_13032014_03132014130802_1.zip,13-03-2014,610.8499755859375,610.8499755859375,565.5,572.9500122070312,533.782470703125,8061906,0.0,0.0,21-03-2014,0
591,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 13, 2014, titled ""sun pharma announces us fda approval for generic temodar""",14-Feb-2014 08:32:00,2014-02-14 08:32:00,-,-,https://nsearchives.nseindia.com/corporate/Sun_Pharmaceutical_Industries_Ltd3_130214_02142014083202_1.zip,14-02-2014,622.5,626.5,605.2000122070312,609.0499877929688,567.41455078125,3027378,0.0,0.0,21-02-2014,0
592,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 13, 2014, titled ""rekha sethi appointed as an additional independent director of sun pharma board"".",14-Feb-2014 08:20:00,2014-02-14 08:20:00,-,-,https://nsearchives.nseindia.com/corporate/sun_Pr_02142014082001_1.zip,14-02-2014,622.5,626.5,605.2000122070312,609.0499877929688,567.41455078125,3027378,0.0,0.0,21-02-2014,0
593,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 13, 2014, titled""sun pharma reports a strong quarter"".",13-Feb-2014 15:08:00,2014-02-13 15:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHAR_pr_13022014_02132014150803_3.zip,13-02-2014,615.0,623.2000122070312,610.2999877929688,615.2999877929688,573.2373657226562,3135266,0.0,0.0,20-02-2014,0
594,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-dec-2013.,13-Feb-2014 14:59:02,2014-02-13 14:59:02,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31dec2013_B_02132014145902_.zip,13-02-2014,615.0,623.2000122070312,610.2999877929688,615.2999877929688,573.2373657226562,3135266,0.0,0.0,20-02-2014,0
595,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated january 29, 2014, titled ""sun pharma to announce third quarter results on february 13, 2014"".",29-Jan-2014 16:32:00,2014-01-29 16:32:00,-,-,https://nsearchives.nseindia.com/corporate/Sun_Pharmaceutical_Industries_Ltd_290114_01292014163201_1.zip,29-01-2014,588.0,604.9000244140625,585.9000244140625,591.4500122070312,551.0177612304688,2412064,0.0,0.0,05-02-2014,0
596,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 12, 2013, titled ""sun pharma announces us fda approval for generic cymbalta"".",12-Dec-2013 16:00:00,2013-12-12 16:00:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_pr_12122013160002_1.zip,12-12-2013,578.0,581.9500122070312,571.5999755859375,574.3499755859375,535.0867309570312,1992788,0.0,0.0,19-12-2013,0
597,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated november 30, 2013 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",03-Dec-2013 17:36:00,2013-12-03 17:36:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmacueiticalindustriesltd_jayantssanghvi_03122013.zip,03-12-2013,598.0,601.9000244140625,587.0,592.9000244140625,552.3687133789062,2312310,0.0,0.0,10-12-2013,0
598,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 13, 2013, titled ""sun pharma reports a strong quarter"".",14-Nov-2013 08:24:00,2013-11-14 08:24:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_pr_14112013_11142013082401_1.zip,14-11-2013,618.9500122070312,620.75,597.0,598.75,557.8187255859375,1912214,0.0,0.0,22-11-2013,0
599,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,sun pharmaceuticals industries limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-sep-2013.,13-Nov-2013 19:55:02,2013-11-13 19:55:02,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_SEP_11132013195501_.zip,13-11-2013,612.0,623.4000244140625,605.0,608.0999755859375,566.5296020507812,3626443,0.0,0.0,21-11-2013,0
600,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 28, 2013, titled ""sun pharma to announce second quarter results on november 13, 2013"".",28-Oct-2013 19:48:00,2013-10-28 19:48:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_Pr_28102013_10282013194802_1.zip,28-10-2013,612.0,612.0499877929688,598.25,603.8499755859375,562.570068359375,1382259,0.0,0.0,05-11-2013,0
601,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the report of proceedings of the annual general meeting of the company held on september 30, 2013.",03-Oct-2013 11:40:00,2013-10-03 11:40:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticalindustriesltd_03102013.zip,03-10-2013,596.0,608.5,592.4000244140625,600.9000244140625,559.8218994140625,2598595,0.0,0.0,10-10-2013,1
602,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 01, 2013, titled ""sun pharma and intrexon form joint venture to develop new class of therapeutics for ocular diseases"". ",01-Oct-2013 17:16:00,2013-10-01 17:16:00,-,-,https://nsearchives.nseindia.com/corporate/Sun_Pharmaceutical_10012013171602_3.zip,01-10-2013,594.7000122070312,598.3499755859375,588.1500244140625,590.0,549.6669311523438,1138970,0.0,0.0,09-10-2013,1
603,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 14, 2013, titled ""sun pharma announces usfda approval for generic prevacid(r)"".",16-Sep-2013 08:36:00,2013-09-16 08:36:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_09162013083601_1.zip,16-09-2013,576.2999877929688,584.6500244140625,554.0,563.5999755859375,522.681884765625,2130891,0.0,0.0,23-09-2013,0
604,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"sun pharmaceuticals industries limited has submitted to the exchange vide letter dated august 26, 2013 a copy of disclosure pursuant to regulation 13(4), 13(4a) and 13(6) of the sebi (prohibition of insider trading) regulations, 1992",29-Aug-2013 12:24:00,2013-08-29 12:24:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmacuticalindustriesltd_29082013.zip,29-08-2013,509.0,515.0,493.6000061035156,510.6499938964844,473.5762023925781,2769581,0.0,0.0,05-09-2013,0
605,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding press release dated august 9, 2013 titled ""sun pharma reports strong quarter"" ",12-Aug-2013 16:12:00,2013-08-12 16:12:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_PR_12082013_08122013161202_1.zip,12-08-2013,521.0,552.0,521.0,541.7000122070312,502.3718872070313,3185173,0.0,0.0,20-08-2013,-1
606,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results along with the limited review report for the period ended june 30,2013.",12-Aug-2013 09:50:06,2013-08-12 09:50:06,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30JUN2013_B_Q1.zip,12-08-2013,521.0,552.0,521.0,541.7000122070312,502.3718872070313,3185173,0.0,0.0,20-08-2013,-1
607,SUNPHARMA,Sun Pharmaceutical Industries Limited,dividend updates,"sun pharmaceuticals industries limited has informed the exchange as follows : ""we would like to state and confirm that post-bonus dividend i.e. dividend now payable to the equity shareholders for the accounting year ended march 31, 2013 will be @ rs.2.50 per outstanding equity share of re.1/- each.""",08-Aug-2013 10:44:00,2013-08-08 10:44:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_08082013104401_1.zip,08-08-2013,512.0,518.9000244140625,495.0,505.7000122070313,468.9855346679688,3169712,0.0,0.0,19-08-2013,0
608,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 23, 2013, titled ""sun pharma to announce first quarter results on august 09, 2013"". ",24-Jul-2013 09:24:00,2013-07-24 09:24:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_24072013_07242013092402_1.zip,24-07-2013,552.5,565.4000244140625,551.0,563.625,522.7051391601562,1756166,0.0,0.0,31-07-2013,0
609,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide letter dated july 19, 2013 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",23-Jul-2013 14:08:00,2013-07-23 14:08:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceutical_jayantssanghvi_23072013.zip,23-07-2013,557.0,558.7249755859375,545.5,553.25,513.0833129882812,1785728,0.0,0.0,30-07-2013,0
610,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure of voting pattern - clause 35a,sun pharmaceuticals industries limited has informed the exchange regarding the result of postal ballot as per clause 35a of the listing agreement.,16-Jul-2013 09:00:00,2013-07-16 09:00:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_Disc35_16072013_07162013090002_1.zip,16-07-2013,552.0,564.9249877929688,550.7999877929688,559.7999877929688,519.1578369140625,1068354,0.0,0.0,23-07-2013,0
611,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 12, 2013, titled ""sun pharma announces usfda approval for generic prandin"".",12-Jul-2013 08:12:00,2013-07-12 08:12:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_12072013_07122013081201_1.zip,12-07-2013,555.0,557.5,545.0,554.3499755859375,514.1034545898438,1765166,0.0,0.0,19-07-2013,0
612,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 12, 2013 titled ""sun pharma settles generic protonix litigation"".",12-Jun-2013 17:52:00,2013-06-12 17:52:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_12062013_06122013175202_1.zip,12-06-2013,491.2000122070313,495.6499938964844,485.75,490.3500061035156,454.74993896484375,2231638,0.0,0.0,19-06-2013,0
613,SUNPHARMA,Sun Pharmaceutical Industries Limited,postal ballot updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of notice of postal ballot pursuant to the provisions of section 192a of the companies act, 1956 (""the act"") read with the companies (passing of the resolution by postal ballot) rules, 2011.",12-Jun-2013 09:48:00,2013-06-12 09:48:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pb_12062013_06122013094802_1.zip,12-06-2013,491.2000122070313,495.6499938964844,485.75,490.3500061035156,454.74993896484375,2231638,0.0,0.0,19-06-2013,0
614,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 04, 2013 titled ""sun pharma announces usfda approval for generic depo -testosterone injection"".",04-Jun-2013 16:24:00,2013-06-04 16:24:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_PR_040602013_06042013162402_1.zip,04-06-2013,505.0,516.375,499.3250122070313,509.125,472.161865234375,2693116,0.0,0.0,11-06-2013,0
615,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 28, 2013 titled ""sun pharma reports strong performance"".",29-May-2013 11:24:00,2013-05-29 11:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr01_29052013_05292013112402_1.zip,29-05-2013,520.2999877929688,540.3499755859375,510.0,532.875,494.1874694824219,7929878,0.0,0.0,05-06-2013,0
616,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 28, 2013, titled ""sun pharma announces 1:1 bonus"".",29-May-2013 11:24:00,2013-05-29 11:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr02_29052013_05292013112402_2.zip,29-05-2013,520.2999877929688,540.3499755859375,510.0,532.875,494.1874694824219,7929878,0.0,0.0,05-06-2013,0
617,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results for the period ended march 31,2013.",28-May-2013 16:31:41,2013-05-28 16:31:41,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31MAR2013_B_Q4A.zip,28-05-2013,510.5,511.5,494.0750122070313,498.125,461.96044921875,3192018,0.0,0.0,04-06-2013,0
618,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 17, 2013 titled ""sun pharma to announce q4 and fy13 results on may 28, 2013"".",17-May-2013 15:32:00,2013-05-17 15:32:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_17052013_05172013153201_1.zip,17-05-2013,485.0499877929688,488.2999877929688,479.0,483.0750122070313,448.003173828125,829624,0.0,0.0,24-05-2013,0
619,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange, vide letter dated april 25, 2013 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",30-Apr-2013 14:28:00,2013-04-30 14:28:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticalindustries_jayantssanghvi_29042013.zip,30-04-2013,471.0249938964844,482.4750061035156,470.2999877929688,475.5249938964844,441.0012817382813,1419360,0.0,0.0,08-05-2013,0
620,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 13, 2013, titled ""sun pharma announces tentative usfda approvals for generic januvia and generic glumetza"".",15-Apr-2013 08:28:00,2013-04-15 08:28:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_15042013_04152013082802_3.zip,15-04-2013,436.5,439.0,433.0,436.5,404.80950927734375,1054114,0.0,0.0,23-04-2013,1
621,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide its letter dated april 06, 2013 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",10-Apr-2013 18:12:00,2013-04-10 18:12:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmaceuticalindustries_jayantssanghvi_10042013.zip,10-04-2013,441.0,441.0,423.1499938964844,428.7250061035156,397.5989990234375,2028646,0.0,0.0,17-04-2013,1
622,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide its letter dated march 21, 2013 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",03-Apr-2013 18:40:00,2013-04-03 18:40:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharmacetuicalindustries_jayantssanghvi_03042013.zip,03-04-2013,426.4750061035156,438.5499877929688,424.75,432.1499938964844,400.7753601074219,2615936,0.0,0.0,10-04-2013,0
623,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 08, 2013, titled ""sun pharma and taro announce termination of proposed transaction"".",08-Feb-2013 18:28:00,2013-02-08 18:28:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr1_08022013_02082013182802_3.zip,08-02-2013,375.7000122070313,379.0,370.8250122070313,373.0499877929688,345.9660949707031,3330272,0.0,0.0,15-02-2013,1
624,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 08, 2013, titled ""sun pharma reports a strong quarter"".",08-Feb-2013 11:24:00,2013-02-08 11:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_08022013_02082013112401_1.zip,08-02-2013,375.7000122070313,379.0,370.8250122070313,373.0499877929688,345.9660949707031,3330272,0.0,0.0,15-02-2013,1
625,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results along with the limited review report for the period ended december 31,2012.",08-Feb-2013 10:59:48,2013-02-08 10:59:48,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31DEC2012_B_Q3.zip,08-02-2013,375.7000122070313,379.0,370.8250122070313,373.0499877929688,345.9660949707031,3330272,0.0,0.0,15-02-2013,1
626,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 05, 2013, titled""sun pharma announces usfda approval for generic doxil "".",05-Feb-2013 09:08:00,2013-02-05 09:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_pr_0522013_02052013090802_2.zip,05-02-2013,367.5,376.0,365.4249877929688,374.75,347.5426940917969,4320004,0.0,0.0,12-02-2013,0
627,SUNPHARMA,Sun Pharmaceutical Industries Limited,court convened meeting updates,"sun pharmaceuticals industries limited has informed the exchange regarding the proceedings of court convened meeting of equity shareholders of the company held on january 25, 2013.",01-Feb-2013 09:04:00,2013-02-01 09:04:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_OM_01022013_02012013090401_1.zip,01-02-2013,359.0249938964844,362.0,358.25,359.95001220703125,333.8171691894531,494318,0.0,0.0,08-02-2013,0
628,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated january 25, 2013, titled ""sun pharma to announce third quarter results on february 08, 2013""  ",28-Jan-2013 07:40:00,2013-01-28 07:40:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_25012013_01252013200802_2.zip,28-01-2013,365.0,365.1749877929688,357.54998779296875,360.2749938964844,334.1184997558594,767284,0.0,0.0,04-02-2013,0
629,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 20, 2012, titled ""caraco pharmaceutical laboratories announces successful tender offer to acquire dusa"".",10-Jan-2013 17:39:00,2013-01-10 17:39:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR01_20122012.zip,10-01-2013,382.0,382.4500122070313,375.1000061035156,377.125,349.7452697753906,1012396,0.0,0.0,17-01-2013,0
630,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 17, 2012, titled ""sun pharma acquires url generic business from takeda"".",17-Dec-2012 20:29:00,2012-12-17 20:29:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_PR02_17122012.zip,17-12-2012,357.04998779296875,362.3999938964844,357.04998779296875,360.5249938964844,334.35040283203125,2047662,0.0,0.0,24-12-2012,0
631,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide its letter dated december 04, 2012 a copy of disclosure in terms of  regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",06-Dec-2012 17:18:00,2012-12-06 17:18:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_REG31_06122012.zip,06-12-2012,350.54998779296875,354.4750061035156,346.45001220703125,351.57501220703125,326.0502319335937,2032942,0.0,0.0,13-12-2012,0
632,SUNPHARMA,Sun Pharmaceutical Industries Limited,proceedings of annual general meeting,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the proceedings of the annual general meeting of the company held on november 08, 2012.",12-Nov-2012 10:04:00,2012-11-12 10:04:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_PAGM_12112012.ZIP,12-11-2012,349.3500061035156,349.92498779296875,342.0,345.9750061035156,320.8568115234375,739238,0.0,0.0,21-11-2012,0
633,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 08, 2012, titled ""sun pharma to acquire dusa pharmaceuticals, inc"".",08-Nov-2012 17:46:00,2012-11-08 17:46:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_08112012_001.zip,08-11-2012,350.45001220703125,357.0,345.1000061035156,348.2749938964844,322.9897766113281,3533206,0.0,0.0,19-11-2012,0
634,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 08, 2012, titled ""sun pharma report a strong quarter"".",08-Nov-2012 15:50:00,2012-11-08 15:50:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_08112012.zip,08-11-2012,350.45001220703125,357.0,345.1000061035156,348.2749938964844,322.9897766113281,3533206,0.0,0.0,19-11-2012,0
635,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results along with the limited review report for the period ended september 30,2012.",08-Nov-2012 15:19:29,2012-11-08 15:19:29,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30SEP2012_B_Q2.zip,08-11-2012,350.45001220703125,357.0,345.1000061035156,348.2749938964844,322.9897766113281,3533206,0.0,0.0,19-11-2012,0
636,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 22, 2012, titled ""sun pharma to announce second quarter results on november 08, 2012"".",22-Oct-2012 12:06:00,2012-10-22 12:06:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_pr_22102012.zip,22-10-2012,347.45001220703125,350.0,340.25,349.54998779296875,324.1722106933594,1168318,0.0,0.0,31-10-2012,0
637,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide letter dated october 17, 2012 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",18-Oct-2012 17:38:00,2012-10-18 17:38:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_Jayant_18102012.zip,18-10-2012,355.125,357.29998779296875,349.125,349.8999938964844,324.4968566894531,2388514,0.0,0.0,29-10-2012,0
638,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the notice of the annual general meeting of the members of the company scheduled will be held on november 08, 2012.",17-Oct-2012 11:23:00,2012-10-17 11:23:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_AGM_11102012.ZIP,17-10-2012,360.5249938964844,361.5,355.04998779296875,355.75,329.9220886230469,751248,0.0,0.0,25-10-2012,0
639,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s sanghvi has submitted to the exchange vide its letter dated october 09, 2012 a copy of disclosure in terms of  regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",12-Oct-2012 12:40:00,2012-10-12 12:40:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_REG31_11102012.ZIP,12-10-2012,361.5,363.1499938964844,354.82501220703125,356.625,330.7335510253906,1129144,0.0,0.0,19-10-2012,0
640,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under insider trading regulation,"kirti ganorkar has submitted to the exchange vide its letter dated oct 03, 2012 a copy of disclosure under regulation 13(4) and 13(6) of sebi (prohibition of insider trading) regulations, 1992.",04-Oct-2012 17:33:00,2012-10-04 17:33:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_kirti_03102012.zip,04-10-2012,352.5,352.5,347.0,349.375,324.00994873046875,3083848,0.0,0.0,11-10-2012,0
641,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide letter dated september 25, 2012, a copy of disclosure under regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",26-Sep-2012 16:13:00,2012-09-26 16:13:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_Jayant_26092012.zip,26-09-2012,335.5,341.2250061035156,334.79998779296875,337.8500061035156,313.3216552734375,1266006,0.0,0.0,04-10-2012,0
642,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide letter dated september 14, 2012, a copy of disclosure under regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",17-Sep-2012 14:57:00,2012-09-17 14:57:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_JAYANT_17092012.zip,17-09-2012,340.625,341.75,330.625,336.45001220703125,312.0233154296875,3814960,0.0,0.0,25-09-2012,0
643,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide letter dated september 01, 2012, a copy of disclosure under regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",07-Sep-2012 12:07:00,2012-09-07 12:07:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_Jayant_07092012.zip,07-09-2012,328.04998779296875,332.7749938964844,328.04998779296875,332.29998779296875,308.174560546875,1185380,0.0,0.0,14-09-2012,0
644,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 28, 2012 titled ""caraco receives usfda clearance to resume operations"".",28-Aug-2012 14:06:00,2012-08-28 14:06:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_28082012.zip,28-08-2012,335.0,341.45001220703125,332.75,340.67498779296875,315.9415283203125,2911176,0.0,0.0,04-09-2012,0
645,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide letter dated august 11, 2012, a copy of disclosure under regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",14-Aug-2012 19:17:00,2012-08-14 19:17:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_14082012.zip,14-08-2012,338.5,338.5,330.5,333.6499938964844,309.4266662597656,2894370,2.125,0.0,23-08-2012,0
646,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 13, 2012, titled ""sun pharma to take taro private"".",13-Aug-2012 09:25:00,2012-08-13 09:25:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_13082012.zip,13-08-2012,340.0,344.5249938964844,338.54998779296875,341.0,314.2722473144531,1647378,0.0,0.0,22-08-2012,0
647,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 10, 2012, titled ""sun pharma reports a strong quarter"".",10-Aug-2012 14:54:00,2012-08-10 14:54:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_10082012.zip,10-08-2012,339.95001220703125,344.95001220703125,335.25,337.7250061035156,311.25390625,4555986,0.0,0.0,21-08-2012,0
648,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results along with the limited review report for the period ended june 30,2012.",10-Aug-2012 14:52:52,2012-08-10 14:52:52,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30JUN2012_B_Q1.zip,10-08-2012,339.95001220703125,344.95001220703125,335.25,337.7250061035156,311.25390625,4555986,0.0,0.0,21-08-2012,0
649,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide letter dated july 30, 2012, a copy of disclosure under regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",01-Aug-2012 16:00:00,2012-08-01 16:00:00,-,-,https://nsearchives.nseindia.com/corporate/SUN_PHARM_01082012.zip,01-08-2012,327.75,330.5,323.20001220703125,329.92498779296875,304.0652770996094,1494284,0.0,0.0,08-08-2012,0
650,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 30, 2012, titled ""sun pharma to announce first quarter results on august 10, 2012"".",31-Jul-2012 08:30:00,2012-07-31 08:30:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_30072012.zip,31-07-2012,323.125,328.5,320.9750061035156,326.79998779296875,301.1852111816406,1153766,0.0,0.0,07-08-2012,0
651,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide letter dated june 28, 2012 a copy of disclosure under regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",02-Jul-2012 18:01:00,2012-07-02 18:01:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_jayant_02072012.zip,02-07-2012,318.0,319.82501220703125,315.17498779296875,317.3500061035156,292.4759521484375,1658388,0.0,0.0,09-07-2012,0
652,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide its letter dated may 30, 2012 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",01-Jun-2012 18:18:00,2012-06-01 18:18:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_jayant_01062012.zip,01-06-2012,280.67498779296875,285.82501220703125,280.67498779296875,284.5249938964844,262.2237548828125,1370470,0.0,0.0,08-06-2012,0
653,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 29, 2012, titled ""sun pharma reports strong performance"".",29-May-2012 18:49:00,2012-05-29 18:49:00,-,-,https://nsearchives.nseindia.com/corporate/SPIL_PR_29052012.zip,29-05-2012,286.04998779296875,288.5,281.75,282.875,260.703125,1343318,0.0,0.0,05-06-2012,0
654,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 29, 2012, titled ""israel makov appointed chairman of sun pharma board"".",29-May-2012 17:45:00,2012-05-29 17:45:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_29052012.zip,29-05-2012,286.04998779296875,288.5,281.75,282.875,260.703125,1343318,0.0,0.0,05-06-2012,0
655,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results for the period ended march 31,2012.",29-May-2012 16:44:56,2012-05-29 16:44:56,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31MAR2012_B_Q4A.zip,29-05-2012,286.04998779296875,288.5,281.75,282.875,260.703125,1343318,0.0,0.0,05-06-2012,0
656,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 24, 2012, titled ""sun pharma announces usfda approval for generic astelin nasal spray"".",24-May-2012 13:09:00,2012-05-24 13:09:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_PR_24052012.zip,24-05-2012,289.0,289.0,280.54998779296875,284.4750061035156,262.1776733398437,1482068,0.0,0.0,31-05-2012,0
657,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 18, 2012, titled ""sun pharma announces usfda approval for generic plavixﾮ tablets"".",18-May-2012 13:57:00,2012-05-18 13:57:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_18052012.zip,18-05-2012,285.2749938964844,294.5249938964844,284.8999938964844,290.875,268.0760803222656,1012422,0.0,0.0,25-05-2012,0
658,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 15, 2012, titled ""sun pharma to announce q4 and fy12 results on may 29, 2012"".",15-May-2012 12:37:00,2012-05-15 12:37:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_pr_15052012.zip,15-05-2012,286.0249938964844,299.25,285.07501220703125,297.42498779296875,274.1127014160156,1260638,0.0,0.0,22-05-2012,0
659,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 24, 2012, titled ""sun pharma announces usfda approval for generic zyprexaﾮ tablets"".",24-Apr-2012 12:29:00,2012-04-24 12:29:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharm_pr_24042012.zip,24-04-2012,297.5,302.4750061035156,295.75,297.7250061035156,274.3891296386719,1996560,0.0,0.0,02-05-2012,0
660,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide its letter dated april 17, 2012 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",19-Apr-2012 17:51:00,2012-04-19 17:51:00,-,-,https://nsearchives.nseindia.com/corporate/Jayant_sunpharma_19042012.zip,19-04-2012,302.5249938964844,303.5,297.2250061035156,298.70001220703125,275.28778076171875,866778,0.0,0.0,26-04-2012,0
661,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 18, 2012, titled ""favorable ruling by united states supreme court on prandinﾮ litigation"".",18-Apr-2012 09:31:00,2012-04-18 09:31:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_18042012.zip,18-04-2012,294.0249938964844,300.75,294.0,298.32501220703125,274.942138671875,1001600,0.0,0.0,25-04-2012,0
662,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide its letter dated april 09, 2012 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",10-Apr-2012 18:48:00,2012-04-10 18:48:00,-,-,https://nsearchives.nseindia.com/corporate/Jayant_sunpharm_10042012.zip,10-04-2012,282.0,285.0,279.1499938964844,283.3999938964844,261.1869506835937,752576,0.0,0.0,17-04-2012,0
663,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated march 28, 2012, titled ""sun pharma announces usfda approval for generic seroquel(r) tablets"".",28-Mar-2012 12:49:00,2012-03-28 12:49:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_28032012.zip,28-03-2012,289.8500061035156,293.0,280.125,284.0249938964844,261.76300048828125,928234,0.0,0.0,04-04-2012,0
664,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide its letter dated march 20, 2012 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",22-Mar-2012 14:35:00,2012-03-22 14:35:00,-,-,https://nsearchives.nseindia.com/corporate/Jayant_sunpharm_22032012.zip,22-03-2012,286.95001220703125,288.32501220703125,280.25,282.75,260.587890625,2537198,0.0,0.0,29-03-2012,0
665,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange vide its letter dated march 15, 2012 a copy of disclosure in terms of regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",20-Mar-2012 11:50:00,2012-03-20 11:50:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_jayant_20032012.zip,20-03-2012,280.95001220703125,287.42498779296875,279.0,285.45001220703125,263.0762939453125,2498238,0.0,0.0,27-03-2012,0
666,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 29, 2012, titled ""sun pharma announces usfda approval for generic zyprexa zydisﾮ tablets"".  ",29-Feb-2012 16:16:00,2012-02-29 16:16:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_pr_290220123.zip,29-02-2012,273.04998779296875,282.8999938964844,273.04998779296875,275.20001220703125,253.62966918945312,1596572,0.0,0.0,07-03-2012,0
667,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange a copy of disclosure under regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",24-Feb-2012 13:21:00,2012-02-24 13:21:00,-,-,https://nsearchives.nseindia.com/corporate/Jayant_sun_24022012.zip,24-02-2012,274.8999938964844,275.95001220703125,269.07501220703125,273.8999938964844,252.4315185546875,1189874,0.0,0.0,02-03-2012,0
668,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 15, 2012, titled ""sun pharma: an update to generic protonix litigation"".  ",16-Feb-2012 08:58:00,2012-02-16 08:58:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_PR_16022012.zip,16-02-2012,269.75,273.8999938964844,267.5,270.54998779296875,249.3441772460937,2472766,0.0,0.0,24-02-2012,0
669,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 13, 2012, titled ""sun pharma reports strong performance"".",13-Feb-2012 14:17:00,2012-02-13 14:17:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharmaInds01_pr_13022012.zip,13-02-2012,273.5,279.82501220703125,273.5,276.57501220703125,254.8970184326172,4020990,0.0,0.0,21-02-2012,0
670,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results for the period ended december 31,2011.",13-Feb-2012 13:58:31,2012-02-13 13:58:31,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31DEC2011_B_Q3.zip,13-02-2012,273.5,279.82501220703125,273.5,276.57501220703125,254.8970184326172,4020990,0.0,0.0,21-02-2012,0
671,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant sanghvi has submitted to the exchange a copy of disclosure in terms of  regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",02-Feb-2012 16:42:00,2012-02-02 16:42:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharmInds_jayant_02022012.zip,02-02-2012,275.57501220703125,277.2250061035156,267.57501220703125,271.95001220703125,250.63438415527344,2939066,0.0,0.0,09-02-2012,0
672,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated january 31, 2012, titled ""sun pharma to announce third quarter results on february 13, 2012"".",31-Jan-2012 12:26:00,2012-01-31 12:26:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_Pr_31012012.zip,31-01-2012,269.3999938964844,276.0,267.54998779296875,274.25,252.75418090820312,2012762,0.0,0.0,07-02-2012,0
673,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange a copy of disclosure in terms of  regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",19-Jan-2012 14:18:00,2012-01-19 14:18:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_disc_19012012.zip,19-01-2012,260.17498779296875,266.0,257.625,263.57501220703125,242.9158477783203,1503506,0.0,0.0,27-01-2012,0
674,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange a copy of disclosure in terms of  regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",22-Dec-2011 12:19:00,2011-12-22 12:19:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_jayant_22122011.zip,22-12-2011,250.0,250.0,247.2250061035156,248.0749969482422,228.6307678222656,2117982,0.0,0.0,29-12-2011,0
675,SUNPHARMA,Sun Pharmaceutical Industries Limited,disclosure under sebi takeover regulations,"jayant s. sanghvi has submitted to the exchange a copy of disclosure in terms of  regulation 31(1) and 31(2) of sebi (substantial acquisition of shares & takeovers) regulations, 2011.",15-Dec-2011 18:52:00,2011-12-15 18:52:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_Jayant_Reg_15122011.zip,15-12-2011,257.6000061035156,262.5,257.6000061035156,261.3500061035156,240.865234375,2127162,0.0,0.0,22-12-2011,-1
676,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 09, 2011, titled ""sun pharma announces usfda approval for generic ultram er tablets""",09-Dec-2011 19:56:00,2011-12-09 19:56:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_09122011.zip,09-12-2011,256.1000061035156,259.45001220703125,253.6000061035156,256.45001220703125,236.34930419921875,1156182,0.0,0.0,16-12-2011,0
677,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 13, 2011, titled ""sun pharma reports strong performance for q2fy12.""",14-Nov-2011 08:51:00,2011-11-14 08:51:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_14112011.zip,14-11-2011,255.6000061035156,262.4750061035156,254.3000030517578,255.3999938964844,235.38162231445312,1951568,0.0,0.0,21-11-2011,0
678,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results for the period ended september 30,2011.",14-Nov-2011 08:22:15,2011-11-14 08:22:15,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30SEP2011_B_Q2H.zip,14-11-2011,255.6000061035156,262.4750061035156,254.3000030517578,255.3999938964844,235.38162231445312,1951568,0.0,0.0,21-11-2011,0
679,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 03, 2011, titled ""sun pharma to announce second quarter results on november 13, 2011"".",03-Nov-2011 17:53:00,2011-11-03 17:53:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_03112011.zip,03-11-2011,254.5,255.0249938964844,249.5,251.875,232.13287353515625,1217320,0.0,0.0,14-11-2011,0
680,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 31, 2011, titled ""sun pharma announces usfda approval for generic cardizem cd"".",31-Oct-2011 17:18:00,2011-10-31 17:18:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_31102011.zip,31-10-2011,254.5,254.5,249.125,252.2250061035156,232.45545959472656,1434860,0.0,0.0,08-11-2011,0
681,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the chairman speech delivered at the annual general meeting of the company held on september 16, 2011.",26-Sep-2011 07:54:00,2011-09-26 07:54:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_updates_26092011.zip,26-09-2011,236.375,237.5,227.625,233.4250030517578,215.1290283203125,2628950,0.0,0.0,03-10-2011,0
682,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 19, 2011, titled ""sun pharma subsidiary resolves usfda warning letter"".",19-Sep-2011 08:49:00,2011-09-19 08:49:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_19092011.zip,19-09-2011,248.5,248.5,235.2749938964844,236.75,218.19338989257807,1605906,0.0,0.0,26-09-2011,0
683,SUNPHARMA,Sun Pharmaceutical Industries Limited,proceedings of annual general meeting,"sun pharmaceuticals industries limited has submitted to the exchange a copy of proceedings of the annual general meeting of the company held on september 16, 2011.",16-Sep-2011 15:26:00,2011-09-16 15:26:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARM_fagm_16092011.zip,16-09-2011,241.5249938964844,248.3500061035156,239.5,242.9750061035156,223.93048095703125,3369606,0.0,0.0,23-09-2011,0
684,SUNPHARMA,Sun Pharmaceutical Industries Limited,annual general meeting,"sun pharmaceuticals industries limited has submitted to the exchange a copy of the notice of the annual general meeting of the members of the company to be held on september 16, 2011.",09-Sep-2011 17:42:00,2011-09-09 17:42:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_agmnotice_09092011.zip,09-09-2011,246.5,247.7250061035156,238.5500030517578,241.375,222.45587158203125,1382136,0.0,0.0,16-09-2011,0
685,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 29, 2011, titled ""sun pharma announces usfda tentative approval for generic plavix tablets"".",29-Jul-2011 18:24:00,2011-07-29 18:24:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_29072011.zip,29-07-2011,261.0,262.20001220703125,256.57501220703125,259.1000061035156,237.09152221679688,1444394,0.0,0.0,05-08-2011,0
686,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 28, 2011, titled ""sun pharma reports financials for q1fy12"".",28-Jul-2011 14:19:00,2011-07-28 14:19:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_pr_28072011.zip,28-07-2011,256.0,262.375,254.0,259.7250061035156,237.66342163085932,4204540,0.0,0.0,04-08-2011,0
687,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results for the period ended june 30,2011.",28-Jul-2011 13:37:26,2011-07-28 13:37:26,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_30JUN2011_B_Q1.zip,28-07-2011,256.0,262.375,254.0,259.7250061035156,237.66342163085932,4204540,0.0,0.0,04-08-2011,0
688,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 20, 2011, titled ""sun pharma to announce first quarter results on july 28, 2011"".",20-Jul-2011 17:35:00,2011-07-20 17:35:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_20062011.zip,20-07-2011,255.5749969482422,256.75,250.7250061035156,251.1000061035156,229.77101135253903,497366,0.0,0.0,27-07-2011,0
689,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 19, 2011, titled ""sun pharma announces usfda approval for generic uroxatral er tablets"".",19-Jul-2011 13:10:00,2011-07-19 13:10:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_19072011.zip,19-07-2011,252.0,255.0,250.5749969482422,254.8500061035156,233.20248413085932,1071658,0.0,0.0,26-07-2011,0
690,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 21, 2011, titled ""sun pharma announces usfda approval for generic imitrex(r) injection"".",22-Jun-2011 08:21:00,2011-06-22 08:21:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_22062011.zip,22-06-2011,245.8000030517578,251.75,244.5,247.4499969482422,226.4310607910156,3744308,0.0,0.0,29-06-2011,0
691,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 28, 2011, titled ""sun pharma reports fy2010-11 financials"".",30-May-2011 08:57:00,2011-05-30 08:57:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_30052011.zip,30-05-2011,224.4499969482422,233.5249938964844,224.0,232.1999969482422,212.47642517089844,5225874,0.0,0.0,06-06-2011,0
692,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange vide its letter dated april 25, 2011 titled "" msd in india and sun pharmaceutical industries ltd. enter strategic partnership to co-market msd's diabetes drugs - sitagliptin and sitagliptin plus metformin - in india.""",25-Apr-2011 10:32:00,2011-04-25 10:32:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_25042011.zip,25-04-2011,223.9750061035156,225.0,221.5,223.0,204.05789184570312,788672,0.0,0.0,02-05-2011,0
693,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 11, 2011, titled ""merck & co., inc., and sun pharma establish joint venture to develop and commercialize novel formulations and combinations of medicines in emerging markets"".",11-Apr-2011 16:59:00,2011-04-11 16:59:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA111_PR_11042011.zip,11-04-2011,226.25,227.4499969482422,222.5500030517578,225.1999969482422,206.071029663086,3026028,0.0,0.0,20-04-2011,0
694,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated april 11, 2011, titled ""update on operations and strategy"".",11-Apr-2011 13:06:00,2011-04-11 13:06:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_11042011.zip,11-04-2011,226.25,227.4499969482422,222.5500030517578,225.1999969482422,206.071029663086,3026028,0.0,0.0,20-04-2011,0
695,SUNPHARMA,Sun Pharmaceutical Industries Limited,updates,"sun pharmaceuticals industries limited has informed the exchange vide its letter dated february 22, 2011 regarding ""proposed going private transaction for sun pharma's us subsidiary, caraco pharma"".",23-Feb-2011 09:10:00,2011-02-23 09:10:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHAR_update_23022011.zip,23-02-2011,210.75,212.4499969482422,207.125,208.1000061035156,190.42355346679688,1148008,0.0,0.0,03-03-2011,0
696,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated february 03, 2011, titled ""sun pharma announces usfda approval for generic razadyne er"".",03-Feb-2011 13:58:00,2011-02-03 13:58:00,-,-,https://nsearchives.nseindia.com/corporate/Sun_PR_03022011.zip,03-02-2011,216.5249938964844,220.25,214.0749969482422,218.6499938964844,200.0774078369141,2141106,0.0,0.0,10-02-2011,0
697,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated january 31, 2011, titled ""sun pharma reports q3 fy2010-11 financials"".",31-Jan-2011 15:12:00,2011-01-31 15:12:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharm_pr_31012011.zip,31-01-2011,214.0249938964844,225.75,214.0249938964844,220.4250030517578,201.70162963867188,2736258,0.0,0.0,07-02-2011,-1
698,SUNPHARMA,Sun Pharmaceutical Industries Limited,financial result updates,"sun pharmaceuticals industries limited has submitted to the exchange the standalone and consolidated financial results for the period ended december 31,2010.",31-Jan-2011 14:13:32,2011-01-31 14:13:32,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_31DEC2010_B_Q3.zip,31-01-2011,214.0249938964844,225.75,214.0249938964844,220.4250030517578,201.70162963867188,2736258,0.0,0.0,07-02-2011,-1
699,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated january 18, 2011, titled ""sun pharma to announce q3 results on january 31, 2011"".",18-Jan-2011 14:02:00,2011-01-18 14:02:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_18012011.zip,18-01-2011,233.0,243.9250030517578,233.0,242.1750030517578,221.6041412353516,1368432,0.0,0.0,25-01-2011,0
700,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated december 30, 2010, titled ""sun pharma announces usfda tentative approval for generic boniva"".",30-Dec-2010 18:34:00,2010-12-30 18:34:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_30122010.zip,30-12-2010,242.5,244.125,236.6000061035156,241.2250061035156,220.73483276367188,2085146,0.0,0.0,06-01-2011,0
701,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 30, 2010 , titled "" sun pharma announces usfda tentative approval for generic aricept.""",30-Nov-2010 12:09:00,2010-11-30 12:09:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_PR_30112010.zip,30-11-2010,224.75,227.5,221.0249938964844,223.7749938964844,204.7670745849609,1541054,0.0,0.0,07-12-2010,0
702,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated november 24, 2010, titled ""sun pharma announces usfda tentative approval for generic cymbalta"".",25-Nov-2010 08:45:00,2010-11-25 08:45:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_25112010.zip,25-11-2010,227.5,237.375,222.6000061035156,227.0,207.71815490722656,1944798,0.0,5.0,02-12-2010,0
703,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding press release dated november 18, 2010, titled ""sun pharma announces usfda approval for generic diltiazem er"". and ""sun pharma announces usfda approval for generic clarinex"".",18-Nov-2010 13:08:00,2010-11-18 13:08:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_18112010.zip,18-11-2010,234.8000030517578,234.8000030517578,227.5,228.8999938964844,209.45675659179688,1809430,0.0,0.0,25-11-2010,0
704,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 19, 2010, titled ""sun pharma to announce q2 and h1 2010-11 results on october 30, 2010"".",19-Oct-2010 12:32:00,2010-10-19 12:32:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma01_pr_19102010.zip,19-10-2010,206.6999969482422,206.6999969482422,202.1100006103516,204.78500366210932,187.39013671875,1176220,0.0,0.0,26-10-2010,0
705,SUNPHARMA,Sun Pharmaceutical Industries Limited,notice of postal ballot,sun pharmaceuticals industries limited has informed the exchange that following resolutions are proposed to be passed by postal ballot: (1) ordinary resolution for sub-division of equity shares of the company from face value rs.5/- each to face value re.1/- each. and consequent alteration of the memorandum of association. (2) special resolution for alteration of the articles of association consequent to the sub-division of the shares of the company from face value rs.5/- each to face re.1 each.,05-Oct-2010 18:03:00,2010-10-05 18:03:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharmaceutical_POB_05102010.ZIP,05-10-2010,208.44000244140625,208.44000244140625,205.1100006103516,206.1000061035156,188.59344482421875,1479130,0.0,0.0,12-10-2010,0
706,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated october 01, 2010, titled ""sun pharma announces usfda tentative approval for generic stalevo(r)"".",01-Oct-2010 16:41:00,2010-10-01 16:41:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_01102010.zip,01-10-2010,202.3000030517578,204.8999938964844,201.0,203.03500366210932,185.7887725830078,1504270,0.0,0.0,08-10-2010,0
707,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 29, 2010, titled ""sun pharma announces usfda tentative approval for generic crestor(r)"".",30-Sep-2010 08:31:00,2010-09-30 08:31:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_30092010.zip,30-09-2010,199.6000061035156,203.4750061035156,199.6000061035156,202.0500030517578,184.887435913086,3902690,0.0,0.0,07-10-2010,0
708,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 29, 2010, titled ""sun pharma announces expiration of subsequent offering period"".",29-Sep-2010 18:30:00,2010-09-29 18:30:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_pr_29092010.zip,29-09-2010,197.5,201.5,197.5,200.06500244140625,183.0710601806641,3386350,0.0,0.0,06-10-2010,0
709,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 28, 2010, titled ""sun pharma announces usfda tentative approval for generic rilutek"".",28-Sep-2010 15:10:00,2010-09-28 15:10:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_28092010.zip,28-09-2010,193.3999938964844,197.3999938964844,193.3999938964844,197.0050048828125,180.2709808349609,1674770,0.0,0.0,05-10-2010,0
710,SUNPHARMA,Sun Pharmaceutical Industries Limited,proceedings of annual general meeting,"sun pharmaceuticals industries limited has submitted to the exchange a copy of proceedings of the annual general meeting of the company held on september 24, 2010.",24-Sep-2010 13:03:00,2010-09-24 13:03:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PROAGM_24092010.ZIP,24-09-2010,189.9949951171875,194.0,188.1000061035156,192.1199951171875,175.80093383789062,2768870,0.0,0.0,01-10-2010,1
711,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 21, 2010, titled ""sun pharma acquires controlling stake in taro"".",22-Sep-2010 08:38:00,2010-09-22 08:38:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_22092010.zip,22-09-2010,194.8999938964844,198.375,191.47000122070312,192.1750030517578,175.85125732421875,4357790,0.0,0.0,29-09-2010,0
712,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 15, 2010, titled ""sun pharmaceutical announces expiration of offer for taro"".",15-Sep-2010 11:04:00,2010-09-15 11:04:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR_15092010.ZIP,15-09-2010,174.85000610351562,181.2350006103516,174.5050048828125,180.58999633789065,165.2503204345703,3631770,0.0,0.0,22-09-2010,1
713,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated september 07, 2010, titled ""supreme court of israel rules in favor of sun pharma"".",08-Sep-2010 09:05:00,2010-09-08 09:05:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_08092010.zip,08-09-2010,174.0,184.8000030517578,174.0,175.38499450683594,159.22923278808594,10281660,0.0,0.0,16-09-2010,0
714,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 31, 2010, titled ""sun pharma announces usfda approval for generic strattera (r) capsules"".",01-Sep-2010 09:19:00,2010-09-01 09:19:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_01092010.zip,01-09-2010,175.0,176.1999969482422,174.0,175.05499267578125,158.9296112060547,1677640,0.0,0.0,08-09-2010,0
715,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange  regarding a press release dated august 31, 2010 titled ""sun pharma subsidiary receives warning letter from usfda"".",01-Sep-2010 09:16:00,2010-09-01 09:16:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_31082010.zip,01-09-2010,175.0,176.1999969482422,174.0,175.05499267578125,158.9296112060547,1677640,0.0,0.0,08-09-2010,0
716,SUNPHARMA,Sun Pharmaceutical Industries Limited,revised press release,"sun pharmaceuticals industries limited has informed to the exchange regarding a revised press release dated august 19, 2010 titled ""sun pharma announces usfda approval for generic venlafaxine extended release tablets"".",19-Aug-2010 10:23:00,2010-08-19 10:23:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_REVISEDPR_19082010.zip,19-08-2010,178.47999572753906,180.8999938964844,176.01499938964844,179.05499267578125,162.5612030029297,1946970,0.0,0.0,26-08-2010,0
717,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated august 19, 2010 titled ""sun pharma announces usfda approval for generic venlafaxine extended release tablets"".",19-Aug-2010 09:15:00,2010-08-19 09:15:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_19082010.zip,19-08-2010,178.47999572753906,180.8999938964844,176.01499938964844,179.05499267578125,162.5612030029297,1946970,0.0,0.0,26-08-2010,0
718,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 29, 2010 titled ""us appeals court rules gemzar patent invalid"".",29-Jul-2010 08:53:00,2010-07-29 08:53:00,-,-,https://nsearchives.nseindia.com/corporate/sunphara_pr_29072010.ZIP,29-07-2010,181.0,184.0,176.47000122070312,177.97500610351562,161.58065795898438,3540910,0.0,0.0,05-08-2010,0
719,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 28, 2010 titled ""sun pharma reports strong performance in q1fy11; sales 1400 crores, up 78%, net profit 564 crores, up 244%"".",28-Jul-2010 14:45:00,2010-07-28 14:45:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_PR1_27072010.zip,28-07-2010,177.9949951171875,181.3600006103516,177.6999969482422,180.7400054931641,164.09097290039062,4418560,0.0,0.0,04-08-2010,0
720,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding the press release dated july 17, 2010 titled ""sun pharma: an update on generic protonix(r) litigation"".",19-Jul-2010 09:34:00,2010-07-19 09:34:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_19072010.zip,19-07-2010,173.3000030517578,173.3000030517578,169.72999572753906,171.97999572753906,156.13787841796875,3730250,0.0,0.0,26-07-2010,0
721,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 16, 2010 titled ""sun pharma announces usfda approval for generic flomax(r)"".",16-Jul-2010 13:24:00,2010-07-16 13:24:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr01_16072010.zip,16-07-2010,175.8699951171875,175.9550018310547,173.01499938964844,174.02499389648438,157.99452209472656,1936080,0.0,0.0,23-07-2010,0
722,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 15, 2010 titled ""u.s. district court rules in favor of sun pharmaceutical, dismisses all of taro's claims"".",15-Jul-2010 12:03:00,2010-07-15 12:03:00,-,-,https://nsearchives.nseindia.com/corporate/sun_pr_15072010.ZIP,15-07-2010,174.43499755859375,178.0,173.0,174.7949981689453,158.69357299804688,3518620,0.0,0.0,22-07-2010,0
723,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 13, 2010 titled ""sun pharma to announce first quarter 2010-11 results on july 28, 2010"".",13-Jul-2010 15:34:00,2010-07-13 15:34:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_13072010.zip,13-07-2010,174.0,175.6999969482422,172.7550048828125,174.1649932861328,158.1216278076172,1605890,0.0,0.0,20-07-2010,0
724,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated july 01, 2010, titled ""sun pharma announces launch of generic exelon (r) in us"".",02-Jul-2010 09:16:00,2010-07-02 09:16:00,-,-,https://nsearchives.nseindia.com/corporate/SUNPHARMA_pr_02072010.zip,02-07-2010,175.26499938964844,177.5800018310547,175.0,175.5800018310547,159.40625,1286100,0.0,0.0,09-07-2010,0
725,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 26, 2010, titled ""sun pharma: an update on generic eloxatin(r) injection"".",28-Jun-2010 09:08:00,2010-06-28 09:08:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma_PR_28062010.zip,28-06-2010,177.55499267578125,181.25,177.5,179.0749969482422,162.5792694091797,855650,0.0,0.0,05-07-2010,0
726,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 22, 2010, titled ""sun pharma settles litigation over generic stalevo and comtan"".",22-Jun-2010 11:05:00,2010-06-22 11:05:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma1_pr_22062010.zip,22-06-2010,177.3000030517578,178.38999938964844,174.9149932861328,176.1649932861328,159.93739318847656,1914680,0.0,0.0,29-06-2010,0
727,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 22, 2010, titled ""sun pharma announces usfda approval for generic optivar"".",22-Jun-2010 10:33:00,2010-06-22 10:33:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_22062010.zip,22-06-2010,177.3000030517578,178.38999938964844,174.9149932861328,176.1649932861328,159.93739318847656,1914680,0.0,0.0,29-06-2010,0
728,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 18, 2010, titled ""sun pharma announces usfda approval for generic xanax ﾮ tablets"".",18-Jun-2010 12:27:00,2010-06-18 12:27:00,-,-,https://nsearchives.nseindia.com/corporate/SunPharma_PR_18062010.zip,18-06-2010,170.1999969482422,172.18499755859375,168.8000030517578,171.3350067138672,155.55227661132812,1151500,0.0,0.0,25-06-2010,0
729,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated june 17, 2010 , titled ""sun pharma announces usfda approval for generic keppra (r) injection"".",17-Jun-2010 12:34:00,2010-06-17 12:34:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_17062010.zip,17-06-2010,170.58999633789062,172.0,168.5,169.875,154.226806640625,1508370,0.0,0.0,24-06-2010,1
730,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 24, 2010, titled ""sun pharma reports 2009-10 financials, net sales rs.4103 crores, net profit rs.1351 crores, r&d spend rs.247 crores"".",24-May-2010 15:08:00,2010-05-24 15:08:00,-,-,https://nsearchives.nseindia.com/corporate/Sunpharma01_PR_24052010.zip,24-05-2010,155.14999389648438,156.5,152.0,154.82000732421875,140.55860900878906,3036590,0.0,0.0,31-05-2010,1
731,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 17, 2010, titled ""sun pharma to announce q4fy10 results on may 24, 2010"".  ",17-May-2010 13:24:00,2010-05-17 13:24:00,-,-,https://nsearchives.nseindia.com/corporate/sunpharma_pr_17052010.zip,17-05-2010,158.19000244140625,158.89999389648438,155.02999877929688,158.05499267578125,143.49560546875,1271080,0.0,0.0,24-05-2010,0
732,SUNPHARMA,Sun Pharmaceutical Industries Limited,press release,"sun pharmaceuticals industries limited has informed the exchange regarding a press release dated may 06, 2010, titled "" sun pharma announces usfda approval for generic namendaﾮ tablets"". a copy of the press release shall be available on the nse website (http://www.nseindia.com) under: corporates > latest announcements and on the extranet server (/common/corporate announcements).",06-May-2010 19:17:00,2010-05-06 19:17:00,-,-,https://nsearchives.nseindia.com/corporate/SUN_PR01_06052010.zip,06-05-2010,152.89999389648438,156.89999389648438,151.60000610351562,156.02499389648438,141.65257263183594,4462350,0.0,0.0,13-05-2010,0
